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ABSTRACT 
 
Peripheral arterial function is impaired with age, increasing the risk of cardiovascular 
disease. One therapeutic modality for improving arterial function in aged arteries is aerobic 
exercise; however, the signals associated with exercise that lead to improved arterial function are 
not fully understood. The aim of the research in this dissertation is to determine the importance 
of hemodynamic changes associated with aerobic exercise (increased intraluminal pressure and 
shear stress) which may serve as mechanical signals to promote healthy vascular endothelial and 
smooth muscle function in aged arteries. We hypothesized that a short-duration increase in 
intraluminal pressure would: 1) improve nitric oxide (NO)-mediated endothelium-dependent 
dilation in aged soleus muscle feed arteries (SFA);  2) improve vasoconstrictor responses in aged 
SFA via the Rho pathway; 3) improve vascular smooth muscle contractility in aged denuded 
(endothelium removed) SFA through the Rho pathway; and, 4) in combination with increased 
shear stress, induce greater improvements of endothelium-dependent dilation than a short-
duration increase in pressure alone. SFA from young (4 mo) and old (24 mo) Fischer 344 rats 
were isolated and cannulated. Intact SFA or denuded (endothelium removed) SFA were exposed 
to increased intraluminal pressure for 1 h before assessment of vasodilator or vasoconstrictor 
function.  The results from these experiments demonstrated that exposure to a short-duration 
increase in pressure, within a range believed to be present in SFA during exercise 1) improved 
NO-mediated, endothelium-dependent vasodilator responses in aged SFA; 2) improved 
vasoconstrictor responses in aged intact SFA via the Rho pathway; 3) impaired vasoconstrictor 
responses in aged denuded SFA; and, 4) did not interact with increased shear stress to produce 
greater improvements in endothelium-dependent dilation than pressure alone. Collectively, these 
data indicate that a short-duration increase in intraluminal pressure improves age-impaired 
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arterial function and suggests that increased intraluminal pressure is one mechanical signal 
associated with aerobic exercise which promotes healthy endothelial and smooth muscle 
function in aged arteries. 
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CHAPTER I  
INTRODUCTION 
1.1 Introduction 
Cardiovascular Disease 
One of the most devastating health related phenomena of the past century is the rampant 
emergence of cardiovascular disease as a primary cause of death
1
. Cardiovascular disease, 
manifested by an impairment of the function of the heart and/or blood vessels, occurs due to a 
variety of causes. Notably, the bursting, occlusion, or dysfunction of blood vessels may cause a 
reduction or elimination of blood flow to target tissues. Without the ability to adequately deliver 
O2 and nutrients, and to remove waste products, the target tissue will become hypoxic and 
ultimately necrotic. 
Cardiovascular disease is a debilitating ailment that reduces the patient’s quality of life, 
and is often fatal. One third of American deaths are the result of cardiovascular disease
2
, and 
Americans spend $315 billion annually in direct and indirect costs associated with the diagnosis 
and treatment of cardiovascular diseases, more than any other disease
2
. Though the death rate 
from cardiovascular disease has fallen in recent years, its incidence rate remains relatively 
unchanged
3
. To this end, it is important to note that the suffering from cardiovascular diseases 
reaches beyond the individual patient. 
When a patient suffers from cardiovascular disease, it affects the patient’s entire family. 
A patient’s family will suffer from stress, anxiety, and worry.  Additionally, family members 
often serve as primary caregivers, a professional service worth an estimated $200 billion 
annually
4
. Caregiving adds an additional layer of stress to the family. Indeed, caregiving itself 
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serves as a research model for chronic stress
5
 and can lead to impaired psychological and 
physical health of the caregiver
6
. Therefore, identifying ways to prevent and treat cardiovascular 
disease is a research priority. 
Vascular Anatomy 
Arteries are composed of three distinct layers of cells. The fatty/connective tissue layer, 
the tunica adventitia, is the outer most layer. The tunica adventitia anchors the vessel to its 
surrounding tissue. The vascular smooth muscle layer, the tunica media, consists of layers of 
concentric vascular smooth muscle cells that wrap around the vessel and regulate the diameter of 
the blood vessel. The third layer is referred to as the tunica intima and is comprised of a single 
layer of endothelial cells. The endothelium lines the inner most portion of the artery, separating 
the vessel lumen from the surrounding vascular smooth muscle. Originally perceived solely as a 
permeability barrier, the works of Furchgott, Ignarro, and Murad demonstrated that the 
endothelium plays an integral role in regulating vascular smooth muscle cell (VSMC) relaxation 
via the signaling molecule endothelium-derived relaxing factor (EDRF), now known to be nitric 
oxide (NO)
7-9
. To date, there are three known cell signaling pathways that promote endothelium-
dependent dilation: NO, endothelium-derived hyperpolarizing factor (EDHF), and prostacyclin 
(PGI2). 
Aging 
An impairment of an artery’s endothelial layer to signal vascular smooth muscle 
relaxation, or endothelial dysfunction, occurs with age and is an independent risk factor for 
cardiovascular disease. Though relatively well preserved the first 40-50 years of life, endothelial 
function, as measured by flow-mediated dilation, declines rapidly beginning in the early 40s 
(men) and early 50s (women)
10
. While aging does not result in reduced skeletal muscle blood 
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flow at rest, the ability to increase muscle blood flow during exercise is impaired with age, 
which is believed to contribute to exercise intolerance in the elderly 
11,12
. 
In addition, the ability to direct blood flow to actively contracting muscle fibers is 
impaired with age. Specifically, Musch et al. documented an age-associated redistribution of 
blood flow away from highly oxidative muscle fibers and toward the more fatigable, less 
oxidative muscle fibers during exercise
13
. Importantly, Muller-Delp et al. reported that 
endothelium-dependent dilation to acetylcholine (ACh) was impaired in first-order arterioles of 
the oxidative soleus muscle but not in the first-order arterioles of the gastrocnemius muscle
14
. 
Selective impairment of endothelial function in highly oxidative muscles was also reported by 
Woodman et al, who documented attenuated endothelium-dependent vasodilator responses in the 
soleus muscle feed artery, but not in the gastrocnemius muscle feed artery
15
. Thus, in addition to 
being a risk factor for cardiovascular disease, the decrement in endothelial function is believed to 
contribute to an impaired muscle blood flow to actively contracting skeletal muscle and 
decreased exercise tolerance in the elderly
16
. 
The mechanisms accounting for the age-induced decline in endothelial function are not 
fully understood but are believed to be due, in large part, to a decrease in NO bioavailability 
17
, 
through an impairment in PI3K/AKT signaling
18
. NO bioavailability is determined by the 
balance between NO production and NO degradation.  The primary mechanism of NO 
degradation is through its interaction with superoxide (O2
-
). NO reacts readily with O2
-
 to 
produce peroxynitrite, thereby degrading NO and decreasing NO bioavailability. O2
-
 is produced 
as a by-product of cellular metabolism through proteins like NAD(P)H oxidase and xanthine 
oxidase. Trott et al. showed previously that  O2
-  
produced by NAD(P)H oxidase contributes to 
impaired NO bioavailability in aged rats
19
. Elevated peroxynitrite formation is a by-product of 
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O2
- 
and NO reactions and has been documented in the aorta of aged rats. Perhaps as a 
compensatory mechanism to increased O2
- 
 production, in an attempt to increase NO 
bioavailability, the aorta of aged rats have shown a sevenfold higher eNOS activity
20
. 
Importantly, the NO producing protein, eNOS, may become uncoupled and produce O2
-
, 
contributing to the elevated O2
-
 and subsequent decreased NO bioavailability.  To produce NO, 
eNOS requires the co-factor tetrahydrobiopterin (BH4). In its absence, the eNOS protein 
becomes uncoupled and produces O2
-
, exacerbating the degradation of NO and reducing the NO 
available to promote VSMC relaxation. Sindler et al. reported that BH4 concentrations decrease 
with age and are restored following exercise training
21
. These data indicate that the age-related 
decline in NO bioavailibity is associated with curtailed production and enhanced degradation of 
NO. 
Exercise 
Physical inactivity is an independent risk factor for cardiovascular disease
22
, and is 
believed to be responsible for 12%
23
 of cardiovascular diseases. Furthermore, physical activity, 
like endothelial function, declines with age 
24
. Importantly, participation in regular physical 
activity can improve or even reverse age-induced endothelial dysfunction
25,26
. DeSouza and 
Seals measured forearm blood flow (FBF) responses to ACh and SNP in young and old subjects. 
They noted a 25% reduction in the increase of FBF in response to ACh in aged, sedentary men 
compared to young, sedentary men, indicating impaired endothelium-dependent dilation. 
Furthermore, they showed no between group differences in the FBF response to the 
endothelium-independent dilator SNP, an indicator of vascular smooth muscle function. The 
age-related decrement in endothelial function was not present in chronically, endurance trained 
older men
26
. Additionally, age-impaired endothelial function was ameliorated following 
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completion of an aerobic exercise training program. Thus, De Souza et al. concluded that 
endothelial function is maintained in age-matched competitive runners and that a short-duration 
aerobic exercise program can improve endothelial function in aged individuals
26
, reducing an 
important risk factor for cardiovascular disease
27
. 
Though the signals associated with exercise that lead to improved endothelial function 
are unclear, DeSouza and others have postulated that the endothelial improvements may be due, 
at least in part, to mechanical forces experienced by the endothelial layer during individual bouts 
of exercise. Specifically, short-duration increases in intraluminal pressure and/or shear stress 
associated with exercise may be responsible for the promotion of a healthy endothelial 
phenotype
26,28-31
. 
The mechanism accounting for the beneficial effect of exercise on endothelial function is 
not fully understood but it is believed to be due, in large part, to enhanced NO signaling 
25
, with 
improvements in endothelial function observable even after a single bout of aerobic exercise 
32
.  
Using an isolated cannulated artery preparation, Trott et al. showed that a moderate-aerobic 
exercise training program restored endothelium-dependent, ACh-induced dilation of aged rodent 
SFAs to the levels of young rodent SFAs, and that this benefit was mediated by improvements in 
NO bioavailibity
25
. The signals associated with exercise that lead to an improvement in NO-
mediated endothelial function have not yet been fully defined; however, increases in intraluminal 
pressure and intraluminal shear stress, changes in the hemodynamic forces experienced by the 
vasculature during exercise, are potential signals responsible for improvement in endothelial 
function 
31
. 
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1.2 Endothelial Function  
Mechanisms of Endothelium-Dependent Vasodilation 
The vascular endothelium elicits relaxation of surrounding smooth muscle via three 
different cell signaling pathways: PGI2, EDHF, and NO. The production of PGI2 in the 
endothelial cell begins with the phospholipids of the plasmalemma
33
. These phospholipids are 
first converted to arachadonic acid (AA) by the enzyme phospholipase A2. Subsequent 
modification by the enzyme cyclooxygenase (COX) converts AA into prostaglandin H2 (PGH2). 
Lastly, PGH2 is converted into PGI2 by prostacyclin synthase. PGI2 is then free to diffuse across 
the plasma membrane of the endothelial cell and stimulate a Gs protein receptor on the vascular 
smooth muscle cell
33
. 
EDHF is a term that refers to several vasoactive molecules that can hyperpolarize 
vascular smooth muscle cells and promote vasorelaxation. Although much less is known about 
EDHFs, they are thought to be derived, in part, from arachidonic acid in a reaction catalyzed by 
Cytochrome P450
34
. The epoxide, 11,12-epoxyeicosatrienoic acid (11,12-EET) has been 
suggested to be a Cytochrome P450-derived EDHF metabolite
34,35
. Fisslthaler demonstrated 
EDHF-mediated dilation following enhanced formation of 11,12-EET in coronary arteries
34
.  
Alternatively, Sindler et al. showed that H2O2, the byproduct of O2
-
 scavenging by SOD, is an 
important vasodilator in skeletal muscle arterioles
21
, and has been demonstrated to be an 
important  contributor to flow-induced dilation in coronary arterioles
36
. Though the mechanism 
of action has not been fully elucidated, it is believed that EDHFs promote vasorelaxation via the 
hyperpolarization of smooth muscle cells through the reduction of intracellular Ca
2+
 and the 
opening of VSMC K
+
 channels
37,38
. 
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Nitric oxide is produced by a reaction catalyzed by the eNOS protein in the endothelial 
cell. eNOS is regulated by a Ca
2+
/calmodulin-dependent cycle with caveolin
39
, in which, eNOS 
remains inactive while attached to the golgi apparatus, along with caveolin-1 and a polmytoyl 
group. Once eNOS is polmytoylated, myristoylated, and transferred to a caveolus with caveolin-
1, eNOS and caveolin-1 become incorporated into the plasmalemma. Phosphorylation of eNOS 
by Akt releases eNOS from the plasmalemma into the cytosol. Concomitant increases in Ca
2+
 are 
promoted by IP3 stimulation of calcium channels on the sarcoplasmic reticulum.  Ca
2+
 associates 
with calmodulin, and further interacts with eNOS, thus activating the protein
33,39
. eNOS 
produces NO as long as it has the substrate, L-arginine, and the co-factor, BH4. eNOS is 
deactivated by dephosphorylation and the removal of intracellular calcium. eNOS becomes re-
polmytoylated and reattached to the golgi apparatus, completing the cycle. Once NO is 
produced, it is free to diffuse across the plasma membrane into the VSMC and stimulate 
vasodilation
33
. 
Endothelium-dependent dilation can be stimulated by chemical ligands or by shear 
stress. Shear stress is the mechanical force experienced by endothelial cells as blood flows across 
the surface of the endothelium. The plasmalemma of the endothelium is disturbed by shear stress 
which prompts the influx of Ca
2+
 into the endothelial cell, where it binds to calmodulin and 
associates with eNOS. The association of calmodulin with eNOS is enhanced by heat shock 
protein 90 (Hsp90), which facilitates the production of NO by eNOS
40-42
. Additionally, the 
vascular endothelial growth factor (VEGF) receptor is sensitive to shear stress and can activate 
PI3K and subsequently Akt. Akt phosphorylates and activates eNOS along with Ca
2+
/calmodulin 
to produce NO
33
. 
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One ligand that promotes endothelium-dependent vasodilation is ACh. It is thought that 
ACh released at the myoneural junction can “spillover” and stimulate the M2 receptor on the 
endothelium. The M2 receptor is associated with a g-protein-coupled receptor and activates the 
PI3K/Akt pathway to promote NO formation and vascular smooth muscle relaxation
33
. 
Any impairment in endothelium-dependent dilation, regardless of the mechanism of 
impairment, is classified as endothelial dysfunction. Endothelial dysfunction is an independent 
risk factor for cardiovascular disease and is therefore an important research target for the 
treatment and prevention of cardiovascular disease
43-48
. 
Exercise and NO-Dependent Endothelial Function 
In young, healthy individuals, aerobic exercise training increases maximal cardiac 
output, which is directed primarily to the actively contracting skeletal muscle during a bout of 
exercise
49
. Exercise also has a beneficial effect on the NO pathway, which may contribute to 
enhanced muscle blood flow and may act to preserve healthy endothelial function with age. 
Laughlin et al., using miniature swine, showed that eNOS protein content in the arterial network 
is increased differentially throughout the vascular tree following completion of 4-5 months of 
combined sprinting and endurance exercise training
50
. Interestingly, Laughlin reported variable 
increases in eNOS protein content in the coronary resistance arteries and arterioles, but no 
changes in eNOS protein content of the coronary conduit arteries in fully trained animals. 
Laughlin suggested that the differences in local shear stress and intraluminal pressures 
experienced by the different arteries and arterioles may be responsible for the differential 
changes in eNOS protein content
50
. The increase in eNOS protein content is consistent with the 
demonstrated increase in eNOS mRNA
51
 and improved NO-mediated endothelium-dependent 
dilation documented by exercise training studies
52,53
. Along with increases in eNOS mRNA and 
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protein content, the O2
- 
scavenger, Cu/Zn SOD is increased following exercise training, thus 
promoting a decrease in oxidative stress and an increase in NO bioavailibity
54
. Furthermore, 
Haram and colleagues demonstrated that a single bout of exercise improves NO-dependent 
vasodilation for up to 24 h, and that chronic exercise training extends these NO-dependent 
benefits
32
. These adaptations in NO-dependent vasodilation following exercise training likely 
contribute to the functional improvements in aged endothelium. 
Exercise and Age-Induced Endothelial Dysfunction 
Aerobic exercise has been shown to improve or restore endothelial function in aged 
humans and animals. DeSouza et al. measured ACh-induced FBF responses in young, aged, and 
chronically trained aged individuals and showed that age-related decrements in endothelium-
dependent FBF responses of the aged group were absent when compared to chronically trained, 
aged individuals
26
.  Other work by Taddei et al. attributed the beneficial effect of exercise on 
endothelial function to improvements in NO bioavailability
55
. Additionally, Spier et al. showed 
increased eNOS mRNA and protein content in aged, rodent skeletal muscle arterioles following 
an exercise training program
56
 and further showed that age-induced impairments of flow-induced 
dilation are mitigated with exercise, primarily through the NO pathway
57
. Furthermore, exercise 
preserves mechanisms responsible for preventing degradation of NO by oxidative stress in aged 
subjects
58,59
.  Trott et al. extended these findings by showing that a 12 week moderate, aerobic 
exercise program improved NO-mediated, endothelium-dependent vasodilation and increased 
the extracellular superoxide dismutase (SOD) protein content in the SFA of aged rats
25
. 
Regulation of Endothelial Cell Phenotype by Shear Stress 
The endothelium is a dynamic layer of cells, which responds to its local environment. 
Blood flow is pulsatile, increasing during systole and decreasing during diastole.  The velocity of 
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blood flow is a vector quantity defined by the speed and direction of blood flow. Shear stress 
experienced by the vascular endothelium is determined by the viscosity, volumetric flow rate, 
and vessel radius relationship (τ = 4ηQ/πr3): where η refers to the viscosity, Q to the volumetric 
flow rate, and r to the vessel radius
29
. Blood is a non-Newtonian fluid composed primarily of a 
mixture of erythrocytes, lipoproteins, proteins, and water. The viscosity of blood is not constant, 
but is often cited as 4 times that of water, or 4 centipoise, and can change with low flow rates 
and in smaller branch order arterioles and capillaries
60
.  The volumetric flow rate is a measure of 
the volume of blood flowing through an area and is affected by the contractile state of the heart 
and by its location in the circulatory system
60
.  The volume of blood that the vessel can accept at 
any given time is determined by the radius of the blood vessel. 
Blood flowing through a vessel lumen and under its Reynolds number (Re) will adopt a 
laminar flow pattern or layered, cylindrical sheets, of linear, non-mixing blood flow. The 
Reynolds number is an indication of the blood’s inertial force to viscous force ratio. As the 
velocity of blood flow increases, so do the inertial and viscous forces. The inertial forces 
increase faster than the viscous force. When the inertial forces surpass the viscous force, laminar 
flow will become turbulent
61
. Laminar flow is the condition where the blood nearest the 
endothelial layer of the vessel experiences frictional forces, or drag. This drag is greatest along 
the tunica intima and weakest at the radial center, creating a force characteristic that increases in 
magnitude from the radial center of the vessel lumen.  Turbulent flow is a departure from the 
layered, non-mixing flow patterns and characterized as swirling and chaotic, with vortices or 
eddies that can be stationary or propagated through the blood vessel
62
.  Endothelial cells modify 
their morphology and orientation to align with the direction of blood flow, in part through 
modification of their cytoskeletal organization and in the absence of endothelial cell division, 
indicating the synthesis of proteins like f-actin and stress fiber proteins
63-65
.  Along with 
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cytoskeletal modifications, shear stress has also been documented to regulate the endothelial 
genes for COX-2, MnSOD, and eNOS
66
. 
The force of blood moving along the tunica intima creates shear stress on the endothelial 
cells. Rodbard was among the first to suggest endothelial vasomotor regulation by shear 
stress
67,68
.  Subsequent studies using endothelial cell cultures demonstrated that eNOS, COX-2, 
MnSOD , and Cu/Zn SOD mRNA are up-regulated following exposure to laminar shear stress, 
while the mRNA for the vasoconstrictor gene, endothelin, is down-regulated and the 
constitutively expressed COX-1 protein remains unchanged
66,69-73
. These data suggest the 
potential for improved endothelium-dependent vasodilation following exposure to laminar shear 
stress. Further cell culture work by Uematsu and Harrison demonstrated that increased shear 
stress of up to 15 dyn/cm
2
 for as little as 3 h increased eNOS mRNA expression in a 
concentration-dependent manner
74
.  The initial NO release in response to shear stress, in cultured 
cells, has been shown to be Ca
2+
-calmodulin-dependent
75
, while the NO released during 
sustained exposures to shear stress appears to occur via Ca
2+
-independent mechanisms, possibly 
through serine/threonine and tyrosine kinases
75-80
. 
Modulation of endothelial phenotype by shear stress was first documented at the tissue 
level by Fry in 1968
62
.  Fry reported that exposure of dog thoracic aorta to high levels of shear 
stress, for as little as 1 h, created endothelial cytoplasmic swelling, deformation, and 
disintegration of the endothelium. However, it is important to note that the increased blood flow 
produced by the intra-aortic device used by Fry exposed the thoracic aorta to turbulent flow 
patterns
62
. Subsequent experiments revealed that laminar shear stress exerted positive 
modifications of the vasculature through increases in NO production, vascular remodeling, and 
by promoting the formation of new blood vessels
81
. In isolated coronary arterioles exposed to a 
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high shear stress with laminar flow, Woodman et al. showed improved NO-dependent 
vasodilation, an increased eNOS mRNA content and an increased Cu/Zn SOD mRNA 
content
29,82
. Maximal flow-mediated dilation is achieved at around 6 dyn/cm
2
 in rat soleus feed 
arteries
83
. The vasodilation to shear stress in isolated vessels is NO-dependent, and  mediated 
only in part by changes in intracellular Ca
2+ 84-86 
and  is largely attributed to Ca
2+
-independent 
mechanisms
86
. 
While exposure to shear stress can positively benefit vascular function, too much or too 
little shear stress can be detrimental. Too little shear stress can negatively modulate endothelial 
cell phenotype, as in the case of atherosclerosis, where atherosclerotic lesions occur 
preferentially in areas of low shear-stress, non-laminar flow regions near branch points and 
curves in the arteries
87,88
. Low shear stress and non-laminar flow generate a greater time in 
contact of plaque forming particles with the vessel wall, while high shear stress and laminar flow 
promotes the rapid removal of those particles from an individual blood vessel area
87,89
. 
Furthermore, exposure to low shear stress (1.8 dyn/cm
2
) or a short-duration exposure to 10 
dyn/cm
2
  promotes the release of the vasoconstrictor endothelin-1
90
. Although low shear stress 
has been associated with disease states like atherosclerosis, in the right magnitude and duration it 
remains an important mechanical signal for healthy vascular function and is likely a key 
component to the exercise-induced improvements in the vascular function of the elderly. 
Regulation of Endothelial Cell Phenotype by Intraluminal Pressure 
Pressure within the vasculature fluctuates cyclically and is dependent on the contractile 
status of the heart. Blood pressure increases during systole and falls continuously through 
diastole.  Blood pressure may be increased chronically in disease states, like hypertension, or 
13 
 
may be acutely increased during physical activity to aid in the perfusion of exercising skeletal 
muscle
91-95
. 
Cell culture studies have revealed that endothelial cells are sensitive to changes in 
pressure. When exposed to cyclic stretching, endothelial cells orient themselves to a position of 
least mechanical deformation and undergo a reorganization of actin filaments to produce parallel 
arrays of actin filaments
96
. Mechanical stress not only affects cellular structure, but has been 
shown to increase the release of the vasoconstrictor endothelin in cultured endothelial cells
97,98
. 
Furthermore, cell culture studies by Hishikawa et al. indicate that NAD(P)H-derived O2
-
 
production is increased following exposure to pulsatile stretch. Following 24 h of stretch, total 
cytosolic eNOS RNA and protein content are increased
99
 and the increase in O2
-
 is coupled with 
an increase in BH4-mediated NO synthesis, perhaps as a compensatory mechanism by which NO 
scavenges the O2
-
 free radical.
100
 
At the artery level, chronic exposure to elevated intraluminal pressure, as in 
hypertension, is associated with an increased peripheral vascular resistance
101
 and associated 
with a dysfunctional endothelial phenotype
102,103
. This hypertension-associated endothelial 
dysfunction is largely attributed to decreased NO bioavailability
102,104-107
. Similarly to 
Hishikawa’s cell culture studies, Gan et al. suggest that the mRNA of the vasoconstrictor 
endothelin is increased after 6 h of exposure to an increase intraluminal pressure; however, 
unlike Hishikawa’s cell culture studies, the mRNA of the vasodilator promoting protein eNOS, 
is increased after only 3 h of an increase in intraluminal pressure
108
.  Gan et al. further showed by 
immunohistochemical localization, a greater immunoreactivity of eNOS in umbilical veins 
perfused under high pressure than those perfused with low pressure
108
. A decrease in NO 
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bioavailibity, an increase in endothelium-derived O2
-
, and an impaired NO-dependent 
vasodilation have also been demonstrated in spontaneously hypertensive rats
109,110
. 
At the arterial level, long-term exposures to elevated intraluminal pressure, as in 
hypertension, can be detrimental to endothelial function. Taddei et al. characterized 
hypertension-associated endothelial dysfunction as a form of accelerated NO-mediated, age-
induced endothelial dysfunction, or premature aging
111
. Further studies by Taddei et al. 
concluded that regular physical activity serves to prevent age-induced endothelial dysfunction
55
. 
DeSouza et al. also showed that regular physical activity can prevent age-induced endothelial 
dysfunction, and that chronic physical activity can reverse age-induced endothelial 
dysfunction
26
. DeSouza and others have proposed that exercise-induced improvements in 
endothelial function are due, at least in part, to mechanical forces experienced during exercise, 
like increased intraluminal pressure or shear stress
26,28-31
. Additionally, Nelson et al. documented 
a decrease in the blood pressure of essential hypertensive patients following a regular exercise 
training program
112
. These data indicate that there are components of physical exercise, i.e. a 
transient increase in intraluminal pressure, that benefit NO-dependent dilation, while chronic 
elevations of intraluminal pressure are detrimental to NO-dependent dilation. Indeed, isolated 
cannulated artery experiments performed by Woodman et al. demonstrated improved 
endothelium-dependent dilation in aged arteries following exposure to a 4 h increased 
intraluminal pressure
30
. These data suggest that unlike the chronic elevations of intraluminal 
pressure in hypertension, a short-duration increase in intraluminal pressure, as experienced 
during an exercise bout, may be an important mechanical signal for the promotion of a healthy 
endothelium. 
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1.3 Vascular Smooth Muscle Cell (VSMC) Function 
Mechanisms of Vascular Smooth Muscle Relaxation 
Endothelial cells produce vasodilatory factors, but the vascular smooth muscle must 
respond appropriately to the vasodilator signal. EDHFs have been proposed to work through 
potassium channels, inhibiting calcium channels, and hyperpolarizing smooth muscle cells. Both 
PGI2 and NO have separate protein kinase pathways to induce vasorelaxation of the VSMC. NO 
diffuses through the smooth muscle plasmalemma and activates the enzyme guanylate cyclase to 
make cGMP from GTP. cGMP activates protein kinase G (PKG).  PGI2 stimulates a Gs protein 
that activates adenylate cyclase. Adenylate cyclase produces cAMP from ATP and subsequently 
activates protein kinase A (PKA). Both PKA and PKG inhibit the phosphorylation of the 
myosin/actin contractile elements, impair Ca
2+
 entry into the cell, promote Ca
2+
sequestering by 
the sarcoplasmic reticulum, and inhibit the Gq/IP3 pathway to relax the VSMC
33
. 
Myogenic Response 
Vascular smooth muscle cells respond dynamically to changes in intraluminal pressure.  
The myogenic response is classically defined as the constriction of a blood vessel in response to 
elevations in intravascular pressure
113
. The myogenic response was first proposed by W.M. 
Bayliss, in 1902, and later became a key stanchion of the auto-regulation of blood flow 
concept
113,114
. Though the mechanism has not been fully elucidated, vascular smooth muscle 
contraction following an increase in intraluminal pressure is believed to play an integral role in  
maintaining optimal sarcomere length
115,116
 and wall tension
117
.  It has been proposed that the 
greater excitation-contraction coupling achieved by the myogenic response is accomplished 
through membrane depolarization and enhanced Ca
2+
 permeability
118
 of stretch activated Ca
2+
 
channels
119,120
. 
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Vasoconstrictor Response of Vascular Smooth Muscle 
The most prominent vasoconstrictor mechanism in vascular smooth muscle is the 
stimulation of Gq protein and the formation of IP3. When an agonist such as norepinephrine, 
phenylephrine, endothelin, or IP3 diffuses into the cytosol, DAG will travel the plasma 
membrane. Both IP3 via phospholipase C (PLC) and DAG will increase Ca
2+
 influx through 
stimulation of the sarcoplasmic reticulum to release Ca
2+
. Once in the cytosol, Ca
2+
 associates 
with calmodulin and activates myosin light chain kinase, which phosphorylates myosin at the 20 
kDa residue and initiates contraction
121-123
. 
There is some evidence in the literature that suggests that IP3-induced contractions are 
transient, and that sustained contractions are mediated by DAG
124
. An IP3-independent source of 
DAG has been documented. Phosphatidylcholine (PC), in the plasma membrane, may be 
converted into DAG, by an independent PC specific PLC (PC-PLC). Additionally, PC may be 
converted into phosphatidic acid by phospholipase D, and subsequently converted into DAG
125
. 
DAG subsequently opens calcium channels and promotes phosphorylation of myosin light chain 
kinase at residues other than 20 kDa
122
. 
An additional mechanism of vasoconstriction is through voltage gated calcium channels 
in smooth muscle. When potassium leaves the cell, as in depolarization, or when the 
concentration of potassium outside the cell is elevated, the membrane potential is reduced and 
potassium-dependent and voltage-gated calcium channels open, allowing calcium to flow into 
the cell
121
. 
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Exercise and Aged-Vascular Smooth Muscle Cell Function 
Morphologically, aged vascular smooth muscle cells show an increased thickening and 
an invasion into the endothelial layer
126
. Functionally, the current dogma suggests that NO-
mediated vascular smooth muscle cell relaxation is preserved with age, which is well supported 
by exogenous NO donor studies
15,18,19,25,30,127
 and not altered with exercise training
25
. However, 
there is some evidence that the hormone stimulated relaxation response of VSMC, specifically  β 
adrenergic relaxation, is decreased with age
128
. 
Vascular smooth muscle cell constriction is altered with age; the age-effect is dependent 
on the location of the vessel and vasoconstriction may be enhanced or impaired with age
129-131
. 
Exercise training improves age-impaired myogenic constriction in soleus first order arterioles
129
. 
In aged gastrocnemius muscle first order arterioles, Donato et al. demonstrated an increased 
sensitivity of vascular smooth muscle to the vasoconstrictor ET-1, likely mediated by the ETa 
receptor. Furthermore, they showed that exercise training did not alter ET-1 vasoconstriction in 
these aged arterioles
132
.  Vascular smooth muscle cell production of the potent vasoconstrictor, 
Angiotensin II, is increased with age
133
. Griendling et al. reported that Ang II also increases 
NAD(P)H derived O2
-
 in cultured VSMC
134
.  An increased sensitivity to, or production of, 
vasoconstrictors coupled with impaired endothelium-dependent dilation, may lead to an 
increased peripheral vascular resistance, chronically increased intraluminal pressures, and 
ultimately to pathological hypertension
135
. 
In addition to increased production and sensitivity to vasoconstrictors, aging also 
disrupts proteins responsible for mechano-force transduction, providing a possible mechanism 
for age-impaired vasoconstriction.  RhoA is a protein that helps regulate vascular smooth muscle 
cell contraction by increasing the phosphorylation of myosin light chain proteins and by 
18 
 
strengthening agonist-induced contraction of the VSMC
136
. RhoA is stimulated by O2
-137,138
  and 
has been shown to increase with age
136,139
. 
Guanosine triphosphate bound RhoA (GTP-RhoA) is the active isoform of RhoA
140
.  
RhoA is activated from its inactive, cytosolic state upon fatty acyl-mediated assimilation into the 
plasma membrane
141
. By overexpressing RhoA in cultured NIH 3T3 cells, Kimura et al. showed 
increased phosphorylation of myosin light chain and the myosin binding subunit of myosin 
phosphatase, which promote smooth muscle contraction. These investigations proposed Rho-
associated kinase (ROK) as a mediator for RhoA-induced, Ca
2+
-dependent smooth muscle 
contraction
140
. 
RhoA also plays a critical role in enhancing the formation of actin and focal 
adhesions
142
. Focal adhesions are complex groups of proteins that serve as important regulators 
of the contractile actin fibers, and also transfer force from the cytoskeleton to the extracellular 
matrix
143
. RhoA is a potential target for improving age-impaired VSMC function. Aerobic 
exercise training has been shown to be successful in reducing RhoA gene expression 
144
, and has 
been suggested to inhibit the RhoA signaling pathway
145
. Taken together, these data indicate that 
there is a component of exercise that is responsible for maintaining healthy vascular smooth 
muscle function. 
Regulation of Vascular Smooth Muscle Cell Phenotype by Intraluminal Pressure 
One exercise-associated hemodynamic force experienced by vascular smooth muscle is 
an increase in intraluminal pressure. Using cell culture techniques, the morphological 
deformation caused by increased intraluminal pressure, is simulated by stretching cultured 
VSMC. Cyclic stretching of cultured VSMC reorganizes the cytoskeletal F-actin
146
, increases the 
number of focal adhesions
146
, and increases the vascular endothelial growth factor (VEGF) 
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mitogen
147
. Chronic exposure to elevated intraluminal pressure (i.e. hypertension) is detrimental 
and associated with elevated RhoA, increased RhoA activation
148
, VSMC hypertrophy, and 
increased vascular tone in resistance vessels
149
.  However, previous studies suggest that exposure 
to baseline pressure and mechanical stimulation is important for inhibiting cell 
proliferation
150,151
, preserving sensitivity to vasoconstrictors and contractile function
152
, and 
maintaining cell morphology
153,154
. Therefore, exposure to short-duration increases in 
intraluminal pressure during individual bouts of exercise may be an important mechanical signal 
for the maintenance of a healthy vascular smooth muscle function in aged arteries. 
1.4 Hypothesis and Specific Aims 
Hypothesis 
The general aim of the research in this dissertation is to determine the importance of 
intraluminal pressure and shear stress in regulating vascular endothelial and smooth muscle 
function in aged arteries. We hypothesized that short-duration increases in intraluminal pressure 
and shear stress promote healthy endothelial and smooth muscle cell function in aged arteries. 
Our hypothesis was tested by the following specific aims: 
Specific Aim 1 (SA1) 
Determined whether a short-duration increase in intraluminal pressure improved 
endothelium-dependent vasodilator responses in aged SFA.  We utilized an isolated artery 
preparation and immunoblot analysis to test the hypothesis that a short-duration (1 h) increase in 
intraluminal pressure, to mimic a time duration representative of an exercise bout, would 
attenuate age-induced impairments in endothelium-dependent dilation in SFA via the NO 
pathway. 
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Specific Aim 2 (SA2) 
Determined whether a short-duration increase in intraluminal pressure improved 
vascular smooth muscle cell constrictor responses in aged, intact SFA. We utilized an isolated 
artery preparation to test the hypothesis that a short-duration (1 h) increase in intraluminal 
pressure would attenuate age-induced impairments of vasoconstrictor responses in soleus muscle 
feed arteries via the Rho pathway. 
Specific Aim 3 (SA3) 
Determined whether a short-duration increase in intraluminal pressure would improve 
vascular smooth muscle contractility in aged, endothelium-denuded SFA. We utilized an isolated 
artery preparation to test the hypothesis that a short-duration (1 h) increase in intraluminal 
pressure would attenuate age-induced impairments of vascular smooth muscle contraction in 
denuded (endothelium removed) soleus muscle feed arteries via the Rho pathway. 
Specific Aim 4 (SA4) 
Determined whether intraluminal pressure and shear stress interact to produce greater 
improvements in endothelium-dependent vasodilator responses in aged SFA than increased 
intraluminal pressure alone. We utilized an isolated artery preparation and immunoblot analysis 
to test the hypothesis that increased intraluminal pressure and shear stress interact to produce 
greater improvements in endothelium-dependent dilation than pressure alone.  
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CHAPTER II 
ACUTE INCREASES IN INTRALUMINAL PRESSURE IMPROVE 
VASODILATOR RESPONSES IN AGED SOLEUS MUSCLE FEED ARTERIES*  
2.1 Introduction 
Endothelial function declines with age in humans and animals 
10,15,18,56,155,156
. The 
decrement in endothelial function is characterized, in part, by impaired nitric oxide (NO)-
mediated, endothelium-dependent dilation in conduit and resistance arteries 
15,55,56,155,156
. 
Endothelial dysfunction in conduit arteries is a risk factor for cardiovascular disease in older 
adults 
157,158
, whereas impaired endothelium-dependent dilation in resistance arteries may result 
in impaired exercise hyperemia and reduced exercise tolerance in the elderly 
11,13,157,159
. 
Aerobic exercise training improves endothelium-dependent vasodilator responses in 
aged arteries 
25,26,56,57
. Although the mechanism accounting for the beneficial effect of exercise 
training has not been fully elucidated, training-induced enhancement of NO bioavailability is 
believed to play an integral role 
21,25
 . 
Haram et al. 
32
 reported previously that NO-mediated endothelium-dependent 
vasodilation in rat aorta was improved following a single bout of exercise, and that enhanced 
endothelial function persisted for up to 48 h following the exercise bout. The signal(s) associated 
with exercise that leads to training-induced improvements in endothelial function is not known; 
however, it has been proposed that short-duration increases in arterial pressure, which occur  
*Reprinted with permission from Springer and the European Journal of Applied Physiology, Volume 114, 
(2014), Pages 2213-2221, “Acute increases in intraluminal pressure improve vasodilator responses in aged 
soleus muscle feed arteries,” by JW Seawright, MJ Luttrell, CR Woodman, Figures 1-8, Copyright by 
Springer-Verlag Berlin Heidelberg 2014; with kind permission from Springer Science and Business 
Media. 
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during individual bouts of exercise, may provide a mechanical signal leading to improved 
endothelial function 
26,30
. Specifically, short-duration mechanical stimulation of vascular 
endothelium during exercise, as a result of increased arterial pressure, may induce long-term 
changes in the capacity of endothelial cells to produce NO. This speculation is supported by 
previous studies indicating that treatment of isolated arteries with increased intraluminal pressure 
for 4 h, restored endothelium-dependent dilation in aged arteries to levels exhibited in young 
arteries 
30
. 
While the study by Woodman et al. revealed that exposure to increased intraluminal 
pressure improved endothelial function in aged arteries, the 4 h pressure stimulus used in their 
study was substantially longer than a typical bout of exercise 
30
. Therefore, it is not known 
whether exposure to an acute increase in intraluminal pressure, within a time frame 
representative of an exercise bout, improves endothelium-dependent dilation in aged arteries. In 
addition, no experiments were performed to determine how long the adaptation persisted after 
return to normal pressure. Therefore, the purpose of this study was to test the hypothesis that 
exposure to an acute increase in intraluminal pressure, for a time duration representative of an 
exercise bout (60 min), improves NO-mediated endothelium-dependent dilation in aged soleus 
muscle feed arteries (SFA).  In addition, we tested the hypothesis that improved endothelial 
function in aged arteries would persist after a 2 h recovery period at normal pressure.  SFA were 
studied, because they provide an active site of regulation of resistance to blood flow to the soleus 
muscle at rest and during exercise 
160
 and because an age-related decline in endothelium-
dependent dilation is well documented in these arteries
15,29,156
. 
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2.2 Methods 
Animals 
This study was approved by the Institutional Animal Care and Use Committee at Texas 
A&M University and conformed to the National Institutes of Health Guide for the Care and Use 
of Laboratory Animals. Male Fischer 344 rats (4 and 24 month) were obtained from the National 
Institute on Aging (NIA) and housed at the College of Veterinary Medicine’s Comparative 
Medicine Program Facility. Animals were housed under a 12:12-h light-dark cycle, and food and 
water were provided ad libitum.  The rats were examined daily by the Comparative Medicine 
Program’s veterinarians.  Fischer 344 rats were studied, in part, because of the absence of 
atherosclerosis and hypertension in this animal model 
161
. 
Isolation of Feed Arteries 
Soleus muscle feed arteries were isolated as described previously
15,19,25,30,156
. In brief, rats 
were anesthetized with an injection of pentobarbital sodium (60 mg/kg body wt. ip). The 
soleus/gastrocnemius/plantaris muscle complex from each hind limb was dissected out and 
placed in cold (4
 
ºC) MOPS-buffered physiological saline solution (PSS), composed of (in mM) 
145.0 NaCl, 4.7 KCl, 2.0 CaCl2, 1.17 MgSO4, 1.2 NaH2PO4, 5.0 glucose, 2.0 pyruvate, 0.02 
EDTA and 25.0 MOPS (pH 7.4). SFA were then transferred to a Lucite chamber containing 
MOPS-PSS for cannulation. 
Cannulation of Feed Arteries 
SFA were cannulated on both ends with resistance-matched glass micropipettes and 
secured with a single strand of surgical thread. Micropipettes were attached to pressure 
reservoirs filled with MOPS-PSS containing albumin (1g/100ml). All SFA were initially 
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pressurized to 60 cmH2O (1 mmHg = 1.36 cmH2O) and checked for leaks. When a SFA was 
determined to be leak free, intraluminal pressure was increased to 90 cmH2O or 130 cmH2O for 
60 min at 37 ºC. These pressures were selected to correspond to mean arterial pressures believed 
to be present in these arteries at rest and during exercise, respectively
160
. At the end of the 60 min 
pressure treatment, intraluminal pressure in the P130 SFA was lowered to 90 cm H2O, and SFA 
were allowed to develop spontaneous, stable tone for 10 minutes before assessment of 
vasodilator responses. 
Assessment of Vasodilation 
Procedures used to assess vasodilator responses in SFA have been published 
previously
15,30,162
. Briefly, endothelium-dependent, flow-induced dilation was assessed by 
establishing intraluminal flow in the SFA by raising and lowering the heights of the pressure 
reservoirs in equal but opposite directions while maintaining constant pressure at the midpoint of 
the artery
84
. Flow-induced dilation was assessed at pressure gradients of 0, 2, 4, 6, 8, 10, 15, 20, 
30 and 40 cmH2O, corresponding to flow rates of 0-62 µl/min
83
. Endothelium-dependent, 
acetylcholine (ACh)-induced dilation was assessed in SFA by adding increasing concentrations 
of ACh over the range of 10
-9
-10
-4
 M in whole log increments. Endothelium-independent dilation 
was assessed by adding increasing concentrations of sodium nitroprusside (SNP) over the range 
of 10
-9
-10
-4
 M in whole log increments.  The use of SNP to assess vascular smooth muscle 
responses to NO has been validated previously by Hirai et al
163
. After the SNP concentration 
response curve, SFA were incubated in Ca
2+
 free PSS for 60 min to assess maximal passive 
diameter. 
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Experimental Protocol 1: Effect of Acute High Pressure Treatment on Vasodilator Responses 
To test the hypothesis that treatment of aged SFA with an acute increase in intraluminal 
pressure attenuates or reverses age-induced impairments of endothelium-dependent dilation, 
SFA were pressurized for 60 min at 90 or 130 cmH2O to approximate mean arterial pressures 
believed to be present in these arteries at rest and during exercise, respectively
160
. The same 
pressures were used for young and old SFA since Musch et al reported previously that mean 
arterial pressure during submaximal exercise was similar in young and old rats
13
. At the end of 
the 60 min treatment period, intraluminal pressure in the P130 SFA was lowered to 90 cm H2O, 
and SFA were allowed to develop stable spontaneous tone for 10 minutes.  Endothelium-
dependent vasodilator function was assessed by measuring vasodilator responses to intraluminal 
flow or ACh.  Endothelium-independent vasodilator function was assessed by measuring 
vasodilator responses to SNP. 
Experimental Protocol 2: Role of Nitric Oxide 
On the basis of the results indicating that treatment of old SFA with high pressure 
improved endothelium-dependent vasodilator responses in the aged arteries, we completed an 
additional experiment to determine whether the beneficial effect of the high pressure treatment 
was mediated by NO. Specifically, old SFA were pressurized for 60 min at 90 or 130 cmH2O as 
described in protocol 1, and endothelium-dependent vasodilator responses to flow and ACh were 
assessed in the absence or presence of N
ω
-nitro-L-arginine (L-NNA; 300 μM) to inhibit nitric 
oxide synthase (NOS).  L-NNA was added to the vessel bath 20 min before the assessment of 
vasodilator responses and remained in the bath for the duration of the experiment. 
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Experimental Protocol 3: Recovery from Acute High Pressure Treatment 
To determine whether the beneficial effect of the acute high pressure treatment in the old 
SFA persisted following a recovery period at normal pressure, old SFA were pressurized for 60 
min at 90 or 130 cmH2O as described in experimental protocol 1. At the end of the 60 min 
pressure treatment, intraluminal pressure in the P130 SFA was lowered to 90 cmH2O for 2 h 
before assessment of vasodilator responses. 
Quantification of p-eNOS
ser1177 
and eNOS Protein Content 
Relative differences in p-eNOS
ser1177
 and total eNOS protein contents were assessed in 
SFA using immunoblot analysis as described previously in detail
50,164
. p-eNOS
ser1177 
was assessed 
using a monoclonal antibody (1:250, BD Biosciences catalog no. 612393).  Total eNOS was 
assessed using a monoclonal antibody (1:1,250, BD Biosciences catalog no. 610297) after the 
membrane was stripped using Restore Western Blot Stripping Buffer (Thermo).  Immunoblots 
were evaluated using enhanced chemiluminescence (ECL, Amersham) and densitometry using a 
LAS-4000 Luminescent Image Analyzer and Multi-Gauge Image Analysis Software (FUJIFILM 
Medical Systems).  Protein data were expressed as a ratio of p-eNOS
ser1177
-to-total eNOS. 
Statistical Analysis 
All data are presented as means ± SE. Between-group differences in body mass, 
maximal diameters, total eNOS, p-eNOS
ser1177
 and p-eNOS
ser1177
/eNOS protein ratios were 
assessed using Student’s t-test or one-way ANOVA where appropriate. Vasodilator response 
data were assessed as percent possible dilation calculated as [(Ddose – DB)/(DP
 – DB)] x 100 where 
Ddose is the measured diameter for a given dose/flow rate, DB is the baseline diameter before the 
dose response curve and DP is maximal passive diameter.  Two-way ANOVA with repeated 
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measures on one factor (flow rate or dose) was used to determine differences in vasodilator 
responses. Statistical significance was defined as P ≤ 0.05. 
2.3 Results 
Characteristics of Rats and SFA 
Body weights were significantly greater in old (430 ± 7 g) compared to young rats (353 
± 6 g). Maximal passive diameter was similar in SFA from old (179 ± 4 µm) and young (173 ± 5 
µm) rats. 
ACh-Induced Dilation 
ACh-induced vasodilator responses were significantly impaired in old P90 SFA relative 
to young P90 SFA (Fig. 2.1). Treatment of SFA with increased intraluminal pressure (130 
cmH20) for 60 min improved ACh-induced vasodilation in old (not young) SFA (Fig. 2.1).  
 
Figure 2.1. Effect of an acute increase in intraluminal pressure on acetylcholine (ACh)-
induced vasodilation in young and old soleus muscle feed arteries (SFA). SFA were 
pressurized to 90 (P90) or 130 (P130) cmH2O for 60 min.  At the end of the 60 min treatment 
period, intraluminal pressure in P130 SFA was lowered to 90 cmH2O and allowed to develop 
spontaneous stable tone for 10 minutes. ACh-induced dilation was then assessed in all SFA at an 
intraluminal pressure of 90 cmH2O. B is baseline diameter before the first dose of ACh. Values 
are mean ± SE; n = 10-20 rats/group. *Dose-response curve significantly different from all other 
curves, p ≤ 0.05. #Dose-response curve significantly different from young P90, p ≤ 0.05 
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In the presence of L-NNA, to inhibit NOS, ACh-induced vasodilator responses in Old 
P130 SFA were abolished (Fig. 2.2). In addition, the beneficial effect of pressure treatment on 
old P130 SFA was not present following the 2 h recovery period at normal pressure (Fig. 2.3). 
 
 
Figure 2.2. Role of nitric oxide (NO) in ACh-induced vasodilation in old SFA treated with 
an acute increase in intraluminal pressure. Old SFA were pressurized to 90 (P90) or 130 
(P130) cmH2O for 60 min. At the end of the 60 min treatment period, intraluminal pressure in 
P130 SFA was lowered to 90 cmH2O and allowed to develop spontaneous stable tone. 
Vasodilator responses were assessed in the absence or presence of N
ω
-nitro-L-arginine (L-NNA; 
300 µM), to inhibit NOS. B, baseline diameter before the first dose of ACh.  Values are mean ± 
SE; n = 7-19 rats/group. *Dose-response curve significantly different from all other curves, p ≤ 
0.05 
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Figure 2.3. Effect of an acute increase in intraluminal pressure on acetylcholine (ACh)-
induced vasodilation in old soleus muscle feed arteries following a 2 h recovery period at 
normal pressure.  Old SFA were pressurized at 90 (P90) or 130 (P130) cmH2O for 60 min. At 
the end of the 60 min treatment period, intraluminal pressure in the p130 SFA was lowered to 90 
cmH2O for 2 h before ACh-induced vasodilator responses were assessed. B, baseline diameter 
before the first dose of ACh. Values are mean ± SE; n = 7-19 rats/group. *Dose-response curve 
significantly different from Old p90, p ≤ 0.05 
 
Flow-Induced Dilation 
Flow-induced vasodilation was significantly impaired in old P90 SFA relative to young 
P90 SFA (Fig. 2.4). Treatment of young SFA with elevated pressure for 60 min did not alter 
flow-induced dilation (Fig. 2.4). Treatment of old SFA with increased pressure significantly 
improved flow-induced dilation (Fig. 2.4) such that flow-induced vasodilator responses in the 
old P130 arteries were significantly greater than old P90 arteries and were not different from 
young P90 SFA (Fig. 2.4).  
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Figure 2.4. Effect of an acute increase in intraluminal pressure on flow-induced 
vasodilation in young and old soleus muscle feed arteries. SFA were pressurized to 90 (P90) 
or 130 (P130) cmH2O for 60 min.  At the end of the 60 min treatment period, intraluminal 
pressure in P130 SFA was lowered to 90 cmH2O and allowed to develop spontaneous stable tone 
for 10 minutes. Flow-induced dilation was then assessed in all SFA at an intraluminal pressure of 
90 cmH2O. Values are mean ± SE; n = 10-20 rats/group. *Dose-response curve significantly 
different from old p130, p ≤ 0.05. #Dose-response curve significantly different from young p90,  
p ≤ 0.05 
 
In the presence of L-NNA, flow-induced vasodilator responses in Old P130 SFA were 
abolished (Fig. 2.5). Furthermore, the beneficial effect of pressure treatment on flow-induced 
dilation in old P130 SFA was not present following a 2 h recovery period at normal pressure 
(Fig. 2.6). 
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Figure 2.5. Role of nitric oxide (NO) in flow-induced vasodilation in old SFA treated with 
an acute increase in intraluminal pressure. Old SFA were pressurized to 90 (P90) or 130 
(P130) cmH2O for 60 min. At the end of the 60 min treatment period, intraluminal pressure in 
p130 SFA was lowered to 90 cmH2O. Vasodilator responses were assessed in the absence or 
presence of L-NNA (300 µM), to inhibit NOS. Values are mean ± SE; n = 7-19 rats/group. 
*Dose-response curve significantly different from old p130, p ≤ 0.05 
 
 
Figure 2.6. Effect of an acute increase in intraluminal pressure on flow-induced 
vasodilation in old soleus muscle feed arteries following a 2 h recovery period at normal 
pressure. Old SFA were pressurized at 90 (P90) or 130 (P130) cmH2O for 60 min. At the end of 
the 60 min treatment period, intraluminal pressure was lowered to 90 cmH2O for 2 h before 
assessment. Values are mean ± SE; n = 7-19 rats/group.  *Dose-response curve significantly 
different from old p90, p ≤ 0.05 
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SNP-Induced Dilation 
SNP-induced vasodilation was significantly impaired in old P90 SFA compared to 
young, P90 SFA (Fig. 2.7). Treatment of young SFA with elevated pressure for 60 min improved 
maximal SNP-induced dilation (Fig 2.7).  Treatment of old SFA with increased pressure 
significantly improved SNP-induced dilation such that SNP-induced vasodilator responses in the 
old P130 arteries were significantly greater than old P90 arteries and were not different from 
young P90 SFA (Fig. 2.7). The beneficial effect of pressure treatment on SNP-induced dilation 
was not present after a 2 h recovery (Fig. 2.8). 
 
Figure 2.7. Effect of an acute increase in intraluminal pressure on SNP-induced 
vasodilation in young and old soleus muscle feed arteries. SFA were pressurized to 90 (P90) 
or 130 (P130) cmH2O for 60 min.  At the end of the 60 min treatment period, intraluminal 
pressure in P130 SFA was lowered to 90 cmH2O and allowed to develop spontaneous stable tone 
for 10 minutes. SNP-induced dilation was then assessed in all SFA at an intraluminal pressure of 
90 cmH2O. Values are mean ± SE; n = 10-20 rats/group. *Dose-response curve significantly 
different from all other curves, p ≤ 0.05. #Maximal dilation different from all other groups, p ≤ 
0.05 
 
 
 
33 
 
 
Figure 2.8. Effect of an acute increase in intraluminal pressure on SNP-induced 
vasodilation in old soleus muscle feed arteries following a 2 h recovery period at normal 
pressure. Old SFA were pressurized at 90 (P90) or 130 (P130) cmH2O for 60 min. At the end of 
the 60 min treatment period, intraluminal pressure in the p130 SFA was lowered to 90 cmH2O 
for 2 h before assessment of vasodilator responses. Values are mean ± SE; n = 7-19 rats/group.  
*Dose-response curve significantly different from old p90, p ≤ 0.05 
 
p-eNOS/eNOS Protein Content 
Immunoblot analysis revealed that eNOS, p-eNOS
ser1177
 and the p-eNOS
ser1177
/eNOS 
ratio were not altered by age or pressure treatment (Data not shown). 
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2.4 Discussion 
The purpose of this study was to test the hypothesis that exposure to an acute increase in 
intraluminal pressure, to mimic mean arterial pressure associated with a bout of exercise, 
improves NO-mediated endothelium-dependent dilation in aged soleus muscle feed arteries 
(SFA). In addition, we tested the hypothesis that improved endothelial function in aged arteries 
would persist after a 2 h recovery period at normal pressure. The primary new findings of this 
study were as follows: (1) Treatment with increased pressure for 60 min improved ACh- and 
flow-induced dilations in old (not young) SFA. (2) The beneficial effect of pressure treatment on 
ACh- and flow-induced dilation in old SFA was abolished in the presence of L-NNA and was 
not present after a 2 h recovery period. (3) Treatment with increased pressure for 60 min 
improved SNP-induced dilation in old and young SFA. (4) The beneficial effect of pressure 
treatment on SNP-induced dilation was not present following a 2 h recovery period at normal 
pressure. Collectively, these results indicate that exposure to an acute increase in intraluminal 
pressure improves NO-mediated endothelium-dependent vasodilator function in old SFA. 
Importantly, the beneficial effect of the pressure treatment occurs within a time frame 
representative of a bout of exercise (i.e. 60 min). Contrary to our hypothesis, the beneficial effect 
of pressure does not persist after a 2 h recovery period. 
SFA were used in the present study because these arteries provide an active site of 
regulation of resistance to blood flow to the soleus muscle at rest and during exercise 
160
 and 
because NO-mediated, endothelium-dependent dilation declines with age in these 
arteries
15,18,19,30,156
. In addition, endurance exercise training reverses age-induced endothelial 
dysfunction in SFA
25
. Thus these arteries are well suited for experiments to determine the signals 
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associated with exercise resulting in improved endothelium-dependent vasodilator responses in 
aged arteries. 
Woodman and colleagues demonstrated previously that treatment of aged SFA with 
increased intraluminal pressure for 4 h restored endothelial function in old SFA by enhancing 
NO bioavailability
30
. While the study by Woodman et al. revealed that exposure to a short-
duration increase in intraluminal pressure improved endothelial function in aged arteries, it is 
important to note that the 4 h treatment period used was substantially longer than a typical bout 
of exercise
30
. Therefore, in the present study we wished to extend these findings to determine 
whether exposure to an acute increase in intraluminal pressure, within a time frame 
representative of an actual exercise bout (i.e. 60 min), would improve or restore endothelium-
dependent dilation in aged SFA. 
Results indicating that flow- and ACh-induced dilations were significantly blunted in old 
P90 SFA relative to young P90 SFA (Figs. 2.1, 2.4) are consistent with previous studies and 
confirmed that endothelial function was impaired in the old SFA
15,18,19,25,156
. Treatment of SFA 
with an acute (60 min) increase in intraluminal pressure, within a range of pressure believed to 
be present in these arteries during exercise, significantly improved ACh-induced dilation in old 
SFA (Fig. 2.1).  In addition, pressure treatment completely restored flow-induced vasodilator 
responses in old SFA such that the response was not different from young SFA (Fig. 2.4). While 
previous studies revealed improved endothelium-dependent dilation following 4 h exposure to 
elevated intraluminal pressure
30
, these data are the first to demonstrate a beneficial effect of an 
acute increase in pressure on endothelial function within a time frame (60 min) representative of 
an actual bout of exercise. 
36 
 
Previous studies indicate that aerobic exercise training improves endothelium-dependent 
vasodilator responses in aged arteries by enhancing NO bioavailability
21,25
. In addition, we 
demonstrated previously that treatment of aged SFA with increased arterial pressure for 4 h 
restored NO-mediated endothelium-dependent vasodilation in old SFA
30
.  To determine whether 
the acute pressure stimulus (i.e. 60 min) used in the present study also improved endothelium-
dependent dilation in old SFA by enhancing NO-mediated dilation, ACh- and flow-induced 
vasodilator responses were assessed in the presence of a nitric oxide synthase inhibitor (L-NNA). 
Addition of L-NNA abolished endothelium-dependent vasodilator responses to ACh and flow in 
old SFA treated with a short-duration increase in pressure. These results indicate that the 
beneficial effect of the acute pressure treatment in old SFA was mediated by NO. Equally 
important, these results demonstrate that the beneficial effect of pressure on NO-mediated 
vasodilator function occurred within a time frame representative of a bout of exercise (i.e. 60 
min). 
Trott et al. 
25
 reported previously that endurance exercise training improved NO-
mediated endothelium-dependent vasodilator responses in old SFA. These findings, taken 
together with results of the present study, suggest that an acute increase in intraluminal pressure 
that occurs during individual bouts of exercise may provide an important mechanical signal by 
which exercise improves or restores NO-mediated endothelium-dependent vasodilation in 
arteries that perfuse skeletal muscle that is recruited during exercise. 
Importantly, McCullough et al. 
165
 reported that exercise training also reverses age-
induced endothelial dysfunction in arteries perfusing skeletal muscle that is not recruited during 
exercise. Improved endothelial function in vascular beds that do not exhibit a hyperemic 
response to exercise cannot be attributed to increased blood flow/shear stress. Therefore, these 
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investigators proposed that increased blood pressure during exercise may provide a mechanism 
for enhanced endothelium-dependent vasodilation in aged arteries that would be independent of 
changes in shear stress.  Results presented in the current study, indicating that acute increases in 
pressure improved or restored endothelium-dependent dilation in aged SFA, are consistent with 
the interpretation that increased arterial pressure associated with individual bouts of exercise 
contributes to the beneficial effect of exercise on endothelial function in aged arteries. 
Based on our results indicating that exposure to an acute increase in pressure improved 
endothelium-dependent dilation in old SFA, we completed an additional experiment to determine 
whether the beneficial effect of the high pressure treatment persisted following a recovery period 
at normal pressure. Contrary to our hypothesis, the beneficial effect of pressure treatment on 
ACh- and flow-induced dilation in old SFA was not present following a 2 h recovery period at 
normal pressure (Figs. 2.3, 2.6). 
Interestingly, Haram et al. 
32
 reported previously that endothelium-dependent dilation 
was improved for up to 48 hours following a single bout of treadmill exercise. The mechanism 
accounting for the persistent improvement in NO-mediated endothelium-dependent dilation 
following a bout of exercise is not known; however, arteries in an exercising animal would be 
exposed to multiple mechanical signals, not just an increase in intraluminal pressure. Woodman 
et al. 
29
 reported previously that exposure to a short-duration increase in intraluminal shear stress 
also improves NO-mediated endothelium-dependent dilation in aged SFA. Thus, during exercise 
it is conceivable that exercise-induced increases in intraluminal pressure and shear stress interact 
to produce longer lasting improvements in endothelial function than pressure alone. Further 
studies are needed to determine whether pressure and shear stress work synergistically to 
promote a healthy endothelium in aged arteries. In addition, studies are needed to determine 
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whether pulsatile increases in pressure augment the beneficial effects of pressure on vasodilator 
function in aged arteries. 
In the present study, treatment of young SFA with increased pressure for 60 min did not 
improve endothelium-dependent dilation (Figs. 2.1, 2.4). These results are in agreement with 
findings indicating that treatment of young SFA with increased intraluminal pressure for 4 h did 
not improve endothelium-dependent dilation in young SFA
30
.  In addition, these results are in 
accord with the findings by Trott et al.
25
 indicating that endurance exercise training did not 
enhance endothelium-dependent dilation in young SFA. 
Based on results indicating that exposure to increased intraluminal pressure for 60 min 
improved NO-mediated endothelium-dependent dilation in old SFA, we wished to determine 
whether the acute pressure stimulus resulted in enhanced phoshphorylation of eNOS. In vascular 
endothelial cells, eNOS is the enzyme primarily responsible for the synthesis on NO and 
phosphorylation of eNOS on serine residue 1177 plays an integral role in its activation
41,166
. 
Thus, enhanced phosphorylation of eNOS on ser
1177
 could increase eNOS activity and contribute 
to enhanced NO-mediated vasodilator responses observed in the old SFA exposed to the high 
pressure stimulus. Results indicated that the 60 min pressure treatment did not alter the 
phosphorylation state of eNOS on ser
1177
 indicating that the beneficial effect of pressure 
treatment on NO-mediated dilation was not mediated by enhanced phosphorylation of eNOS on 
ser
1177
. 
In the present study, acute pressure treatment improved vasodilator responses to SNP (a 
NO donor) in old SFA.  Based on these findings, it could be argued that the improvement in 
ACh- and flow-induced dilation observed in the old SFA was due to enhanced responsiveness of 
vascular smooth muscle to NO rather than an enhanced capacity of vascular endothelium to 
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produce NO.  It is important to note however, that acute pressure treatment also improved SNP-
induced vasodilation in young SFA, but did not enhance endothelium-dependent vasodilator 
responses to ACh or flow in the young arteries. Thus, it is likely that improved vasodilator 
responses in old SFA treated with high pressure were due to enhanced endothelium-dependent 
and endothelium-independent vasodilator responses. The mechanism by which pressure 
treatment improved vascular smooth muscle responses to NO in old SFA is not known; however, 
it is conceivable that they are a result of alterations in the cyclic GMP signaling pathway
167
. 
In summary, the results of this study indicate that exposure of old SFA to an acute 
increase in intraluminal pressure, to mimic mean arterial pressure associated with a bout of 
exercise, improves vasodilator responses. The beneficial effect of pressure was mediated by 
enhanced NO-mediated endothelium-dependent dilation and occurred within a time frame (60 
min) representative of a bout of exercise. Contrary to our hypothesis, the beneficial effect of the 
pressure treatment was not present following a 2 h recovery period at normal pressure. These 
results suggest that increased intraluminal pressure is one signal by which NO-mediated, 
endothelium-dependent vasodilator function is improved by exercise in aged arteries.  Further 
study is needed to determine whether repeated exposures to increased pressure, as well as 
pulsatile increases in pressure, augment the effects of pressure on vasodilator function in aged 
arteries. 
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CHAPTER III 
A SHORT-DURATION INCREASE IN INTRALUMINAL PRESSURE 
PROMOTES HEALTHY VASOCONSTRICTOR RESPONSES IN AGED 
SKELETAL MUSCLE FEED ARTERIES 
3.1 Introduction 
Aging is associated with a decline in vascular smooth muscle constrictor responses in 
central
168
 and peripheral arteries
169
. The age-related decrement in vascular function is 
characterized by impaired constrictor responses to KCl, NE, and vasopressin
168
. The reduced 
ability of the vasculature to promote constriction may contribute to orthostatic intolerance, 
impaired ability to properly distribute skeletal muscle blood flow, and reduced exercise capacity 
in aged individuals
13
. 
The ability of the vascular system to respond to molecular or mechanical signals 
declines with age 
10,14,15,18,19,21,56,155,168,170
.  Aging alters the normal, healthy function of vessels by 
increasing or decreasing their vasoconstrictor responses. This aging response appears to be 
dependent on the location and function of the vessel.  Age-related alterations in vasoconstrictor 
function have been reported in gastrocnemius and soleus first-order arterioles to both receptor-
dependent and receptor-independent stimuli.  Receptor-dependent Ang II- and endothelin-1-
induced vasoconstriction has been reported to be increased in some vessels, while receptor-
dependent NE and vasopressin and receptor-independent KCL-induced vasoconstriction is 
reduced with age
132,168,170
.  
The mechanism(s) through which age-impaired vasoconstriction occurs has yet to be 
fully elucidated. There is some evidence indicating that aging disrupts proteins responsible for 
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mechano-force transduction and may provide a mechanistic insight and a target for preventing or 
improving vascular function with age. The vascular smooth muscle small g-protein, RhoA, and 
its downstream effector Rho Kinase (ROCK) play an important role in the vasoconstrictor 
response. ROCK and RhoA are essential for Ca
2+
-dependent smooth muscle contraction and are 
responsible for mechano-force transduction, in part, by actin organization and increasing myosin 
light chain phosphorylation
136
. Furthermore, it is reported that defects in the Rho pathway can 
lead to cardiovascular diseases like hypertension and atherosclerosis
171
. Because the Rho 
pathway’s association with cardiovascular diseases and it’s integral role in the vasoconstrictor 
response, the Rho pathway may play a role in age-impaired vasoconstriction. 
Exercise training has been shown to be effective in attenuating or reversing the 
detrimental effects of aging on vasoconstrictor responses. In soleus and gastrocnemius muscle 
first-order arterioles, Park et al. demonstrated that aerobic exercise training reduced age-
increased Ang II-induced constriction in these arterioles, thereby mitigating age-induced 
vasoconstrictor dysfunction
170. Donato et al. have shown that aging increases α-adrenergic 
vasoconstriction in aged soleus first order arterioles and that this vasoconstrictor dysfunction is 
mitigated following exercise training
172
. Moreover, aerobic exercise training improves impaired 
myogenic constrictor responses in aged arterioles
129
. These data indicate that aerobic exercise 
may be an important modality for maintaining or improving a healthy vasoconstrictor function in 
some arteries. 
Additionally, aerobic exercise has been shown to decrease RhoA gene expression in an 
endothelial cell
145
, while long-term increases in intraluminal pressure have been shown to 
increase RhoA  in vascular smooth muscle cells
148
, suggesting the Rho pathway is sensitive to 
changes in pressure. Although the mechanism(s) through which aerobic exercise improves age-
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impaired vasoconstriction have yet to be fully elucidated, it is possible that short-duration 
increases in intraluminal pressure during a bout of exercise are important for maintaining healthy 
vascular smooth muscle function via the Rho pathway. 
The purpose of the present study was to test the hypothesis that exposure to a short-
duration (1 h) increase in intraluminal pressure, to mimic the pressure believed to be present in 
the soleus muscle feed artery during a bout of exercise, would attenuate age-induced 
impairments of vascular smooth muscle constrictor responses in the soleus muscle feed arteries 
via the Rho pathway. 
3.2 Methods 
Animals 
This study followed the Guide for the Care and Use of Laboratory Animals provided by 
National Institutes of Health and was approved by the Institutional Animal Care and Use 
Committee at Texas A&M University. Male Fischer 344 rats aged 4 and 24 mo were received 
from the National Institute on Aging (NIA) and housed at the Laboratory Animal Resources and 
Research facility at Texas A&M University. Care was provided by the Comparative Medicine 
Program through the College of Veterinary Medicine.  Rats were maintained on a 12:12-h 
light:dark cycle and were provided food and water ad libitum. 
Isolation of Feed Arteries 
SFA were isolated as previously described
15,25,30,173
. Briefly, rats were anesthetized with 
an intraperitoneal injection with Ketamine (80 mg/kg body weight) and Xylazine (5 mg/kg body 
weight). Once anesthetized, the soleus-plantaris-gastrocnemius muscle complex was removed 
from each hindlimb and placed in a cold (4 °C) MOPS-buffered physiological saline solution 
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(PSS) - (in mM) 145.0 NaCl. 4.7 KCL, 2.0 CaCl2, 1.17 MgSO4, 1.2 NaH2PO4, 5.0 glucose, 2.0 
pyruvate, 0.02 EDTA, and 25.0 MOPS (pH of 7.4). Rats were euthanized by excising the heart. 
SFA were isolated, excised, and placed in a Lucite dissection chamber containing MOPS-PSS 
(pH 7.4; 37 °C). 
Cannulation of Feed Arteries 
SFA were cannulated on each end with a glass micropipette and secured with surgical 
thread. Each micropipette was attached to a pressure reservoir filled with MOPS-PSS 
supplemented with albumin (1g/ml). SFA were pressurized at 60 cmH2O (1 mmHg = 1.36 
cmH2O) and checked for leaks. Once determined to be leak free, SFA were pressurized to 90 
cmH2O or 130 cmH2O for 1 h. These pressures were selected to correspond to pressure believed 
to be present in rat SFA at rest and during exercise, respectively
160
.  MOPS-PSS in the vessel 
chamber was maintained at 37 °C and changed at 20 min intervals during the pressure treatment. 
Immediately following the 1 h pressure treatment period, intraluminal pressures of all SFA were 
set to 90 cmH2O for the assessment of vasoconstrictor responses. Lastly, to determine the 
maximal passive diameter, SFA were incubated in Ca
2+
-free PSS for 30 min. 
Assessment of Vasoconstrictor Responses 
Vasoconstrictor responses were assessed in SFA by measuring the change in diameter in 
response to cumulative, increasing, whole log additions of norepinephrine (NE), angiotensin II 
(Ang II) and phenylephrine (PE). NE was assessed at concentrations ranging from 10
-9
 to 10
-4
 M 
and was selected for use because it stimulates both the α1 and α2 adrenergic receptors. Ang II 
was assessed at concentrations ranging from 10
-11
 to 10
-4
 M. Ang II stimulates the AT1 and AT2 
receptors. PE was assessed at concentrations ranging from 10
-9
 to 10
-4
 M and is selective for the 
α1 adrenergic receptor. 
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To evaluate the contribution of ROCK, vasoconstrictor responses to NE, Ang II , and PE 
were assessed in the absence or presence of a 20 min incubation with Y27632 (10
-6 
M), a RhoA-
kinase selective inhibitor. Additionally, vasoconstrictor responses were assessed in the absence 
or presence of a 20 min incubation with lipophosphatidic acid (LPA) (10
-5
 M), a short-duration 
activator of RhoA-kinase. 
NE was obtained from Sigma-Aldrich (Cat. A9512). Ang II was obtained from Bachem 
through VWR (Cat. H-1705) and PE was obtained from Sigma-Aldrich (Cat. P6126). Y27632 
was obtained from Sigma Aldrich (Cat. Y0503). LPA was obtained from Sigma Aldrich (Cat. 
L7260). 
Statistical Analysis 
All values are means ± SE. Between group differences in body mass and maximal 
passive diameter were assessed using One-Way ANOVA. Two-Way ANOVA with repeated 
measures on one factor (concentration) was used to determine whether constrictor responses to 
NE, Ang II, or PE differed by group. Concentration-response data were expressed as percent 
constriction and were calculated as [(Db-Dc)/Db] X 100, where Dc is the measured diameter for a 
given concentration. Db is the baseline diameter measured before each concentration response 
curve
170
. When a significant p-value was obtained, post hoc analyses were performed with 
Duncan’s Multiple-Range Test. Statistical significance was set at the p≤ 0.05 probability level. 
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3.3 Results 
Characteristics of Rats and SFA 
Old rats (416 ± 6 g) weighed significantly more than young rats (346 ± 6 g). SFA from 
old rats (145 ± 8 µm) had significantly smaller maximal passive diameter than SFA from young 
rats (200 ± 13 µm). 
Vasoconstrictor Responses 
Vasoconstrictor responses to NE, Ang II, and PE were significantly blunted in Old P90 
SFA relative to Young P90 SFA (Fig. 3.1). 
 
 
 
 
 
 
 
46 
 
  
 
Figure 3.1.  Effect of aging on vasoconstrictor responses of SFA to NE (A), Ang II (B), and 
PE (C). All SFA were pressurized to 90 cmH2O (P90) for 1 h before assessment of 
vasoconstrictor function. B, baseline diameter before the first dose of NE, Ang II, or PE. Values 
are means ± SE; n = 6-8 rats per group. * Significantly different from Young P90; P ≤ 0.05. 
 
Pressure Treatment 
Pretreatment of SFA with 1 h increased intraluminal pressure (130 cmH2O) , to mimic 
the pressure believed to be present during exercise, improved, but did not restore vasoconstrictor 
responses to NE in old SFA (Fig. 3.2A). Pretreatment with increased intraluminal pressure 
restored Ang II-induced vasoconstrictor responses in aged SFA such that they were no longer 
different from the Young P90 SFA vasoconstrictor responses (Fig 3.2B). Pressure pretreatment 
in old SFA did not significantly improve vasoconstrictor responses to PE (Fig. 3.2C). 
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Figure 3.2. Effect of a short-duration increase in intraluminal pressure on vasoconstrictor 
responses to NE (A), Ang II (B), and PE (C). SFA were pressurized to 90 cmH2O (P90) or 130 
cmH2O (P130) for 1 h. At the end of the 1 h treatment period, intraluminal pressure was set to 90 
cmH2O in all SFA for assessment of vasoconstrictor function. B, baseline diameter before the 
first dose of NE, Ang II, or PE. Values are means ± SE; n = 6-8 rats per group. * Significantly 
different from Young P90; # Significantly different from Old P90; P ≤ 0.05. 
 
Role of Rho Kinase 
To assess the role of the Rho pathway, vasoconstrictor responses were assessed in the 
absence or presence of a Rho Kinase inhibitor (Y27632). In the presence of Y27632, NE- and 
PE-induced vasoconstriction was reduced in Old P130 SFA (Fig. 3.3A and Fig. 3.3C). ROCK 
inhibition eliminated Ang II-induced constriction in Old P130 SFA (Fig. 3.3B).  
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Figure 3.3. Effect of Rho Kinase inhibition with a short-duration increase in intraluminal 
pressure on vasoconstrictor responses to NE (A), Ang II (B), and PE (C). Vasoconstrictor 
responses were assessed in the absence or presence of Y27632, a selective inhibitor of Rho 
Kinase. B, baseline diameter before the first dose of NE, Ang II, or PE. Values are means ± SE; 
n = 5-8 rats per group. t Significantly different from all other curves; * Significantly different 
from Old P130; # Significantly different from Old P90; P ≤ 0.05. 
 
To further assess the importance of the Rho signaling pathway, vasoconstrictor 
responses were assessed in the absence or presence of a Rho Kinase activator (LPA). Constrictor 
responses to NE were not improved by LPA (Fig. 3.4A). However, LPA significantly improved 
Ang II-induced vasoconstrictor responses in Old P90 SFA, such that the vasoconstrictor 
responses were no longer different than Young P90 SFA (Fig. 3.4B). Statistical analysis did not 
reveal any significant differences in PE-induced vasoconstriction following incubation with LPA 
(Fig 3.4C). 
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Figure 3.4. Effect of Rho Kinase activation on vasoconstrictor responses to NE (A), Ang II 
(B), and PE (C). Vasoconstrictor responses were assessed in the absence or presence of LPA, a 
selective activator of Rho Kinase. B, baseline diameter before the first dose of NE, Ang II, or 
PE. Values are means ± SE; n = 5-8 rats per group. * Significantly different from Old P130; # 
Significantly different from Old P90; P ≤ 0.05. 
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3.4 Discussion 
The purpose of the present study was to test the hypothesis that exposure to a short-
duration (1 h) increase in intraluminal pressure, to mimic the pressure believed to be present 
during a bout of exercise, would attenuate age-induced impairments of vascular smooth muscle 
constrictor responses in SFA via the Rho pathway. SFA were studied because they play an 
integral role in regulating blood flow to the soleus muscle at rest and during exercise and are 
susceptible to decreased vascular function with age, which can be improved with exercise
15,25,174
. 
The novel findings of this study were as follows: 1) Constrictor responses to NE, Ang II, and PE 
were impaired in old P90 SFA. 2) A short-duration exposure of aged SFA to increased 
intraluminal pressure (P130 cmH2O), to mimic the pressure believed to be present during a bout 
of exercise,  improved NE- and PE-induced vasoconstrictor responses and restored Ang II-
induced vasoconstrictor responses such that the responses in Old P130 SFA were not different 
from Young P90 vasoconstrictor responses. 3) The beneficial effect of increased intraluminal 
pressure on vasoconstrictor responses in aged SFA were eliminated in the presence of a ROCK 
inhibitor (Y27632). 4) Activation of ROCK with LPA restored Old P90 Ang II vasoconstrictor 
responses so that they were no longer different than Young P90 vasoconstrictor responses. 
Previous studies indicate that vasoconstrictor responses are impaired with age
130,169,175
. 
To our knowledge, this study is the first to document an age-related decline in vasoconstrictor 
responses in rat SFA (Fig. 3.1). Ishihata and Delp both have shown an age-impaired 
vasoconstrictor response to endothelin-1 and NE, respectively, in aorta from aged rats
168,176
. Park 
et al. and Donato previously showed enhanced vasoconstrictor responses to Ang II and 
endothelin-1 in rat soleus 1A arterioles
132,170
. These studies indicate that the location of the vessel 
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within the vascular tree, the oxidative/glycolytic state of the vessel’s tissue, and function of the 
vessel in the vascular system plays an important role in determining the response to aging. 
Previous studies have reported that exercise can reduce age-induced augmented 
vasoconstriction and improve age-impaired vasoconstriction
129,170
. Our current study 
demonstrates that a short-duration increase in intraluminal pressure, within a range believed to 
be present during a bout of exercise, improves age-impaired vasoconstrictor responses in aged 
SFA (Fig. 3.2). Together these data are consistent with the interpretation that short-duration 
increases in intraluminal pressure that occur during exercise may promote healthy vascular 
function by improving vasoconstrictor function. 
Our data showed that exposure to a short-duration increase in pressure improved NE-
induced constriction, while having a minimal effect on PE-induced constrictor responses (Fig. 
3.2, 3.3). Since NE binds to both α1 and α2 receptors, whereas phenylephrine selectively binds 
to the α1 receptor, these results suggest a preferential effect of a pressure treatment on the α2 
receptor, or that there is an additive vasoconstrictor effect by stimulating both α1 and α2 receptor 
stimulation on vasoconstrictor response following a short-duration increase in intraluminal 
pressure. 
To directly test the hypothesis that increased intraluminal pressure improves constrictor 
responses in aged arteries via the Rho pathway, vasoconstrictor responses were assessed in the 
absence or presence of a Rho Kinase inhibitor. The finding that the beneficial effect of pressure 
treatment was eliminated in the presence of Y27632 indicates that the beneficial effect of 
pressure was Rho-dependent (Fig. 3.3, 3.4). ROCK signaling is an important mechanism of 
vascular smooth muscle cell constriction by decreasing myosin light chain phosphatase activity 
and increasing the formation of actin fibers
140,142,177
. In cultured vascular smooth muscle cells, 
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Lim et al. reported an increase in myosin light chain phosphorylation following treatment with 
LPA and a decrease in myosin light chain phosphorylation following treatment with Y27632
178
. 
In the current study, Ang II-induced constriction, following treatment with a short-duration 
increase in intraluminal pressure, was nearly abolished following inhibition with the ROCK 
inhibitor Y27632 (Fig. 3.3B). These results indicate that Ang II-induced constriction operates 
almost exclusively through the ROCK pathway. Furthermore, Ang II-induced constriction in 
aged SFA was fully restored following incubation with LPA, a ROCK activator, compared to 
young SFA (Fig. 3.4B). These data further suggest that the impairment of aged Ang II-induced 
vasoconstriction lies within the ROCK pathway. 
Lim et al. have previously reported that the application of tensile stress to live, cultured 
vascular smooth muscle cells produced vascular smooth muscle cell remodeling that was RhoA 
dependent
178
. Additional studies by Lim et al. revealed that the RhoA-mediated response to 
mechanical stimuli was likely modulated through the extracellular matrix
179
. Collectively, these 
data suggest that the improvement in ROCK-mediated vasoconstriction in intact SFA is largely 
due to vascular smooth muscle modifications. 
In summary, the results of this study indicate that aging impairs vasoconstrictor 
responses in rat SFA and that pretreatment with 1 h increased intraluminal pressure can improve 
or restore vasoconstrictor responses in aged arteries. Furthermore, improved vasoconstrictor 
responses following increased intraluminal pressure pre-treatment are mediated by Rho Kinase. 
Collectively, these data suggest that a short-duration increase in intraluminal pressure is one 
mechanical signal associated with exercise that is important for promoting healthy vascular 
function in aged arteries. 
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CHAPTER IV 
A SHORT-DURATION INCREASE IN INTRALUMINAL PRESSURE IMPAIRS 
VASCULAR SMOOTH MUSCLE CONTRACTILITY IN AGED, DENUDED 
SKELETAL MUSCLE FEED ARTERIES 
4.1 Introduction 
Aging impairs vasoconstrictor responses in central and peripheral arteries
130,168,169
. In the 
previous chapter, impaired vasoconstrictor responses were observed in soleus muscle feed 
arteries.  An impaired ability to properly regulate blood flow through appropriate vasoconstrictor 
responses may lead to orthostatic intolerance, reduced blood flow to skeletal muscle, and 
reduced exercise capacity
13
. 
The mechanism(s) by which vasoconstrictor responses are impaired with age has not yet 
been fully elucidated, but may include impaired ability of the vascular smooth muscle to develop 
contractile tension. In the previous chapter, vasoconstriction of aged soleus muscle feed arteries 
to Ang II was decreased. However, in the first-order arterioles studied by Park et al., Ang II 
vasoconstriction was increased with age
170
. Angiotensin II (Ang II) is a potent vasoconstrictor 
through its stimulation of vascular smooth muscle receptors (AT1R and AT2R) but also can 
induce nitric oxide-dependent vasodilation by stimulating endothelial receptors (AT1R)
180-186
. 
Ang II sensitivity is increased in aged, cultured vascular smooth muscle cells
133
. Park et al. 
showed, in aged first-order arterioles, increased vasoconstriction to Ang II; however, removing 
the endothelium eliminated the age effect, suggesting that increased vasoconstriction in aged 
first-order arterioles is due, at least in part, to the biphasic response to Ang II and is both nitric 
oxide synthase-dependent and endothelium mediated
170
. Therefore, it is conceivable, that the 
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decreased vasoconstriction to Ang II in aged SFA observed in the previous chapter may be due 
to an impairment of vascular smooth muscle contractility.  
One component of vascular smooth muscle constriction that may be responsible for age-
impaired vasoconstriction lies within the Rho-Rho kinase pathway. Kimura et al. overexpressed 
RhoA in cultured NIH 3T3 fibroblast cells and showed that RhoA contributes to phosphorylation 
of myosin light chain in these cells, thus setting a precedent and suggesting that RhoA’s role in 
vascular smooth muscle contraction may be through the inhibition of myosin phosphatase by 
Rho kinase
140
. Furthermore, RhoA also contributes to increasing the formation of actin and focal 
adhesions, proteins important for the mechano-transduction of contractile force from the 
cytoskeleton to the extracellular matrix
142,143
. 
Aerobic exercise training has been associated with the restoration of a young vascular 
vasoconstrictor phenotype to aged arterioles, through an endothelium-mediated 
mechanism(s)
170,172
.  In the previous chapter, our lab showed that age-impaired vasoconstrictor 
function is improved with age following exposure to a short-duration increase in intraluminal 
pressure, one hemodynamic force experienced by the vascular smooth muscle during a bout of 
exercise. However, the contribution of vascular smooth muscle to the improved response 
remains unclear. Exposure to elevated intraluminal pressure is associated with elevated RhoA, 
increased RhoA activation, and increased vascular tone
148,149
. Furthermore, mechanical 
stimulation is important for preserving sensitivity to vasoconstrictors and contractile function
152
. 
These data suggest that exposure to short-duration increases in intraluminal pressure, as believed 
to be present during a bout of exercise, may serve to improve or maintain healthy vascular 
smooth muscle constrictor function through improvements in the Rho-Rho kinase pathway. 
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Therefore, the purpose of the present study was to test the hypothesis that a short-
duration (1 h) increase in intraluminal pressure, to mimic the duration and magnitude of pressure 
believed to be present during a typical exercise bout, would improve vascular smooth muscle 
constriction through the Rho-Rho kinase pathway. All studies were performed in denuded 
(endothelium removed) SFA to isolate the effects of age and pressure on vascular smooth 
muscle. 
4.2 Methods 
Animals 
This study was approved by the Institutional Animal Care and Use Committee of Texas 
A&M University and followed the National Institutes of Health Guide for the Care and use of 
Laboratory Animals. Young (4 mo) and Old (23-24 Mo), male Fischer 344 rats were obtained 
from the National Institute on Aging (NIA) and were housed and cared for at the Texas A&M 
College of Veterinary Medicine’s facility for the Comparative Medicine program. Animals were 
examined daily by the Comparative Medicine Veterinary staff and by study investigators. Rats 
were housed on a 12:12 hour light-dark cycle and provided food and water ad libitum. 
Isolation of Feed Arteries 
Soleus muscle feed arteries were isolated as previously described
25,30,173
. In brief, rats 
were anesthetized using an intraperitoneal injection of a Ketamine:Xylazine (80 mg/kg body 
weight Ketamine: 5 mg/kg body weight Xylazine). After rats were fully anesthetized, the soleus-
gastrocnemius-plantaris muscle complex was removed from each hindlimb and placed in a 4 °C  
MOPS-buffered physiological saline solution (PSS)  composed of (in mM) 145.0 NaCl. 4.7 
KCL, 2.0 CaCl2, 1.17 MgSO4, 1.2 NaH2PO4, 5.0 glucose, 2.0 pyruvate, 0.02 EDTA, and 25.0 
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MOPS (pH of 7.4). Rats were euthanized by excising the heart. SFA were isolated, excised, and 
placed in a Lucite dissection chamber containing MOPS-PSS for cannulation. 
Cannulation of Feed Arteries 
One end of the SFA was cannulated with a glass micropipette and secured with surgical 
thread. The endothelium was removed from SFA by passing 5 ml of air through the vessel lumen 
and the remaining end of the SFA was the cannulated and secured with surgical thread. Once 
both ends of the SFA were cannulated and secured, each glass micropipette was connected to a 
pressure reservoir containing MOPS-PSS with Albumin (1 g/mL). SFA were pressurized at 60 
cmH2O and were checked for leaks. SFA determined to be leak free were pressurized at 90 
cmH2O (P90) or 130 cmH2O (P130) for 1 h, at 37 ºC. Intraluminal pressures of 90 cmH2O and 
130 cmH2O were selected based on previous studies
30,173
 and are representative of the 
intraluminal pressure thought to be present in a rat SFA at rest and during exercise, 
respectively
174
. After 1 h, intraluminal pressure was set at 90 cmH2O for all vessels and 
vasoconstrictor responses were assessed. Endothelial removal was confirmed at the completion 
of the experiment by the lack of vasodilation (< 5%) following addition of ACh (3x10-4 M). 
Lastly, to determine the maximal passive diameter, SFA were incubated in Ca
2+
-free PSS for 30 
min. 
Assessment of Vasoconstriction 
Vasoconstrictor responses to adrenergic receptor stimulation were assessed by the 
addition of increasing whole log doses of norepinephrine (NE; 10
-9
 – 10-4 M: Sigma Aldrich, 
A9512) and phenylephrine (PE; 10
-9
 – 10-4 M: Sigma Aldrich P6126). NE stimulates α1 and α2 
adrenergic receptors. PE is selective for the α1 adrenergic receptor. To determine the 
vasoconstrictor responses to the stimulation of the AT1 and AT2 receptors, vasoconstriction was 
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assessed by the addition of increasing whole log doses of angiotensin II (Ang II; 10-11 – 10-6 
M: Bachem via VWR, H-1705). 
To evaluate the role of Rho Kinase, vasoconstrictor responses in aged, denuded SFA not 
receiving the high pressure treatment were assessed in the absence or presence of a Rho Kinase 
inhibitor, Y27632.  A 20 minute incubation with (10
-6
 M) Y27632 was used to inhibit Rho 
Kinase prior to the assessment of vasoconstrictor responses.  
Statistical Analysis 
All values are means ± SE. Between group differences in body mass and maximal 
passive diameter were assessed using One-Way ANOVA. Two-Way ANOVA with repeated 
measures on one factor (concentration) was used to determine whether constrictor responses to 
NE, ANG II, or PE differed by group. Concentration-response data were expressed as percent 
constriction and were calculated as [(Db-Dc)/Db] X 100, where Dc is the measured diameter for a 
given concentration. Db is the baseline diameter measured before each concentration response 
curve
170. When a statistical difference was observed, Duncan’s Multiple Range Test was used for 
post-hoc analysis. Statistical significance was set at the p≤ 0.05 level. 
4.3 Results 
Animal and SFA Characteristics 
Young rats (340 ± 22 g) weighed significantly less than old rats (424 ± 36 g). The 
maximal passive diameters of SFAs were not different across groups: Young P90 (153 ± 41 g), 
Old P90 (163 ± 47 g), OldP130 (132 ± 24 g), OldP90+Y27632 (115 ± 18 g). 
 
58 
 
Vasoconstrictor Responses 
Vasoconstrictor responses to NE, Ang II, and PE were not significantly impaired with 
age (Fig. 4.1). Exposure to a 1 h increase in intraluminal pressure, to mimic the pressure believed 
to be present during exercise, significantly impaired vasoconstrictor responses to Ang II and PE 
in aged, denuded SFA (Fig. 4.2B, 4.2C).  The aged, denuded Ang II vasoconstrictor response 
curve (Old P130) was abolished after exposure to a 1 h increase in intraluminal pressure (Fig. 
4.2B).  
 
 
Figure 4.1. Effect of aging on vasoconstrictor responses to NE (A), Ang II (B), and PE (C). 
All SFA were denuded and pressurized to 90 cm H2O for 1 h before assessment of 
vasoconstrictor responses. B, baseline diameter before the first dose of NE, Ang II, or PE. 
Values are means ± SE. n = 6-12 rats per group. Statistical analysis revealed no significant 
between group differences. 
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Figure 4.2. Effect of a short-duration increase in intraluminal pressure on constrictor 
responses to NE (A), Ang II (B), and PE (C). SFA were denuded and pressurized to 90 cmH2O 
(P90) or 130 cmH2O (P130) for 1 h. At the end of the 1 h treatment period, all SFA were 
pressurized to 90 cmH2O (P90) and vasoconstrictor responses were assessed. B, baseline 
diameter before the first dose of NE, Ang II, or PE. Values are means ± SE, n = 5-12 rats per 
group. * Significantly different than all other curves. P ≤ 0.05. 
 
To determine the contribution of Rho kinase to vascular smooth muscle constrictor 
responses, Rho Kinase was inhibited with Y27632 before assessment of vasoconstrictor 
responses. In the presence of Y27632, vasoconstriction was significantly blunted in aged, 
denuded SFA (Fig. 4.3). Following incubation with Y27632, NE-induced vasoconstriction was 
significantly impaired in Old P90 denuded SFA (Fig. 4.3A). In aged, denuded SFA, Ang II-
induced vasoconstriction, following incubation with Y27632, was significantly impaired 
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compared to Young P90 and Old P90 denuded SFA, and was not different from the Ang-II 
induced vasoconstrictor response of Old denuded SFA pretreated with  1 h of increased 
intraluminal pressure (Fig. 4.3B). Incubation with Y27632 abolished the vasoconstrictor 
response of Old, denuded SFA to PE (Fig. 4.3C). 
 
 
Figure 4.3. Effect of Rho kinase inhibition and a short-duration increase in intraluminal 
pressure on vasoconstrictor responses to NE (A), Ang II (B), and PE (C). SFA were denuded 
and pressurized to 90 cmH2O (P90) or 130 cmH2O (P130) for 1 h. At the end of the 1 h treatment 
period, all SFA were pressurized to 90 cmH2O (P90) and vasoconstrictor responses were 
assessed. Vasoconstrictor responses were assessed in the absence or presence of Y27632, a 
selective inhibitor of Rho kinase. B, baseline diameter before the first dose of NE, Ang II, or PE. 
Values are means ± SE. n = 5 – 11 rats per group.* Significantly different than all other curves. 
# Significantly different than Young P90.  t Significantly different than Old P90. P ≤ 0.05. 
# t 
# t 
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4.4 Discussion 
The purpose of this study was to test the hypothesis that a short-duration (1 h) increase 
in intraluminal pressure, within a range of pressures believed to be present during exercise, 
would improve vascular smooth muscle constriction in aged SFA. Denuded SFA were studied to 
isolate the effects of age and pressure on vascular smooth muscle function. This study revealed 
the following primary findings: 1) Vascular smooth muscle constriction was not different 
between young and old denuded P90 SFA. 2) Exposure to 1 h increased intraluminal pressure 
impaired Ang II and PE vasoconstrictor function in old denuded P130 SFA. 3). Incubation with a 
Rho Kinase inhibitor (Y27632) impaired NE-  and abolished PE- induced vasoconstriction in old 
denuded P90 SFA, and also eliminated Ang II-induced vasoconstriction so that it was no longer 
different than Ang II-induced constriction in old denuded P130 SFA. 
In the present study, vasoconstrictor responses were not significantly impaired in 
denuded SFA (Fig. 4.1). Vasoconstrictor responses are impaired with age in intact 
vessels
130,169,175
. These results are consistent with data presented by Park et al., who showed 
impaired Ang II- induced vasoconstriction in aged, intact soleus and gastrocnemius first-order 
arterioles, but not in denuded soleus or gastrocnemius first-order arterioles
170
. The present study 
extends the findings of Park et al. to the soleus feed artery and also indicate that aged associated 
impairments of  α1 and α2 adrenergic receptor-dependent vasoconstriction are also likely 
mediated by the endothelium. 
Previously, Park et al. reported that in first-order arterioles, aged endothelium-dependent 
Ang II-impaired vasoconstrictor responses were likely due to the biphasic response of Ang II, 
the stimulation of the endothelium at the AT1R and AT2R to produce the vasodilator NO, and its 
stimulation of the vascular smooth muscle at AT1R receptor to induce 
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vasoconstriction
170,180,181,183-186
. In a similar manner to Ang II receptors, α adrenergic receptors 
are present on both endothelium and vascular smooth muscle. The α2 adrenergic receptor on the 
vascular smooth muscle stimulates the vascular smooth muscle to constrict; however, α2 
adrenergic receptors are also present on the vascular endothelial cell and stimulate the 
production of an endothelial-derived relaxing factor
187
. The endothelial-derived relaxing factor, 
NO, not only serves as a vasodilator stimulus in competition with the vasoconstrictor stimulus, 
but also inhibits α2 adrenergic receptor-induced constriction187. In an effort to observe the 
vascular smooth muscle response alone, the endothelium from the SFA of the present study was 
removed, thus competition between endothelium derived- vasodilator and vasoconstrictor 
responses was removed. These data suggest that age-impaired vasoconstriction is endothelium-
dependent and likely dependent on vasodilator and vasoconstrictor competition. 
In the current study, denuded SFA were exposed to 1 h increased intraluminal pressure, 
to mimic the intraluminal pressure believed to be present during a bout of exercise. Contrary to 
our hypothoses, Ang II- and PE- induced vasoconstriction following the increased intraluminal 
pressure treatment was impaired, not improved, in old SFA (Fig. 4.2). The data from the current 
study demonstrates a similar response in SFA to existing data from first-order arterioles. In first-
order arterioles, both age-increased Ang II- and α –adrenergic – induced vasoconstriction were 
reduced following aerobic exercise training
170,172
. NE stimulates both the α1 and α2 adrenergic 
receptor. PE stimulates the α1 adrenergic receptor. Following exposure to increased intraluminal 
pressure in old SFA, vasoconstriction to PE was impaired while NE-induced vasoconstriction 
remained similar to old P90 SFA (Fig 4.2). This may indicate a redundancy in NE-induced 
vasoconstriction that is not present in PE or ANG-II induced vasoconstriction which functions to 
preserve the vasoconstrictor response to NE following increased intraluminal pressure. This 
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study demonstrates that a short-duration exposure to an increased intraluminal pressure reduces 
vasoconstrictor function in aged SFA. 
In order to identify a mechanism of reduced vascular smooth muscle constriction 
following exposure to an exercise-like increase in intraluminal pressure in aged arteries, 
vasoconstrictor function was assessed following incubation with a Rho inhibitor (Y27632) in 
aged, denuded SFA. In the presence of the Rho inhibitor, NE- and PE- induced vasoconstriction 
was reduced, and Ang II-induced vasoconstriction was abolished and not different than Ang II-
induced constriction in old denuded P130 SFA (Fig. 4.3). These data indicate that the reduced 
vasoconstrictor function following exposure to 1 h increased intraluminal pressure is mediated 
by the Rho pathway. Aerobic exercise has been shown to reduce the expression of the RhoA 
gene and has also been suggested to inhibit the Rho signaling pathway
144,145
. The Rho pathway 
plays an integral role the mechano-transduction of force from the cytoskeleton to the 
extracellular matrix via actin fiber and focal adhesion formation and contributes to the 
phosphorylation of myosin light chains
140,142,143
. The data in the present study suggest that the 
reduction of vasoconstrictor responses following a short-duration increase in intraluminal 
pressure in denuded SFA is mediated by the Rho pathway. 
In conclusion, results of this study indicate that vascular smooth muscle-dependent 
vasoconstriction is not impaired in aged SFA. Furthermore, pretreatment with 1 h intraluminal 
pressure, to mimic the pressure believed to be present during a bout of exercise, impairs vascular 
smooth muscle vasoconstrictor responses in the absence of the endothelium, and that this 
detrimental response is mediated, at least in part, through the Rho pathway. Collectively, these 
data suggest that the endothelium is an important target for the age-mitigating effects of a short-
duration increase in intraluminal pressure as experienced during exercise. 
64 
 
CHAPTER V 
REGULATION OF ENDOTHELIAL PHENOTYPE BY PRESSURE AND 
SHEAR STRESS IN AGED SKELETAL MUSCLE FEED ARTERIES 
5.1 Introduction 
Endothelial function declines with age
10,15,18,56,155,156
. The age-related decrements in 
endothelial function are characterized in part by impaired endothelium-dependent vasodilator 
responses. Celermajer et al. demonstrated that endothelium-dependent, flow-induced dilation is 
preserved throughout middle age but begins to decline in the early 40s for men and early 50s for 
women
188
. The age-related decline in endothelial function is an independent risk factor for the 
development of cardiovascular disease
157,158,189
. 
It has been proposed that the age-related decrement in endothelial function can result in 
reduced exercise hyperemia and a decrease in exercise tolerance
13,157
. Moderate, aerobic exercise 
can attenuate or reverse age-induced endothelial dysfunction in some arteries
25,26,56
. Hambrecht 
et al. documented improved, nitric oxide (NO) – dependent endothelial function  in patients with 
cardiovascular disease following the completion of a regular physical exercise training 
program
159
. In addition, Haram et al. showed that endothelial function is improved for up to two 
days following just a single bout of exercise. The mechanism(s) responsible for improved 
endothelial function following physical exercise has yet to be fully elucidated; however, it has 
been proposed that short-duration increases in intraluminal pressure and shear stress associated 
with individual bouts of exercise may provide important mechanical signals that promote healthy 
endothelial function
26,29,30
. 
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Woodman et al. reported previously that exposure of skeletal muscle feed arteries to 
increased intraluminal pressure or shear stress, for a duration of 4 hours, improved endothelium-
dependent dilation in aged arteries
29,30
. Results from these studies are consistent with the 
interpretation that short-term increases in intraluminal pressure and shear stress promote healthy 
endothelial function. Seawright et al. previously demonstrated improved endothelium-dependent 
vasodilator responses in aged skeletal muscle feed arteries following a 1 h increase in 
intraluminal pressure
173
, suggesting that the beneficial effect of pressure on endothelial function 
occurs within a duration of a typical exercise bout. While these two mechanical signals have 
been investigated separately, the question remains if pressure and shear stress interact to produce 
greater benefits than pressure or shear stress alone. 
Therefore, the purpose of the present study was to test the hypothesis that exposure to a 
short-duration (1 h) increase in intraluminal pressure combined with increased shear stress 
(flow), to mimic two mechanical signals associated with a bout of exercise, would induce greater 
improvements of endothelium-dependent dilation in aged arteries than a short-duration increase 
in intraluminal pressure alone. 
5.2 Methods 
Animals 
Approval for this study was provided by the Institutional Animal Care and Use 
Committee at Texas A&M University and conformed to the National Institutes of Health Guide 
for the Care and Use of Laboratory Animals. Male Fischer 344 rats (4 and 24 mo) were provided 
by the National Institute of Aging (NIA) and housed by the College of Veterinary Medicine 
through the Comparative Medicine Program at the facility for Laboratory Animal Resources and 
Research.  Animals were provided food and water ad libitum and were maintained in a 12:12-h 
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light-dark cycle.  Fischer 344 rats were selected for use in these studies because they remain free 
of atherosclerosis and hypertension
161
. 
Isolation of Feed Arteries 
Soleus muscle feed arteries (SFA) were isolated as previously described 
25,29,30,173
. 
Briefly, rats were anesthetized with an intraperitoneal injection of Ketamine (80 mg/kg body 
weight) and Xylazine (5 mg/kg body weight). After anesthetization, the soleus-gastrocnemius-
plantaris muscle complex was dissected free from each hindlimb and placed in a cold (4 °C) 
MOPS-buffered physiological saline solution (PSS). The PSS (pH 7.4) was comprised of (in 
mM) 145.0 NaCl. 4.7 KCL, 2.0 CaCl2, 1.17 MgSO4, 1.2 NaH2PO4, 5.0 glucose, 2.0 pyruvate, 
0.02 EDTA, and 25.0 MOPS. Rats were euthanized by excising the heart. The SFA were 
isolated, excised, and transferred to a Lucite dissection chamber containing MOPS-PSS for 
cannulation. 
Cannulation of Feed Arteries 
SFA were cannulated on both ends with resistance-matched glass micropipettes and 
secured with surgical thread. The micropipettes were then attached to pressure reservoirs which 
contained MOPS-PSS supplemented with albumin (1g/mL). SFA were pressurized to 60 cmH2O 
(1 mmHg = 1.36 cmH2O) and checked for leaks. SFA with leaks were re-secured to eliminate the 
leak. Once a SFA was determined to be leak-free, the pressure reservoirs were raised to 90 
cmH2O or 130 cmH2O for 1 h and the vessel chamber warmed to 37 ºC. Additional SFA were 
exposed to 130 cmH2O pressure and simultaneously exposed to a flow gradient of 40 cmH2O (65 
µl/min). This flow gradient was achieved by raising one pressure reservoir by 20 cmH2O and 
concurrently lowering the other pressure reservoir by an equal 20 cmH2O. Intraluminal pressures 
of 90 cmH2O and 130 cmH2O correspond to the pressures believed to be present in the rat SFA 
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at rest and during exercise, respectively
160
 . The 40 cmH2O flow gradient was chosen based on 
previous publication by Woodman et al, describing improved endothelial function following 4 h 
exposure to a 40 cmH2O flow gradient
29
. SFA baths were changed at 20 minute intervals during 
the 1 h treatment period and after the completion of each concentration response curve. 
Immediately following the 1 h treatment period, pressure in all SFA was set to at 90 cmH2O with 
no flow (0 µl/min). SFA were allowed to develop 10 min of spontaneous, stable tone prior to the 
assessment of vasodilator responses. 
Assessment of Vasodilator Responses 
Vasodilator responses were assessed as previously described
29,30,173
. Briefly, 
endothelium-dependent, flow-induced dilation was assessed by raising and lowering the pressure 
reservoirs in equal and opposite directions. Flow-induced dilation was assessed at flow gradients 
of 0, 2, 4, 6, 8, 10, 15, 20 and 40 cm H2O, which correspond to flow rates of 0-62 µl/min
164
. 
Endothelium-dependent dilation was assessed by adding increasing whole log increments of 
acetylcholine (ACh) from 10
-9
 – 10-4 M. Endothelium-independent dilation was assessed by 
adding increasing whole log increments from 10
-9
 – 10-4 M sodium nitroprusside (SNP), an 
exogenous NO donor. Lastly, to determine the maximal passive diameter, SFA were incubated in 
Ca
2+
-free PSS for 60 min. 
To determine the role of NO, a separate set of SFA was exposed to high pressure (130 
cmH2O) and  high shear stress (40 cmH2O  flow gradient) for 1 h and vasodilator responses were 
assessed in the presence of N
ω
 –nitro-L-arginine (L-NNA; 300 uM), a nitric oxide synthase 
inhibitor. SFA were incubated in L-NNA for 20 minutes prior to the assessment of vasodilator 
responses.  
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Immunoblot Analysis 
p-eNOS
ser1177
 and total eNOS protein content were assessed in SFA as previously 
described
50,164,173
.  p-eNOS
ser1177
 was assessed using a monoclonal antibody (1:250, BD 
Biosciences - 612393). The membrane was subsequently stripped with Thermo Restore Western 
Stripping Buffer and total eNOS was assessed with a monoclonoal antibody (1:1,250, BD 
Biosciences – 610297). All immunoblot data were expressed relative to GAPDH, which served 
as a loading control, and normalized to the Young P90 mean. GAPDH was assessed with a 
monoclonal antibody (1:10,000, Millipore - MAB374). Immunoblots were evaluated with 
enhanced chemiluminescence (ECL plus, Amersham) and assessed by densitometry using a 
LAS-4000 Luminescent Image Analyzer and Multi-Gauge Image Analysis Software (FUJIFILM 
Medical Systems).  The ratio of p-eNOS
ser1177
 to total eNOS was used to quantify ser
1177
 
phosphorylated eNOS protein content. 
Statistical Analysis 
Values are presented as means ± SE. Body weights and maximal passive diameters were 
analyzed by One-Way ANOVA. To determine whether dilator responses to flow, ACh, and SNP 
differed by group, statistical analysis was performed with Two-way ANOVA with repeated 
measures on one factor (concentration). Percent dilation was calculated as: [(Dconc – DB)/(DP – 
DB)] X 100. Dconc is the measured diameter for a given concentration or flow rate. DB is the 
baseline diameter measured before the concentration response curve. DP is the maximal passive 
diameter observed
25,29,30,173
. Total eNOS/GAPDH, p-eNOS
ser1177
/GAPDH, and p-eNOS
ser1177
/total 
eNOS ratios were determined using One-Way ANOVA. Statistical significance was set at p ≤ 
0.05. 
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5.3 Results 
Animal Characteristics 
Body weights were significantly lower in Young rats (352 ± 31 g) than Old rats (429 ± 
26 g). Maximum diameters were not different between Young P90 (179 ± 40 µm), Old P90 (190 
± 28 µm), Old P130 (183 ± 29 µm) and Old P130 + HSS (195 ± 36 µm) vessels. The maximum 
diameters of the Old P130 + HSS + L-NNA group (112 ± 45 µm) were significantly smaller than 
all other vessel groups (Table 5.1). 
Animal Characteristics 
Group 
Body Weight (g) 
Maximal Passive Diameter 
(µm) 
Young P90 352 ± 31*                  179 ± 40   
Old P90      431 ± 38                      190 ± 28   
Old P130      440 ± 24                    183 ± 29   
Old P130 + HSS      427 ± 36                    195 ± 36   
Old P130 + HSS + L-NNA      419 ± 7    112 ± 45* 
Table 5.1. Animal Characteristics. * Different from all other groups. n= 5-10; P≤ 0.05. 
ACh-Induced Dilation 
ACh-induced dilation was significantly lower in Old P90 SFA compared to Young P90 
SFA (Fig.5.1).  
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Figure 5.1. Effect of age on ACh- induced dilation in SFA. ACh-induced dilation was 
assessed in young and old SFA. ACh-induced dilation is impaired in Old SFA. B, baseline 
diameter before first dose of ACh. * Significantly different from Young P90.  n= 6-10; P≤ 0.05. 
 
Pre-treatment with increased intraluminal pressure (P130) or increased intraluminal 
pressure and shear stress (P130 + HSS) SFA for 1 h significantly improved but did not restore 
the maximal dilatory response to ACh in old SFA. Increased intraluminal pressure alone (P130) 
did not improve ACh-induced dilation in Old SFA (Fig. 5.2). Incubation with a NO inhibitor (L-
NNA) impaired ACh-induced dilation in Old P130 + HSS SFA (Fig. 5.3). 
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Figure 5.2. Effect of increased pressure, alone or in combination with increased shear 
stress, on ACh- induced dilation in SFA. ACh-induced dilaton was assessed following pre-
treatment with 1 h of increased intraluminal pressure (P130) or increased intraluminal pressure 
and shear stress (P130 + HSS). Maximal dilation to ACh  was improved, but not restored in Old 
SFA in the P130 + HSS group. B, baseline diameter before first dose of ACh. * Significantly 
different from Young P90, 
t
 Significantly different from Old P90. n= 6-10; P≤ 0.05. 
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Figure 5.3. Effect of NOS inhibition on ACh-induced dilation in SFA. To determine the 
contribution of NO, ACh-induced dilation was assessed in the absence or presence of the nitric 
oxide synthase inhibitor, L-NNA (300 μM). The beneficial effect of the P130 + HSS pre-
treatment was eliminated in the pressence of  L-NNA. B, baseline diameter before the first dose 
of ACh. # Different from all other curves. n= 5-10; P≤ 0.05. 
 
Flow-Induced Dilation 
Flow-induced dilation was significantly impaired in Old P90 SFA relative to Young P90 
SFA (Fig. 5.4). Pre-treatment with increased intraluminal pressure (P130) or increased 
intraluminal pressure and shear stress (P130 + HSS) restored flow-induced dilation such that it 
was no longer different than Young P90 flow-induced dilation (Fig. 5.5). Incubation with L-
NNA eliminated flow-induced dilation in Old P130 + HSS SFA (Fig. 5.6). 
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Figure 5.4. Effect of age on flow- induced dilation in SFA. Flow-induced dilation was 
assessed in young and old SFA. flow-induced dilation was impaired in Old SFA. * Significantly 
different from Young P90. n= 6-10; P≤ 0.05. 
 
 
 
Figure 5.5. Effect of increased pressure, alone or in combination with increased shear 
stress, on flow- induced dilation in SFA. Flow-induced dilaton was assessed following pre-
treatment with 1 h of increased intraluminal pressure (P130) or increased intraluminal pressure + 
shear stress (P130 + HSS). Flow-induced dilation was restored in both Old P130 SFA and Old 
P130 + HSS groups. # Significantly different from all other groups. n = 6-10; P≤ 0.05. 
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Figure 5.6. Effect of NOS inhibition on flow-induced dilation in SFA. To determine the 
contribution of NO to flow-induced dilation, flow-induced dilation was assessed in the absence 
or presence of the nitric oxide synthase inhibitor, L-NNA (300 μM). The beneficial effect of the 
P130 + HSS pre-treatment was blocked by L-NNA. # Different from all other curves. n= 5-10;  
P≤ 0.05. 
 
SNP-Induced Dilation 
SNP-induced dilation was similar in young an old SFA (Fig. 5.7).  Pre-treatment with 
increased intraluminal pressure alone (P130) or increased intraluminal pressure and shear stress 
(P130 + HSS) for 1 h did not improve SNP-induced dilation in Old SFA (Fig. 5.8). 
 
Figure 5.7. Effect of age on SNP- induced dilation in SFA. SNP-induced dilation was assessed 
in young and old SFA. B, baseline diameter before the first dose of SNP. n= 6-10. Statistical 
analysis revealed no significant differences between groups. n= 6-10; P≤ 0.05. 
# 
# 
# 
# 
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Figure 5.8. Effect of increased pressure, alone or in combination with increased shear 
stress, on SNP-induced dilation in SFA. SNP-induced dilaton was assessed following pre-
treatment with 1 h of increased intraluminal pressure (P130) or increased intraluminal pressure 
and shear stress (P130 + HSS). B, baseline diameter before the first dose of SNP. Statistical 
analysis revealed no significant differences in SNP-induced dilation between young and old 
SFA. n= 6-10; P≤ 0.05. 
 
p-eNOS/eNOS Protein Content 
 Immunoblot analysis revealed that total eNOS/GAPDH, p-eNOS
ser1177
/GAPDH, nor p-
eNOS
ser1177
/eNOS ratio were altered by age or pressure treatment (Fig. 5.9). 
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Figure 5.9. Immunoblot analysis for p-eNOS
ser1177
, eNOS, GAPDH protein content in SFA. 
Statistical analysis revealed no significant differences in the ratio of eNOS/GAPDH (A),  
p-eNOS
ser1177
/GAPDH (B), and p-eNOSser1177/total eNOS (C). 1, Young P90; 2, Young P130; 
3, Young HPHSS; 4, Old P90; 5, Old P130; 6, Old HPHSS. Values are means ± SE normalized 
to Young P90 mean. n= 2-3; P≤ 0.05. 
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5.4 Discussion 
The purpose of  this study was to test the hypothesis that exposure to a short-duration (1 
h) increase in intraluminal pressure combined with increased shear stress (flow rate), to mimic 
two mechanical signals associated with a 1 h bout of exercise, would induce greater 
improvements of endothelium-dependent dilation than a short-duration increase in intraluminal 
pressure alone. The primary findings of this study are as follows: 1) Endothelium-dependent 
dilation to flow and ACh was impaired with age. 2) Exposure to a short-duration (1 h) increase 
in intraluminal pressure alone or in combination with increased shear stress improved 
endothelium-dependent dilation to flow.  Exposure to a combination of increased intraluminal 
pressure and shear stress for 1 h improved maximal dilation to ACh. Contrary to our hypothesis, 
the combination of increased intraluminal pressure and shear stress did not produce greater 
benefits than increased intraluminal pressure alone. 3) The improvements in age-impaired 
endothelial function following a short-duration (1 h) increase in intraluminal pressure and shear 
stress were reduced in the presence of the nitric oxide synthase inhibitor, L-NNA, which 
indicates the beneficial response was mediated, at least in part, by NO. 
In the present study endothelium-dependent dilation was impaired in aged SFA (Fig. 5.1, 
5.4), which is in agreement with previous published studies
15,18,156,173
. Consequently, the aged 
arteries were suitable for experiments to determine whether treatment with short-duration 
increases in intraluminal pressure and shear stress improve or restore healthy endothelial 
phenotype. One novel finding of this study was that exposure to a short-duration increase in 
intraluminal pressure restored flow-induced dilation in old SFA such that the flow response was 
no longer different than Young P90 (Fig. 5.5), but did not improve ACh-induced dilation in old 
SFA (Fig. 5.2).   
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The combined increased intraluminal pressure and increased shear stress for 1 h 
improved the maximal dilation to ACh compared to Old P90, was not different than Old P130 
(Fig. 5.2), and restored flow-induced dilation so that it was no longer different than Young P90 
(Fig. 5.5). The improvement of ACh-induced dilation following the combination of increased 
intraluminal pressure and shear stress indicates that pressure and shear stress did not interact to 
produce greater benefits than increased intraluminal pressure alone on receptor-mediated 
dilation. Previously, Woodman et al. demonstrated that exposure to increased shear stress for 4 h 
restored ACh-induced dilation in Old SFA so that it is comparable to Young SFA
29
. Collectively, 
these data suggest that maintenance of healthy ACh-dependent dilation responses may be more 
dependent on exposure to increased shear stress than to increased intraluminal pressure. 
Treatment of aged SFA with increased intraluminal pressure, alone or in combination 
with increased shear stress, fully restored flow-induced dilation in aged, SFA so that it was no 
longer different than Young P90 SFA (Fig. 5.5). However, there was no additional benefit to 
flow-induced dilation in the P130 + HSS group compared to the P130 group alone (Fig. 5.5). 
Previously, exposure to increased intraluminal pressure for durations of 1 and 4 h restored flow-
induced dilation in aged SFA
30,173
. The present data suggest that exposure to increased 
intraluminal pressure alone is sufficient to provide that maximum benefit to flow-induced 
dilation. 
NO is a critical endothelial-derived signaling molecule contributing to healthy 
endothelial-dependent dilation
8
. NO-mediated dilation is impaired with age and has been shown 
to be improved with exercise, after exposure to 1 h and 4 h increased intraluminal pressure, and 
after 4 h exposure to increased shear stress
18,25,29,30,173
.  In an effort to understand the role of NO 
in improved endothelial function following exposure to a combination of increased intraluminal 
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pressure and shear stress for the duration of 1 h, vasodilator responses were assessed in the 
presence of the nitric oxide synthase inhibitor L-NNA. The improvements in both ACh- and 
flow-induced dilation following exposure to P130 + HSS were abolished following incubation 
with the nitric oxide synthase inhibitor L-NNA (Fig. 5.3, 5.6), indicating that the improved 
endothelial-function is mediated by NO. 
In summary, results of this study show that the maximal ACh-induced dilation was 
improved in aged SFA following exposure to a 1 h increase in both intraluminal pressure and 
shear stress; and that age-impaired, flow-induced dilation is restored following exposure to a 1 h 
increase in intraluminal pressure alone. Collectively, these data indicate that increased 
intraluminal pressure alone or in combination with increased shear stress improves endothelium-
dependent dilation in aged SFA. However, contrary to our hypothesis, increases in pressure and 
shear stress did not interact to produce greater benefits that increased intraluminal pressure 
alone. The improvements in aged endothelial phenotype appear to be mediated by NO.  
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
 
6.1 Summary and Conclusions 
The purpose of this dissertation was to determine the importance of intraluminal 
pressure and shear stress in the regulation of vascular endothelial and vascular smooth muscle 
cell phenotype in aged arteries.  
The purpose of the first study was to test the hypothesis that exposure to a short-duration 
increase in intraluminal pressure, to mimic mean arterial pressure believed to be present in 
soleus muscle feed arteries during a bout of exercise, improves NO-mediated endothelium-
dependent dilation. The novel findings of this study were: 1) Treatment with increased pressure 
for 1 h improved ACh-and flow-induced dilation in old SFA. 2) The beneficial effects of 
pressure treatment on ACh- and flow-induced dilation in old SFA were abolished in the presence 
of L-NNA and were not present after a 2 h recovery period. 3) Treatment with increased pressure 
for 1 h improved SNP-induced dilation in old and young SFA. 4) The beneficial effect of 
pressure treatment on SNP-induced dilation was not present following a 2 h recovery period at 
normal pressure. These results indicate that exposure to 1 h increased intraluminal pressure, as 
believed to be present during a bout of exercise, improves NO-mediated dilation and promotes a 
healthy endothelial phenotype in aged arteries. Furthermore, these results suggest that increased 
intraluminal pressure is one mechanical signal by which aerobic exercise improves age-impaired 
endothelial function. 
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The purpose of the second study was to test the hypothesis that exposure to a short-
duration (1 h) increase in intraluminal pressure (130 cmH2O), to mimic the pressure believed to 
be present in the soleus muscle feed artery during a bout of exercise, would attenuate age-
induced impairments of vasoconstrictor responses in the soleus muscle feed arteries via the Rho 
pathway. 
The findings of this study were as follows: 1) Constrictor responses to NE, Ang II, and 
PE were impaired in old P90 SFA. 2) Short-duration exposure of aged SFA to increased 
intraluminal pressure, to mimic the pressure believed to be present during a bout of exercise, 
improved NE- and PE-induced vasoconstrictor responses, and restored Ang II-induced 
vasoconstrictor responses such that the responses in Old P130 SFA were not different from 
Young P90 vasoconstrictor responses. 3) The beneficial effect of increased intraluminal pressure 
on vasoconstrictor responses in aged arteries were eliminated in the presence of a ROCK 
inhibitor (Y27632). 4) Activation of ROCK with LPA restored Old P90 Ang II vasoconstrictor 
responses so that they were no longer different than Young P90 vasoconstrictor responses. 
Collectively, these data indicate that a short-duration increase in intraluminal pressure, as 
believed to occur during a bout of exercise, is an important mechanical signal for exercise-
induced, improvements in vasoconstrictor function in aged SFA via the Rho pathway. 
The purpose of the third study was determine whether the beneficial effect of exposure 
to an increased intraluminal pressure on aged vasoconstrictor responses was mediated by 
enhanced vascular smooth muscle function. We tested the hypothesis that a short-duration (1 h) 
increase in intraluminal pressure, to mimic the pressure believed to be present during a typical 
exercise bout, would improve vascular smooth muscle constriction in aged, denuded SFA, and 
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that the potential benefit of increased intraluminal pressure on vascular smooth muscle 
constriction would be mediated by the Rho pathway. 
The novel findings of the third study were as follows: 1) Vascular smooth muscle 
constrictor responses were not different between young and old denuded P90 SFA. 2) Exposure 
to 1 h increased intraluminal pressure impaired Ang II and PE vasoconstrictor function in old 
denuded P130 SFA. 3). In denuded old P90 SFA, incubation with a Rho inhibitor (Y27632) 
impaired NE- and abolished PE- induced vasoconstriction. Incubation with a Rho inhibitor 
eliminated Ang II-induced vasoconstriction in old P90 SFA so that it was no longer different 
than Ang II-induced constriction in old denuded P130 SFA. Collectively, these data indicate that 
a short-duration increase in intraluminal pressure, as believed to be present during exercise, does 
not improve vascular smooth muscle cell constrictor responses in aged arteries, and that the 
improved vasoconstrictor responses following exposure to increased intraluminal pressure in 
intact arteries is endothelium-dependent.  
The lack of an age difference in SFA constrictor responses in denuded SFA is a novel 
finding and underscores the importance of the endothelium. A decline in endothelial function is 
associated with an increased risk for cardiovascular disease and a decrease in exercise 
tolerance
43,45,190
. These data indicate that the impairment of vasoconstrictor responses, which 
may lead to orthostatic intolerance
191
, are not a consequence of impaired smooth muscle 
function, but are a result of an impairment of the endothelium to provide the appropriate 
vasoconstrictor signal. Taken together with results from study 2, these data indicate that the 
beneficial effect of pressure on constrictor responses in aged arteries is endothelium-dependent, 
and that the beneficial effect of aerobic exercise on the endothelium promotes both a healthy 
vasodilator and vasoconstrictor function.  
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In the final study of this dissertation we tested the hypothesis that exposure to a short-
duration (1 h) increase in intraluminal pressure combined with increased shear stress (flow rate), 
to mimic two mechanical signals associated with a 1 h bout of exercise, would induce greater 
improvements of endothelium-dependent dilation than a short-duration increase in intraluminal 
pressure alone. The major findings of this study were as follows: 1) Endothelium-dependent 
dilation was impaired with age. 2) Age-impaired endothelial function was improved following 
exposure to a short-duration (1 h) increase in intraluminal pressure alone or in combination with 
increased shear stress. 3) The beneficial improvements in age-impaired endothelial function 
following a short-duration (1 h) increase in intraluminal pressure and shear stress were mediated, 
in part, by NO. Collectively, these data suggest that the intraluminal pressure increase is 
sufficient to improve the function of the aged endothelium. While shear-stress has been shown to 
improve endothelial function
29
, the lack of an additional benefit of shear-stress in conjunction 
with increased intraluminal pressure to improve endothelial function may suggest a redundancy 
in the mechanism(s) of improved endothelial function in aged arteries following exercise such 
that increased intraluminal pressure or increased shear stress, both of which occur during 
exercise, is sufficient to improve aged endothelial function and ensure a vascular benefit to 
exercise. 
Collectively, the data presented in this dissertation are consistent with the interpretation 
that short-duration increases in intraluminal pressure that occur during exercise promote healthy 
vascular function in aged arteries through enhanced vasodilator and vasoconstrictor 
function
26,30,173
. The data in the studies 1 and 4 illustrated a NO-dependent mechanism for 
enhanced endothelium-dependent dilation following exposure to a short-duration increase in 
intraluminal pressure. Studies 2 and 3 documented an endothelium-dependent mechanism for 
enhanced Rho-mediated vasoconstrictor function following exposure to a short-duration increase 
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in intraluminal pressure. The mechanism by which the vasoconstrictor signal is transmitted from 
the endothelium to the vascular smooth muscle remains unknown.  
There is some indication that catecholamines, like NE, may play a role in 
vasoconstriction by endothelin-1. NE-induced contraction is potentiated by endothelin-1
192,193
. 
The potentiation effect of endothelin-1 on NE-induced contraction has been observed in old, not 
young, rat mesenteric arteries
194
; indicating that some component of endothelin-1 pathway is 
susceptible to alteration with age.  Additionally, Ang II has been shown to be a stimulant of 
superoxide (O2
-
) production through NAD(P)H in both vessel and cell culture studies and also 
through eNOS uncoupling
19,134,195,196
. O2
-
 increases Ca
2+
 sensitization through RhoA and may 
serve as a pathway through which Ang II-mediated constriction is impaired in aged arteries 
following exposure to increased intraluminal pressure 
197
. 
One proposed mechanism of age-impaired vascular function centers on the role reactive 
oxygen species (O2
-
) and NO bioavailability
17
. NO is a major endothelium-derived signaling 
molecule for inducing vasodilation and is degraded by O2
-
, which is produced in part by 
uncoupled eNOS. Sindler et al. demonstrated that aerobic exercise training reduced eNOS 
uncoupling and improved endothelial dependent dilation in arterioles
21
. Interestingly, Sindler et 
al. also showed that O2
- 
is necessary, on some
 
level, for endothelium-dependent dilation
21
.  O2
- 
increases with age and impairs
 
vasodilator function and promotes vasoconstriction, yet is also a 
component of vasodilation
21,136,139,198,199
. Therefore, a balance must exist between vasoconstrictor 
and vasodilator influences that promote healthy vascular function (Fig. 6.1A). Kellogg et al. 
suggested that during exercise, competition exists between vasoconstrictor and vasodilator 
pathways
200
, making the balance between vasoconstriction:vasodilation important for 
determining the net vascular response; if the balance swings too far in one direction, there is an  
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Figure 6.1. Illustration of the vasoconstrictor signal vs. the vasodilator signal balance with 
age and exercise. Ideal balance between the vasoconstrictor and vasodilator signals in young 
(A) healthy vessels. Aging (B) disrupts the balance between vasoconstrictor and vasodilator 
signals. Exercise (C) promotes a healthy vasodilator and vasoconstrictor balance in aged vessels. 
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Figure 6.2. Proposed model for the effect of a short-duration increase in intraluminal 
pressure on vasodilator and vasoconstrictor function. 
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Figure 6.2. (Continued). A short-duration increase in intraluminal pressure improves age-
impaired, endothelium-mediated Rho-dependent vasoconstriction, through the endothelin-1 
pathway (A). A short-duration increase in intraluminal pressure improves age-impaired 
endothelium-mediated vasodilation, through the NO pathway (B). A combined model showing 
the proposed effect of a short-duration increase in intraluminal pressure on vasodilator and 
vasoconstrictor responses in aged SFA (C). A short-duration increase in intraluminal pressure 
improved NO-mediated vasodilator function and improved Rho-mediated vasoconstrictor 
function in aged SFA. A short-duration increase in intraluminal pressure improved aged 
vasodilator function by increasing NO bioavailability. NO stimulates smooth muscle guanylate 
cyclase to produce cGMP, which stimulates PKG and decreases Ca
2+
 concentration within the 
smooth muscle cell to induce relaxation. Aged vasoconstrictor function is improved following a 
short-duration increase in intraluminal pressure through an endothelium mediator, endothelin-1, 
that stimulates endothelin recepters A and B and potentiates catecholamine-induced (NE, PE) 
contraction through a Rho-dependent mechanism. RhoA and its associated Rho Kinase inhibit 
myosin light chain phosphatase, which increase phospohorylated myosin light chain and increase 
Ca
2+
 within the smooth muscle cell to induce vasoconstriction. Abbreviations: Acetylcholine 
Receptor (AChR), α1 Adrenergic receptor (α1), α2 Adrenergic receptor (α2), Angiotensin 
Receptor 1 (AT1R), Cyclic Guanosine Monophosphate (cGMP), Endothelin Converting Enzyme 
(ECE), Endothelin-1 (ET-1), Endothelin Receptor A (ETA), Endothelin Receptor B (ETB), 
Endothlial Nitric Oxide Synthase (eNOS), Guanosine Triphosphate (GTP), Myosin Light Chain 
(MLC), Myosin Light Chain Phosphatase (MLCPh), Phosphorylated Myosin Light Chain (MLC-
p), Protein Kinase G (PKG). 
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unfavorable outcome (Fig 6.1B). It is likely that aerobic exercise is an effective intervention to 
restore vasoconstrictor:vasodilator balance in the aged population (Fig. 6.1C). 
Results from the studies contained within this dissertation illustrate that increased 
intraluminal pressure is an important mechanical signal associated with exercise that promotes 
proper vasoconstrictor:vasodilator balance and healthy vascular function (Fig 6.2); thus 
improving age-induced vascular dysfunction, increasing exercise tolerance in the elderly, and 
reducing the risk and detrimental effects of cardiovascular disease. 
6.2 Limitations 
Several limitations must be considered when interpreting these studies. First, the 
pressure treatment used in these studies was constant (static). In vivo, intraluminal pressure is 
dynamic and oscillates across a range of pressures associated with the systole and diastole of the 
cardiac cycle. Secondly, the isolated cannulated artery technique used in this dissertation is an ex 
vivo technique, which allowed the determination of the effect of a short-duration increased 
intraluminal pressure on aged SFA function without systemic influence; however, there may be a 
component of age-improved vascular function that is dependent on a hormonal or systemic 
response.  Finally, the soleus muscle feed artery was chosen, in part, for its documented history 
of age-impaired vascular function and improved vascular function following aerobic exercise, 
which make it an ideal artery for determining the mechanism(s) of exercise improved vascular 
function. It should be noted, however, that because of the heterogeneous nature between arteries, 
the mechanical signaling, and the effect of exercise on vascular function, may be different 
between arteries throughout the vascular tree. 
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6.3 Clinical Relevance 
Cardiovascular disease is the primary cause of death in the United States. Consequently, 
developing strategies that lead to the prevention and/or treatment of cardiovascular disease are 
imperative
1
. Vascular dysfunction occurs with age and is an independent risk factor for 
cardiovascular disease.
43-48,188
. Though the mechanism(s) are yet to be fully elucidated, it has 
become apparent that aerobic exercise is an effective therapeutic modality for preventing and 
treating aged vascular dysfunction, and reduces the risk of cardiovascular disease
26,27
. The results 
from the studies in this dissertation show that a short-duration increase in intraluminal pressure 
improves age-impaired vasodilator and vasoconstrictor function and suggests that increased 
intraluminal pressure is one mechanical signal by which aerobic exercise improves age-impaired 
vascular function. Determining the mechanism(s) by which aerobic exercise improves vascular 
function will aid in the development of the most effective exercise prescriptions to treat and 
prevent cardiovascular disease ultimately reducing the incidence of cardiovascular disease, 
improving the quality of life of those whom suffer from cardiovascular disease, and alleviating 
devastating effect of cardiovascular disease on the individual and the family. 
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APPENDIX A CHAPTER II RAW DATA 
Chapter II - Animal and Vessel Characteristics: ACh-Induced Dilation 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J39 Young P90 342.0 172.0 44.2 
J41 Young P90 351.0 234.0 27.8 
J42 Young P90 346.0 168.0 43.5 
J43 Young P90 336.0 150.0 31.3 
J44 Young P90 369.0 145.0 44.1 
J46 Young P90 347.0 141.0 53.2 
J51 Young P90 361.0 134.0 51.5 
J52 Young P90 394.0 170.0 50.6 
J55 Young P90 346.0 168.0 28.0 
J65 Young P90 388.0 198.0 40.9 
 
Mean 358.0 168.0 41.5 
 
Standard Error 6.3 9.4 3.0 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J39 Young P130 342.0 185.0 43.8 
J41 Young P130 351.0 197.0 35.5 
J44 Young P130 369.0 179.0 44.1 
J51 Young P130 361.0 182.0 37.4 
J52 Young P130 394.0 165.0 46.1 
J53 Young P130 339.0 110.0 58.2 
J63 Young P130 381.0 170.0 38.8 
J65 Young P130 388.0 156.0 35.9 
 
Mean 365.6 168.0 42.5 
 
Standard Error 7.4 9.4 2.7 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J48 Old P90 488 168 35.71428571 
J50 Old P90 353 123 25.20325203 
J56 Old P90 502 179 46.36871508 
J57 Old P90 447 129 34.10852713 
J58 Old P90 420 86 33.72093023 
J59 Old P90 486 220 33.18181818 
J61 Old P90 462 216 43.98148148 
J69 Old P90 370 149 25.5033557 
J72 Old P90 452 153 30.71895425 
J73 Old P90 387 176 36.36363636 
J80 Old P90 428 168 33.92857143 
J81 Old P90 469 211 41.70616114 
J82 Old P90 444 199 46.73366834 
J84 Old P90 425 145 42.06896552 
J87 Old P90 384 176 65.05681818 
J88 Old P90 481 225 49.77777778 
J90 Old P90 475 197.5 31.89873418 
 
Mean 439.5882353 171.7941176 38.59033251 
 
Standard Error 10.82686569 9.260631691 2.401405229 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J45 Old P130 424.0 146.0 44.5 
J47 Old P130 426.0 206.0 30.1 
J50 Old P130 353.0 147.0 25.2 
J56 Old P130 502.0 179.0 55.9 
J57 Old P130 447.0 182.0 29.7 
J58 Old P130 420.0 188.0 39.4 
J60 Old P130 428.0 105.0 25.7 
J61 Old P130 462.0 207.0 36.7 
J67 Old P130 332.0 157.0 21.7 
J68 Old P130 367.0 155.0 32.3 
J80 Old P130 428.0 236.0 55.1 
J81 Old P130 469.0 161.0 26.7 
J82 Old P130 444.0 164.0 42.7 
J83 Old P130 352.0 168.0 50.6 
J84 Old P130 425.0 174.0 32.2 
J87 Old P130 384.0 180.0 30.0 
J88 Old P130 481.0 193.0 52.8 
J89 Old P130 433.0 158.5 48.9 
J90 Old P130 475.0 226.0 46.9 
 
Mean 423.8 175.4 38.3 
 
Standard Error 10.8 7.0 2.6 
 
Animal Group 
Body Weight 
(g) 
Maximal 
Diameter (μm) 
% Spontaneous 
Tone 
J80 Old P130 + L-NNA 428.0 187.0 55.6 
J81 Old P130 + L-NNA 469.0 165.0 90.3 
J82 Old P130 + L-NNA 444.0 167.0 37.1 
J86 Old P130 + L-NNA 412.0 150.0 68.7 
J86 Old P130 + L-NNA 412.0 217.0 46.1 
J87 Old P130 + L-NNA 384.0 168.0 66.1 
 
Mean 424.8 175.7 60.6 
 
Standard Error 12.0 9.6 7.7 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J40 Old P130 + recovery 458.0 189.0 28.0 
J48 Old P130 + recovery 488.0 181.0 38.7 
J50 Old P130 + recovery 353.0 177.0 25.4 
J56 Old P130 + recovery 502.0 190.0 39.5 
J57 Old P130 + recovery 447.0 142.0 25.4 
J58 Old P130 + recovery 420.0 170.0 44.7 
J59 Old P130 + recovery 486.0 234.0 26.1 
J61 Old P130 + recovery 462.0 215.0 31.2 
 
Mean 452.0 187.3 32.4 
 
Standard Error 16.9 9.9 2.7 
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Chapter II- Raw Vasodilator Responses: ACh-Induced Dilation 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J39 Young P90 0.0 7.9 19.7 55.3 65.8 60.5 60.5 
J41 Young P90 0.0 0.0 13.8 27.7 27.7 32.3 32.3 
J42 Young P90 0.0 11.0 42.5 75.3 79.5 75.3 75.3 
J43 Young P90 0.0 29.8 31.9 100.0 85.1 85.1 80.9 
J44 Young P90 0.0 0.0 32.8 89.1 93.8 93.8 93.8 
J46 Young P90 0.0 28.0 64.0 88.0 86.7 77.3 77.3 
J51 Young P90 0.0 18.8 50.7 75.4 79.7 82.6 82.6 
J52 Young P90 0.0 48.8 84.9 90.7 91.9 91.9 91.9 
J55 Young P90 0.0 8.5 19.1 55.3 48.9 48.9 34.0 
J65 Young P90 0.0 0.0 8.6 12.3 22.2 28.4 48.1 
 
Mean 0.0 15.3 36.8 66.9 68.1 67.6 67.7 
 
Standard 
Error 0.0 5.1 7.6 9.1 8.3 7.6 7.2 
 
Animal Group Start 10-9 M 10-8 M 10-7 M 10-6 M 10-5 M 10-4 M 
J39 Young P130 0.0 0.0 32.1 77.8 86.4 86.4 86.4 
J41 Young P130 0.0 11.4 62.9 47.1 81.4 81.4 47.1 
J44 Young P130 0.0 69.6 69.6 86.1 91.1 91.1 91.1 
J51 Young P130 0.0 0.0 -11.8 -11.8 -19.1 -11.8 13.2 
J52 Young P130 0.0 27.6 73.7 80.3 84.2 84.2 84.2 
J53 Young P130 0.0 20.3 26.6 26.6 31.3 31.3 31.3 
J63 Young P130 0.0 6.1 43.9 57.6 57.6 57.6 57.6 
J65 Young P130 0.0 0.0 80.4 57.1 85.7 85.7 85.7 
 
Mean 0.0 16.9 47.2 52.6 62.3 63.2 62.1 
 
Standard 
Error 0.0 8.4 10.9 11.5 13.6 12.9 10.4 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J48 Old P90 0.0 5.0 5.0 20.0 20.0 28.3 28.3 
J50 Old P90 0.0 0.0 0.0 0.0 25.8 35.5 61.3 
J56 Old P90 0.0 4.8 12.0 32.5 41.0 41.0 32.5 
J57 Old P90 0.0 0.0 0.0 -11.4 22.7 27.3 15.9 
J58 Old P90 0.0 20.7 20.7 20.7 31.0 37.9 37.9 
J59 Old P90 0.0 0.0 16.4 23.3 30.1 32.9 37.0 
J61 Old P90 0.0 0.0 5.3 10.5 10.5 10.5 10.5 
J69 Old P90 0.0 18.4 18.4 26.3 26.3 26.3 26.3 
J72 Old P90 0.0 0.0 -17.0 -2.1 -2.1 21.3 21.3 
J73 Old P90 0.0 0.0 9.4 39.1 39.1 18.8 18.8 
J80 Old P90 0.0 0.0 61.4 61.4 61.4 61.4 49.1 
J81 Old P90 0.0 0.0 -3.4 -13.6 -19.3 -18.2 -18.2 
J82 Old P90 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
J84 Old P90 0.0 0.0 23.0 23.0 85.2 93.4 93.4 
J87 Old P90 0.0 0.0 -2.5 -6.2 -6.2 -6.2 -6.9 
J88 Old P90 0.0 0.0 44.6 50.9 69.6 73.2 68.8 
J90 Old P90 0.0 11.6 25.4 41.0 46.8 46.8 46.8 
 
Mean 0.0 3.6 12.9 18.6 28.4 31.2 30.8 
 
Standard 
Error 0.0 1.6 4.6 5.4 6.7 6.8 6.8 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J45 Old P130 0.0 20.0 46.2 46.2 46.2 41.5 41.5 
J47 Old P130 0.0 -8.1 1.6 61.3 72.6 72.6 72.6 
J50 Old P130 0.0 0.0 0.0 2.7 18.9 21.6 43.2 
J56 Old P130 0.0 7.0 62.0 74.0 74.0 62.0 62.0 
J57 Old P130 0.0 0.0 0.0 0.0 18.5 31.5 5.6 
J58 Old P130 0.0 12.2 35.1 44.6 51.4 51.4 24.3 
J60 Old P130 0.0 25.9 33.3 33.3 33.3 33.3 37.0 
J61 Old P130 0.0 9.2 9.2 30.3 44.7 51.3 53.9 
J67 Old P130 0.0 0.0 0.0 20.6 20.6 20.6 20.6 
J68 Old P130 0.0 10.0 16.0 50.0 50.0 46.0 46.0 
J80 Old P130 0.0 13.1 41.5 41.5 56.9 55.4 51.5 
J81 Old P130 0.0 0.0 7.0 30.2 30.2 37.2 37.2 
J82 Old P130 0.0 0.0 -5.7 68.6 68.6 47.1 47.1 
J83 Old P130 0.0 62.5 87.5 87.5 87.5 87.5 87.5 
J84 Old P130 0.0 10.7 10.7 10.7 10.7 10.7 10.7 
J87 Old P130 0.0 22.2 22.2 22.2 29.6 29.6 29.6 
J88 Old P130 0.0 0.5 10.3 12.9 16.0 16.0 16.0 
J89 Old P130 0.0 10.1 55.0 58.8 60.6 76.8 77.9 
J90 Old P130 0.0 0.0 84.9 84.9 84.9 84.9 84.9 
 
Mean 0.0 10.9 27.2 41.1 46.1 46.2 44.7 
 
Standard 
Error 0.0 3.6 6.6 6.1 5.6 5.2 5.6 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J80 
Old P130 + 
L-NNA 0.0 10.6 16.3 26.0 26.0 26.0 26.0 
J81 
Old P130 + 
L-NNA 0.0 0.0 4.8 4.8 4.8 4.8 4.8 
J82 
Old P130 + 
L-NNA 0.0 0.0 0.0 20.8 20.8 20.8 20.8 
J86 
Old P130 + 
L-NNA 0.0 0.0 8.7 8.7 8.7 9.7 9.7 
J86 
Old P130 + 
L-NNA 0.0 0.0 0.0 6.0 8.0 8.0 8.0 
J87 
Old P130 + 
L-NNA 0.0 0.0 0.0 2.7 2.7 -0.9 -0.9 
 
Mean 0.0 1.8 5.0 11.5 11.8 11.4 11.4 
 
Standard 
Error 0.0 1.8 2.7 3.9 3.8 4.1 4.1 
 
114 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J40 
Old P130 + 
recovery 0.0 5.7 5.7 15.1 15.1 15.1 -1.9 
J48 
Old P130 + 
recovery 0.0 24.3 31.4 54.3 54.3 51.4 32.9 
J50 
Old P130 + 
recovery 0.0 13.3 13.3 13.3 13.3 13.3 15.6 
J56 
Old P130 + 
recovery 0.0 8.0 12.0 33.3 33.3 30.7 21.3 
J57 
Old P130 + 
recovery 0.0 16.7 16.7 16.7 16.7 16.7 16.7 
J58 
Old P130 + 
recovery 0.0 18.4 57.9 57.9 80.3 92.1 75.0 
J59 
Old P130 + 
recovery 0.0 19.7 36.1 39.3 41.0 42.6 42.6 
J61 
Old P130 + 
recovery 0.0 0.0 6.0 25.4 25.4 25.4 7.5 
 
Mean 0.0 13.3 22.4 31.9 34.9 35.9 26.2 
 
Standard 
Error 0.0 2.9 6.4 6.2 8.2 9.3 8.5 
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Chapter II - Raw Animal and Vessel Characteristics: Flow-Induced Dilation 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J39 Young P90 342 172 54.1 
J41 Young P90 351 234 35.9 
J43 Young P90 336 150 28.0 
J44 Young P90 369 145 37.2 
J46 Young P90 347 141 33.3 
J51 Young P90 361 134 53.0 
J52 Young P90 394 170 25.9 
J53 Young P90 339 204 34.8 
J55 Young P90 346 168 32.7 
J70 Young P90 324 192 91.7 
 
Mean 350.9 171.0 42.7 
 
Standard Error 6.2 9.9 6.2 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J39 Young P130 342.0 186.0 53.8 
J41 Young P130 351.0 197.0 34.5 
J43 Young P130 336.0 155.0 25.2 
J44 Young P130 369.0 179.0 54.2 
J46 Young P130 347.0 149.0 29.5 
J51 Young P130 361.0 182.0 52.2 
J52 Young P130 394.0 165.0 26.1 
J63 Young P130 381.0 170.0 72.4 
 
Mean 360.1 172.9 43.5 
 
Standard Error 7.1 5.7 6.0 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J45 Old P90 424.0 173.0 0.0 
J48 Old P90 488.0 168.0 31.0 
J56 Old P90 502.0 179.0 21.8 
J57 Old P90 447.0 129.0 41.9 
J58 Old P90 420.0 86.0 25.6 
J61 Old P90 426.0 216.0 57.4 
J67 Old P90 332.0 179.0 84.9 
J69 Old P90 370.0 149.0 26.2 
J72 Old P90 452.0 153.0 58.8 
J73 Old P90 387.0 176.0 40.3 
J80 Old P90 428.0 168.0 32.1 
J82 Old P90 469.0 161.0 16.1 
J81 Old P90 444.0 164.0 22.0 
J84 Old P90 425.0 145.0 24.8 
J87 Old P90 384.0 176.0 37.5 
J88 Old P90 481.0 225.0 33.8 
J90 Old P90 475.0 189.0 33.3 
 
Mean 432.6 171.8 36.5 
 
Standard Error 11.0 8.2 4.4 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J45 Old P130 424.0 146.0 39.7 
J47 Old P130 426.0 206.0 48.5 
J50 Old P130 353.0 147.0 25.9 
J56 Old P130 502.0 179.0 32.4 
J57 Old P130 447.0 182.0 25.3 
J58 Old P130 420.0 188.0 48.4 
J59 Old P130 486.0 204.0 33.3 
J60 Old P130 428.0 105.0 32.4 
J67 Old P130 332.0 157.0 83.4 
J73 Old P130 387.0 169.0 41.4 
J79 Old P130 368.0 368.0 66.8 
J80 Old P130 428.0 236.0 47.0 
J81 Old P130 469.0 161.0 42.2 
J82 Old P130 444.0 164.0 40.2 
J83 Old P130 352.0 163.0 60.7 
J84 Old P130 425.0 174.0 31.0 
J87 Old P130 384.0 162.0 57.4 
J88 Old P130 481.0 193.0 36.8 
J89 Old P130 433.0 158.5 56.8 
 
Mean 420.5 182.2 44.7 
 
Standard Error 10.9 12.1 3.4 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J80 Old P130 + L-NNA 428.0 187.0 53.5 
J81 Old P130 + L-NNA 469.0 165.0 74.5 
J82 Old P130 + L-NNA 444.0 167.0 87.4 
J86 Old P130 + L-NNA 412.0 150.0 54.0 
J86 Old P130 + L-NNA 412.0 217.0 37.3 
J87 Old P130 + L-NNA 384.0 168.0 46.4 
 
Mean 424.8 175.7 58.9 
 
Standard Error 12.0 9.6 7.6 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J40 Old P130 + recovery 458.0 216.0 29.6 
J50 Old P130 + recovery 353.0 177.0 26.6 
J56 Old P130 + recovery 502.0 190.0 38.9 
J57 Old P130 + recovery 447.0 142.0 45.1 
J58 Old P130 + recovery 420.0 170.0 42.9 
J59 Old P130 + recovery 486.0 234.0 35.0 
J60 Old P130 + recovery 428.0 159.0 30.2 
J61 Old P130 + recovery 462.0 215.0 29.8 
 
Mean 444.5 187.9 34.8 
 
Standard Error 16.2 11.2 2.4 
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Chapter II - Raw Animal and Vessel Characteristics: Flow-Induced Dilation 
Animal Group Start 2cmH2O 4cmH2O 6cmH2O 8cmH2O 10cmH2O 
J39 Young P90 0.0 40.9 41.9 39.8 39.8 35.5 
J41 Young P90 0.0 25.0 34.5 34.5 34.5 34.5 
J43 Young P90 0.0 0.0 0.0 9.5 21.4 26.2 
J44 Young P90 0.0 18.5 37.0 51.9 51.9 50.0 
J46 Young P90 0.0 40.4 66.0 55.3 55.3 36.2 
J51 Young P90 0.0 4.2 7.0 16.9 16.9 16.9 
J52 Young P90 0.0 29.5 29.5 15.9 15.9 34.1 
J53 Young P90 0.0 40.8 42.3 42.3 42.3 42.3 
J55 Young P90 0.0 10.9 36.4 45.5 45.5 34.5 
J70 Young P90 0.0 0.0 0.0 0.0 0.0 0.0 
 
Mean 0.0 21.0 29.5 31.2 32.3 31.0 
 
Standard 
Error 0.0 5.3 6.7 6.1 5.7 4.4 
 
Animal Group 15cmH2O 20cmH2O 30cmH2O 40cmH2O 
J39 Young P90 39.8 41.9 41.9 43.0 
J41 Young P90 41.7 41.7 45.2 42.9 
J43 Young P90 26.2 23.8 23.8 23.8 
J44 Young P90 50.0 48.1 48.1 48.1 
J46 Young P90 40.4 40.4 40.4 27.7 
J51 Young P90 19.7 19.7 8.5 8.5 
J52 Young P90 38.6 38.6 25.0 27.3 
J53 Young P90 42.3 29.6 29.6 22.5 
J55 Young P90 30.9 30.9 16.4 16.4 
J70 Young P90 0.0 0.0 0.0 0.0 
 
Mean 33.0 31.5 27.9 26.0 
 
Standard Error 4.6 4.5 5.1 4.9 
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Animal Group Start 2cmH2O 4cmH2O 6cmH2O 8cmH2O 10cmH2O 
J39 Young P130 0.0 0.0 2.0 7.0 8.0 8.0 
J41 Young P130 0.0 0.0 13.2 17.6 27.9 27.9 
J43 Young P130 0.0 0.0 0.0 0.0 0.0 2.6 
J44 Young P130 0.0 13.4 20.6 29.9 29.9 20.6 
J46 Young P130 0.0 40.4 66.0 55.3 55.3 36.2 
J51 Young P130 0.0 11.6 22.1 22.1 24.2 24.2 
J52 Young P130 0.0 0.0 7.0 16.3 30.2 30.2 
J63 Young P130 0.0 7.3 7.3 30.1 30.1 30.1 
 
Mean 0.0 9.3 18.7 21.2 25.1 21.4 
 
Standard 
Error 0.0 5.3 8.0 6.3 6.3 4.3 
 
Animal Group 15cmH2O 20cmH2O 30cmH2O 40cmH2O 
J39 Young P130 11.0 11.0 11.0 5.0 
J41 Young P130 33.8 33.8 33.8 33.8 
J43 Young P130 2.6 2.6 2.6 2.6 
J44 Young P130 20.6 42.3 48.5 59.8 
J46 Young P130 40.4 40.4 40.4 27.7 
J51 Young P130 24.2 28.4 28.4 28.4 
J52 Young P130 30.2 30.2 39.5 41.9 
J63 Young P130 30.1 35.8 37.4 37.4 
 
Mean 23.3 27.0 29.2 28.4 
 
Standard Error 4.7 5.3 5.9 7.1 
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Animal Group Start 2cmH2O 4cmH2O 6cmH2O 8cmH2O 10cmH2O 
J45 Old P90 0.0 6.6 9.8 13.1 19.7 29.5 
J48 Old P90 0.0 7.7 7.7 7.7 5.8 5.8 
J56 Old P90 0.0 0.0 0.0 15.4 15.4 -17.9 
J57 Old P90 0.0 7.4 9.3 14.8 14.8 14.8 
J58 Old P90 0.0 -4.5 -4.5 13.6 13.6 13.6 
J61 Old P90 0.0 71.0 56.5 56.5 41.9 29.0 
J67 Old P90 0.0 0.0 5.9 5.9 5.9 5.9 
J69 Old P90 0.0 35.9 35.9 35.9 35.9 35.9 
J72 Old P90 0.0 0.0 0.0 0.0 0.0 0.0 
J73 Old P90 0.0 71.8 49.3 21.1 32.4 32.4 
J80 Old P90 0.0 9.3 9.3 14.8 14.8 14.8 
J82 Old P90 0.0 0.0 0.0 0.0 0.0 -7.9 
J81 Old P90 0.0 8.5 8.5 8.5 8.5 2.8 
J84 Old P90 0.0 0.0 19.4 33.3 33.3 33.3 
J87 Old P90 0.0 2.5 2.5 -13.9 -31.9 -36.0 
J88 Old P90 0.0 51.3 51.3 51.3 51.3 5.3 
J90 Old P90 0.0 16.1 21.9 45.2 49.8 49.8 
 
Mean 0.0 16.7 16.6 19.0 18.3 12.4 
 
Standard 
Error 0.0 6.1 4.8 4.7 5.1 5.2 
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Animal Group 15cmH2O 20cmH2O 30cmH2O 40cmH2O 
J45 Old P90 29.5 29.5 26.2 19.7 
J48 Old P90 1.9 -11.5 -11.5 -15.4 
J56 Old P90 -53.8 -41.0 -41.0 -41.0 
J57 Old P90 1.9 1.9 1.9 44.4 
J58 Old P90 -40.9 -40.9 -63.6 -50.0 
J61 Old P90 21.0 18.5 18.5 19.4 
J67 Old P90 5.9 5.9 28.9 28.9 
J69 Old P90 35.9 35.9 35.9 35.9 
J72 Old P90 0.0 0.0 35.6 35.6 
J73 Old P90 32.4 32.4 32.4 25.4 
J80 Old P90 14.8 14.8 14.8 1.9 
J82 Old P90 -7.9 -7.9 -7.9 -7.9 
J81 Old P90 2.8 -7.0 -7.0 -7.0 
J84 Old P90 33.3 33.3 33.3 33.3 
J87 Old P90 -35.1 -47.4 -52.3 -68.8 
J88 Old P90 14.5 14.5 14.5 14.5 
J90 Old P90 51.0 51.0 51.0 44.5 
 
Mean 6.3 4.8 6.4 6.7 
 
Standard Error 6.9 7.0 8.0 8.3 
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Animal Group Start 2cmH2O 4cmH2O 6cmH2O 8cmH2O 10cmH2O 
J45 Old P130 0.0 15.5 17.2 31.0 31.0 34.5 
J47 Old P130 0.0 33.0 71.0 71.0 72.0 72.0 
J50 Old P130 0.0 15.8 36.8 23.7 23.7 23.7 
J56 Old P130 0.0 24.1 24.1 24.1 24.1 24.1 
J57 Old P130 0.0 13.0 15.2 15.2 15.2 8.7 
J58 Old P130 0.0 11.0 13.2 26.4 27.5 27.5 
J59 Old P130 0.0 16.2 29.4 33.8 33.8 33.8 
J60 Old P130 0.0 0.0 2.9 0.0 0.0 17.6 
J67 Old P130 0.0 0.0 0.0 0.0 0.0 4.6 
J73 Old P130 0.0 64.3 72.9 78.6 67.1 27.1 
J79 Old P130 0.0 4.1 4.1 4.1 4.1 4.1 
J80 Old P130 0.0 0.0 19.8 28.8 33.3 33.3 
J81 Old P130 0.0 53.0 30.3 30.3 22.7 22.7 
J82 Old P130 0.0 48.5 48.5 48.5 22.1 22.1 
J83 Old P130 0.0 12.1 12.1 15.2 15.2 15.2 
J84 Old P130 0.0 44.4 44.4 44.4 50.0 50.0 
J87 Old P130 0.0 6.3 6.3 1.8 -0.9 -13.5 
J88 Old P130 0.0 5.1 5.1 5.1 5.1 10.3 
J89 Old P130 0.0 4.9 4.9 8.1 11.3 11.3 
 
Mean 0.0 19.6 24.1 25.8 24.1 22.6 
 
Standard 
Error 0.0 4.5 5.0 5.2 4.8 4.2 
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Animal Group 15cmH2O 20cmH2O 30cmH2O 40cmH2O 
J45 Old P130 34.5 43.1 43.1 31.0 
J47 Old P130 62.0 59.0 49.0 40.0 
J50 Old P130 34.2 34.2 18.4 18.4 
J56 Old P130 24.1 44.8 55.2 62.1 
J57 Old P130 8.7 -19.6 -19.6 -30.4 
J58 Old P130 22.0 22.0 22.0 22.0 
J59 Old P130 29.4 29.4 23.5 16.2 
J60 Old P130 17.6 26.5 32.4 32.4 
J67 Old P130 4.6 4.6 4.6 4.6 
J73 Old P130 27.1 27.1 27.1 27.1 
J79 Old P130 4.1 4.1 4.1 4.1 
J80 Old P130 25.2 25.2 25.2 18.9 
J81 Old P130 22.7 22.7 22.7 15.2 
J82 Old P130 25.0 25.0 25.0 47.1 
J83 Old P130 15.2 15.2 21.2 27.3 
J84 Old P130 50.0 57.4 57.4 57.4 
J87 Old P130 -22.5 -22.5 -35.1 -35.1 
J88 Old P130 10.3 10.3 10.3 -1.5 
J89 Old P130 12.3 16.7 17.8 19.8 
 
Mean 21.4 22.4 21.3 19.8 
 
Standard Error 4.1 5.0 5.3 5.7 
 
Animal Group Start 2cmH2O 4cmH2O 6cmH2O 8cmH2O 10cmH2O 
J80 
Old P130 + 
L-NNA 0.0 8.0 17.0 17.0 23.0 26.0 
J81 
Old P130 + 
L-NNA 0.0 0.0 -5.7 3.3 3.3 8.9 
J82 
Old P130 + 
L-NNA 0.0 0.0 0.0 0.0 0.0 0.0 
J86 
Old P130 + 
L-NNA 0.0 0.0 0.0 -6.2 -6.2 -6.2 
J86 
Old P130 + 
L-NNA 0.0 0.0 -9.9 -9.9 -9.9 -9.9 
J87 
Old P130 + 
L-NNA 0.0 0.0 -16.7 -16.7 -17.9 -17.9 
 
Mean 0.0 1.3 -2.5 -2.1 -1.3 0.2 
 
Standard 
Error 0.0 1.3 4.7 4.8 5.7 6.4 
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Animal Group 15cmH2O 20cmH2O 30cmH2O 40cmH2O 
J80 Old P130 + L-NNA 29.0 29.0 29.0 29.0 
J81 Old P130 + L-NNA 11.4 11.4 11.4 11.4 
J82 Old P130 + L-NNA 0.0 0.0 4.8 7.5 
J86 Old P130 + L-NNA -6.2 -6.2 -6.2 -6.2 
J86 Old P130 + L-NNA -9.9 -9.9 -9.9 -9.9 
J87 Old P130 + L-NNA -24.4 -24.4 -24.4 -24.4 
 
Mean 0.0 0.0 0.8 1.3 
 
Standard Error 7.5 7.5 7.6 7.6 
 
Animal Group Start 2cmH2O 4cmH2O 6cmH2O 8cmH2O 10cmH2O 
J40 Old P130 + recovery 0.0 7.8 17.2 28.1 32.8 32.8 
J50 Old P130 + recovery 0.0 14.9 27.7 27.7 27.7 23.4 
J56 Old P130 + recovery 0.0 0.0 0.0 5.4 10.8 10.8 
J57 Old P130 + recovery 0.0 14.1 35.9 35.9 32.8 32.8 
J58 Old P130 + recovery 0.0 13.7 37.0 37.0 37.0 37.0 
J59 Old P130 + recovery 0.0 18.3 24.4 25.6 25.6 28.0 
J60 Old P130 + recovery 0.0 10.4 10.4 16.7 16.7 16.7 
J61 Old P130 + recovery 0.0 0.0 15.6 15.6 9.4 9.4 
 
Mean 0.0 9.9 21.0 24.0 24.1 23.9 
 
Standard Error 0.0 2.4 4.5 3.8 3.7 3.7 
         
 
Animal Group 15cmH2O 20cmH2O 30cmH2O 40cmH2O 
J40 Old P130 + recovery 15.6 10.9 10.9 10.9 
J50 Old P130 + recovery 23.4 23.4 23.4 23.4 
J56 Old P130 + recovery 10.8 18.9 18.9 18.9 
J57 Old P130 + recovery 32.8 26.6 32.8 35.9 
J58 Old P130 + recovery 37.0 37.0 37.0 35.6 
J59 Old P130 + recovery 28.0 32.9 35.4 35.4 
J60 Old P130 + recovery -16.7 -16.7 -22.9 -22.9 
J61 Old P130 + recovery 9.4 9.4 -25.0 -25.0 
 
Mean 17.5 17.8 13.8 14.0 
 
Standard Error 6.0 6.0 8.8 8.9 
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Chapter II - Raw Animal and Vessel Characteristics: SNP-Induced Dilation 
Animal 
Group 
Body 
Weight (g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J39 Young P90 342.0 172.0 32.6 
J41 Young P90 351.0 234.0 30.3 
J42 Young P90 346.0 178.0 39.3 
J44 Young P90 369.0 145.0 42.1 
J46 Young P90 347.0 141.0 60.3 
J51 Young P90 361.0 134.0 41.0 
J52 Young P90 394.0 170.0 50.6 
J53 Young P90 339.0 204.0 47.5 
J55 Young P90 346.0 168.0 33.9 
J65 Young P90 388.0 198.0 27.3 
 
Mean 358.3 174.4 40.5 
 
Standard Error 6.1 9.8 3.2 
 
Animal Group 
Body 
Weight (g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J39 Young P130 342.0 186.0 31.7 
J41 Young P130 351.0 197.0 31.0 
J43 Young P130 336.0 155.0 39.4 
J44 Young P130 369.0 179.0 42.5 
J46 Young P130 347.0 149.0 24.8 
J52 Young P130 394.0 165.0 40.6 
J53 Young P130 339.0 110.0 39.1 
J65 Young P130 388.0 156.0 25.6 
 
Mean 358.3 162.1 34.3 
 
Standard Error 8.0 9.5 2.5 
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Animal Group 
Body 
Weight (g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J48 Old P90 488.0 168.0 35.7 
J50 Old P90 353.0 123.0 26.0 
J56 Old P90 502.0 179.0 33.5 
J57 Old P90 447.0 129.0 38.0 
J58 Old P90 420.0 86.0 27.9 
J59 Old P90 486.0 220.0 43.2 
J61 Old P90 426.0 216.0 41.2 
J69 Old P90 370.0 149.0 25.5 
J72 Old P90 452.0 153.0 27.5 
J73 Old P90 387.0 176.0 29.5 
J80 Old P90 428.0 168.0 29.8 
J81 Old P90 469.0 211.0 51.2 
J82 Old P90 444.0 199.0 42.2 
J84 Old P90 412.0 145.0 24.8 
J87 Old P90 384.0 176.0 69.0 
J88 Old P90 481.0 225.0 64.4 
J90 Old P90 475.0 189.0 49.2 
 
Mean 436.7 171.3 38.7 
 
Standard Error 10.8 9.2 3.2 
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Animal Group 
Body 
Weight (g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J45 Old P130 424.0 146.0 32.2 
J50 Old P130 353.0 147.0 25.9 
J56 Old P130 502.0 179.0 49.7 
J57 Old P130 447.0 182.0 37.9 
J58 Old P130 420.0 188.0 36.2 
J59 Old P130 486.0 204.0 25.5 
J61 Old P130 462.0 207.0 28.0 
J67 Old P130 332.0 157.0 22.9 
J68 Old P130 367.0 155.0 25.2 
J73 Old P130 387.0 169.0 30.8 
J80 Old P130 428.0 236.0 47.5 
J81 Old P130 469.0 161.0 26.7 
J82 Old P130 444.0 164.0 39.6 
J83 Old P130 352.0 163.0 30.1 
J84 Old P130 425.0 174.0 28.2 
J87 Old P130 384.0 180.0 25.0 
J88 Old P130 481.0 193.0 49.0 
J89 Old P130 433.0 158.5 62.1 
J90 Old P130 475.0 226.0 25.7 
 
Mean 424.8 178.4 34.1 
 
Standard Error 11.5 5.8 2.5 
 
Animal Group 
Body 
Weight (g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J40 Old P130 + recovery 458.0 216.0 53.2 
J47 Old P130 + recovery 426.0 217.0 27.2 
J50 Old P130 + recovery 353.0 177.0 25.4 
J56 Old P130 + recovery 502.0 190.0 33.2 
J57 Old P130 + recovery 447.0 142.0 29.6 
J58 Old P130 + recovery 420.0 170.0 35.9 
J59 Old P130 + recovery 486.0 234.0 25.6 
J61 Old P130 + recovery 462.0 215.0 32.6 
 
Mean 444.3 195.1 32.8 
 
Standard Error 16.3 10.9 3.2 
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Chapter II - Raw Vasodilator Responses: SNP-Induced Dilation 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J39 Young P90 0.0 17.9 32.1 32.1 58.9 58.9 58.9 
J41 Young P90 0.0 16.9 12.7 12.7 12.7 12.7 28.2 
J42 Young P90 0.0 0.0 -5.7 -5.7 -2.9 1.4 51.4 
J44 Young P90 0.0 1.6 1.6 24.6 27.9 50.8 67.2 
J46 Young P90 0.0 28.2 43.5 52.9 71.8 71.8 91.8 
J51 Young P90 0.0 29.1 29.1 38.2 12.7 29.1 30.9 
J52 Young P90 0.0 48.8 84.9 90.7 91.9 91.9 91.9 
J53 Young P90 0.0 10.3 18.6 24.7 38.1 47.4 62.9 
J55 Young P90 0.0 12.3 36.8 42.1 42.1 54.4 70.2 
J65 Young P90 0.0 31.5 31.5 37.0 37.0 53.7 53.7 
 
Mean 0.0 19.7 28.5 34.9 39.0 47.2 60.7 
 
Standard 
Error 0.0 4.7 8.0 8.1 9.2 8.5 6.8 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J39 Young P130 0.0 0.0 0.0 47.5 91.5 91.5 91.5 
J41 Young P130 0.0 3.3 18.0 55.7 55.7 68.9 96.7 
J43 Young P130 0.0 3.3 23.0 23.0 36.1 49.2 90.2 
J44 Young P130 0.0 42.1 38.2 56.6 61.8 67.1 80.3 
J46 Young P130 0.0 0.0 0.0 0.0 0.0 48.6 70.3 
J52 Young P130 0.0 25.4 25.4 25.4 49.3 53.7 74.6 
J53 Young P130 0.0 11.6 30.2 46.5 51.2 65.1 65.1 
J65 Young P130 0.0 15.0 47.5 72.5 72.5 87.5 87.5 
 
Mean 0.0 12.6 22.8 40.9 52.3 66.5 82.0 
 
Standard 
Error 0.0 5.2 5.9 8.2 9.5 5.8 4.0 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J48 Old P90 0.0 5.0 5.0 11.7 20.0 40.0 43.3 
J50 Old P90 0.0 21.9 21.9 25.0 25.0 25.0 25.0 
J56 Old P90 0.0 5.0 13.3 13.3 13.3 26.7 56.7 
J57 Old P90 0.0 0.0 4.1 4.1 18.4 24.5 34.7 
J58 Old P90 0.0 4.2 4.2 0.0 0.0 12.5 16.7 
J59 Old P90 0.0 0.0 10.5 23.2 23.2 36.8 56.8 
J61 Old P90 0.0 5.6 21.3 30.3 37.1 37.1 42.7 
J69 Old P90 0.0 31.6 31.6 31.6 31.6 31.6 31.6 
J72 Old P90 0.0 2.4 21.4 31.0 42.9 42.9 42.9 
J73 Old P90 0.0 7.7 7.7 19.2 21.2 32.7 48.1 
J80 Old P90 0.0 0.0 20.0 28.0 40.0 66.0 66.0 
J81 Old P90 0.0 0.0 5.6 5.6 5.6 5.6 13.0 
J82 Old P90 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
J84 Old P90 0.0 0.0 44.4 55.6 55.6 66.7 66.7 
J87 Old P90 0.0 0.0 2.7 4.8 5.5 5.5 5.5 
J88 Old P90 0.0 0.0 0.0 16.6 25.5 25.5 30.3 
J90 Old P90 0.0 3.1 9.7 19.1 -18.1 43.9 58.7 
 
Mean 0.0 5.1 13.1 18.8 20.4 30.8 37.6 
 
Standard 
Error 0.0 2.1 3.0 3.5 4.5 4.6 5.0 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J45 Old P130 0.0 0.0 0.0 19.1 29.8 42.6 48.9 
J50 Old P130 0.0 18.4 21.1 31.6 36.8 36.8 36.8 
J56 Old P130 0.0 19.1 31.5 31.5 39.3 46.1 69.7 
J57 Old P130 0.0 0.0 10.1 11.6 18.8 33.3 37.7 
J58 Old P130 0.0 58.8 67.6 82.4 75.0 76.5 76.5 
J59 Old P130 0.0 9.6 26.9 26.9 26.9 40.4 42.3 
J61 Old P130 0.0 29.3 50.0 56.9 62.1 69.0 69.0 
J67 Old P130 0.0 16.7 16.7 33.3 33.3 33.3 33.3 
J68 Old P130 0.0 15.4 28.2 53.8 100.0 100.0 100.0 
J73 Old P130 0.0 0.0 5.8 13.5 19.2 28.8 42.3 
J80 Old P130 0.0 10.7 10.7 17.9 26.8 40.2 42.9 
J81 Old P130 0.0 30.2 60.5 86.0 86.0 90.7 93.0 
J82 Old P130 0.0 9.2 44.6 30.8 67.7 67.7 70.8 
J83 Old P130 0.0 0.0 8.2 26.5 26.5 63.3 53.1 
J84 Old P130 0.0 0.0 55.1 55.1 71.4 85.7 85.7 
J87 Old P130 0.0 20.0 37.8 37.8 37.8 37.8 37.8 
J88 Old P130 0.0 0.0 1.3 -6.7 4.1 15.5 21.8 
J89 Old P130 0.0 7.3 13.6 18.5 26.6 29.5 40.5 
J90 Old P130 0.0 0.0 10.3 51.7 55.2 55.2 67.2 
 
Mean 0.0 12.9 26.3 35.7 44.4 52.2 56.3 
 
Standard 
Error 0.0 3.4 4.8 5.4 5.9 5.4 5.1 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J40 
Old P130 + 
recovery 0.0 0.0 0.0 19.1 19.1 19.1 19.1 
J47 
Old P130 + 
recovery 0.0 10.2 11.9 55.9 61.0 61.0 61.0 
J50 
Old P130 + 
recovery 0.0 13.3 13.3 13.3 13.3 13.3 15.6 
J56 
Old P130 + 
recovery 0.0 6.3 30.2 30.2 47.6 47.6 50.8 
J57 
Old P130 + 
recovery 0.0 0.0 2.4 2.4 33.3 33.3 33.3 
J58 
Old P130 + 
recovery 0.0 16.4 31.1 32.8 32.8 67.2 67.2 
J59 
Old P130 + 
recovery 0.0 13.3 33.3 28.3 38.3 65.0 65.0 
J61 
Old P130 + 
recovery 0.0 11.4 20.0 24.3 24.3 35.7 35.7 
 
Mean 0.0 8.9 17.8 25.8 33.7 42.8 43.5 
 
Standard 
Error 0.0 2.2 4.6 5.6 5.5 7.3 7.2 
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Chapter II - Raw Immunoblot Data 
Vessel Number Group p-eNOS (AU) eNOS (AU) p-eNOS/eNOS (AU) 
360 P90 3670619 3383517 1.084853128 
354 P90 3690609 5767243 0.639926044 
361 P130 3773712 3140305 1.201702382 
355 P130 5621689 6153275 0.913609257 
345 P130 4569595 5995384 0.762185541 
369 P130 2439618 8896825 0.274212205 
364 P130 2828118 6835032 0.41376807 
 
p-eNOS / total eNOS Mean Intensity (AU) Standard Error 
P130 0.713095491 0.167864192 
P90 0.862389586 0.222463542 
 
(p-eNOS / total eNOS) / P90mean Mean Intensity (AU) Standard Error 
P130 0.826883235 0.194650069 
P90 1 0.257961767 
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APPENDIX B CHAPTER III RAW DATA 
 
Chapter III - Raw Animal and Vessel Characteristics: NE-Induced Constriction 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J229 Young P90 361.0 183.0 65.6 
J230 Young P90 316.0 228.0 53.9 
J231 Young P90 349.0 176.0 50.6 
J232 Young P90 350.0 253.0 47.0 
J233 Young P90 353.0 142.0 69.0 
J234 Young P90 351.0 195.0 40.0 
 
Mean 346.7 196.2 54.4 
 
Standard Error 6.4 16.1 4.5 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J219 Old P90 411.0 135.0 51.9 
J220 Old P90 426.0 90.0 2.2 
J221 Old P90 417.0 221.0 0.0 
J223 Old P90 423.0 56.0 3.6 
J224 Old P90 444.0 157.0 63.7 
J225 Old P90 431.0 147.0 1.4 
J226 Old P90 385.0 104.0 1.9 
J228 Old P90 414.0 139.0 0.0 
 
Mean 418.9 131.1 15.6 
 
Standard Error 6.1 17.5 9.3 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J219 Old P130 411.0 122.0 58.2 
J220 Old P130 426.0 119.0 52.9 
J222 Old P130 402.0 235.0 8.9 
J224 Old P130 444.0 141.0 42.6 
J225 Old P130 432.0 158.0 2.5 
J226 Old P130 385.0 90.0 2.2 
 
Mean 416.7 144.2 27.9 
 
Standard Error 8.8 20.4 10.7 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J223 Old P130 + Y27632 423.0 173.0 1.7 
J225 Old P130 + Y27632 432.0 156.0 3.2 
J226 Old P130 + Y27632 385.0 162.0 14.8 
J227 Old P130 + Y27632 410.0 170.0 0.6 
J228 Old P130 + Y27632 414.0 231.0 2.6 
 
Mean 412.8 178.4 4.6 
 
Standard Error 7.9 13.5 2.6 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J223 Old P90 + LPA 423.0 122.0 1.6 
J224 Old P90 + LPA 444.0 147.0 59.9 
J226 Old P90 + LPA 385.0 168.0 38.1 
J227 Old P90 + LPA 410.0 159.0 49.7 
J228 Old P90 + LPA 414.0 122.0 38.5 
 
Mean 415.2 143.6 37.6 
 
Standard Error 9.6 9.4 9.8 
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Chapter III - Raw Vasoconstrictor Responses: NE-Induced Constriction 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J229 Young P90  0.0 14.3 41.3 79.4 81.0 88.9 90.5 
J230 Young P90 0.0 3.8 36.2 87.6 100.0 100.0 100.0 
J231 Young P90 0.0 10.3 58.6 82.8 93.1 93.1 100.0 
J232 Young P90  0.0 9.7 11.2 21.6 75.4 85.1 100.0 
J233 Young P90  0.0 6.8 65.9 84.1 100.0 100.0 100.0 
J234 Young P90  0.0 2.6 50.4 85.5 100.0 100.0 100.0 
 
Mean 0.0 7.9 43.9 73.5 91.6 94.5 98.4 
 
Standard 
Error 0.0 1.8 7.9 10.4 4.4 2.7 1.6 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J219 Old P90 0.0 1.5 9.2 38.5 63.1 64.6 67.7 
J220 Old P90 0.0 3.4 3.4 6.8 13.6 12.5 26.1 
J221 Old P90 0.0 0.0 1.4 46.2 68.8 79.2 80.5 
J223 Old P90 0.0 1.9 3.7 18.5 29.6 50.0 59.3 
J224 Old P90 0.0 0.0 22.8 71.9 94.7 94.7 100.0 
J225 Old P90 0.0 0.0 0.0 10.3 29.7 44.1 55.2 
J226 Old P90 0.0 1.0 1.0 21.6 37.3 50.0 56.9 
J228 Old P90 0.0 1.4 1.4 1.4 4.3 18.7 30.2 
 
Mean 0.0 1.2 5.4 26.9 42.6 51.7 59.5 
 
Standard 
Error 0.0 0.4 2.7 8.4 10.8 9.9 8.6 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J219 Old P130 0.0 9.8 29.4 86.3 92.2 90.2 90.2 
J220 Old P130 0.0 0.0 5.4 75.0 78.6 83.9 100.0 
J222 Old P130 0.0 0.0 4.2 38.3 81.3 93.5 95.8 
J224 Old P130 0.0 0.0 16.0 65.4 91.4 92.6 93.8 
J225 Old P130 0.0 0.0 5.8 17.5 59.1 60.4 88.3 
J226 Old P130 0.0 0.0 0.0 13.6 38.6 58.0 59.1 
 
Mean 0.0 1.6 10.1 49.4 73.5 79.8 87.9 
 
Standard 
Error 0.0 1.6 4.4 12.5 8.5 6.7 6.0 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J223 
Old P130 + 
Y27632 0.0 0.0 0.0 4.7 7.1 7.6 7.6 
J225 
Old P130 + 
Y27632 0.0 0.0 0.0 2.6 4.0 4.0 6.6 
J226 
Old P130 + 
Y27632 0.0 0.0 0.0 8.0 26.8 49.3 52.2 
J227 
Old P130 + 
Y27632 0.0 0.6 1.8 7.1 9.5 12.4 31.4 
J228 
Old P130 + 
Y27632 0.0 0.0 0.9 10.2 28.4 37.8 39.6 
 
Mean 0.0 0.1 0.5 6.5 15.2 22.2 27.5 
 
Standard 
Error 0.0 0.1 0.4 1.3 5.2 9.0 8.9 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J223 
Old P90 + 
LPA 0.0 0.8 0.8 7.5 38.3 59.2 67.5 
J224 
Old P90 + 
LPA 0.0 0.0 0.0 -1.7 3.4 5.1 16.9 
J226 
Old P90 + 
LPA 0.0 0.0 9.6 30.8 67.3 73.1 90.4 
J227 
Old P90 + 
LPA 0.0 0.0 5.0 60.0 72.5 80.0 81.3 
J228 
Old P90 + 
LPA 0.0 0.0 14.7 48.0 80.0 90.7 94.7 
 
Mean 0.0 0.2 6.0 28.9 52.3 61.6 70.2 
 
Standard 
Error 0.0 0.2 2.8 11.7 14.1 15.0 14.1 
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Chapter III - Raw Animal and Vessel Characteristics: Ang II-Induced Constriction  
  
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J229 Young P90 361.0 183.0 62.8 
J230 Young P90 316.0 228.0 0.0 
J231 Young P90 349.0 176.0 50.0 
J232 Young P90 350.0 253.0 58.5 
J233 Young P90 353.0 142.0 69.7 
J234 Young P90 351.0 195.0 55.4 
 
Mean 346.7 196.2 49.4 
 
Standard Error 6.4 16.1 10.3 
 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J219 Old P90 411.0 135.0 45.9 
J220 Old P90 426.0 90.0 1.1 
J221 Old P90 417.0 221.0 45.7 
J223 Old P90 423.0 56.0 17.9 
J224 Old P90 444.0 157.0 49.0 
J225 Old P90 431.0 147.0 15.0 
J226 Old P90 385.0 104.0 31.7 
J228 Old P90 414.0 139.0 19.4 
 
Mean 418.9 131.1 28.2 
 
Standard Error 6.1 17.5 6.2 
 
 
Animal Group 
Body 
Weight (g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J219 Old P130 411.0 122.0 59.8 
J220 Old P130 426.0 119.0 -1.7 
J222 Old P130 402.0 235.0 54.0 
J224 Old P130 444.0 141.0 0.0 
J225 Old P130 432.0 158.0 39.9 
J226 Old P130 385.0 90.0 16.7 
 
Mean 416.7 144.2 28.1 
 
Standard Error 8.8 20.4 11.0 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J223 Old P130 + Y27632 423.0 173.0 2.3 
J225 Old P130 + Y27632 432.0 156.0 3.8 
J226 Old P130 + Y27632 385.0 162.0 8.6 
J227 Old P130 + Y27632 410.0 170.0 5.3 
J228 Old P130 + Y27632 414.0 231.0 1.7 
 
Mean 412.8 178.4 4.4 
 
Standard Error 7.9 13.5 1.2 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J223 Old P90 + LPA 423.0 122.0 42.6 
J224 Old P90 + LPA 444.0 147.0 51.0 
J226 Old P90 + LPA 385.0 168.0 58.3 
J227 Old P90 + LPA 410.0 159.0 64.8 
J228 Old P90 + LPA 414.0 122.0 50.0 
 
Mean 415.2 143.6 53.4 
 
Standard Error 9.6 9.4 3.8 
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Chapter III - Raw Vasoconstrictor Responses: Ang II-Induced Constriction 
Animal Group Start 10
-11
 M 10
-10
 M 10
-9
 M 10
-8
 M 10
-7
 M 
J229 Young P90 0.0 17.6 17.6 25.0 1.5 1.5 
J230 Young P90 0.0 58.3 71.9 69.7 60.1 69.7 
J231 Young P90 0.0 3.4 53.4 53.4 38.6 29.5 
J232 Young P90 0.0 11.4 15.2 17.1 13.3 7.6 
J233 Young P90 0.0 30.2 39.5 37.2 37.2 25.6 
J234 Young P90 0.0 21.8 27.6 27.6 27.6 27.6 
 
Mean 0.0 31.8 42.6 43.1 35.7 31.4 
 
Standard Error 0.0 10.4 9.1 8.3 9.3 9.4 
 
 
Animal Group Start 10
-11
 M 10
-10
 M 10
-9
 M 10
-8
 M 10
-7
 M 
J219 Old P90 0.0 5.5 11.0 16.4 16.4 12.3 
J220 Old P90 0.0 1.1 0.0 1.1 1.1 -1.1 
J221 Old P90 0.0 25.8 43.3 38.3 39.2 41.7 
J223 Old P90 0.0 2.2 10.9 4.3 2.2 2.2 
J224 Old P90 0.0 8.8 17.5 17.5 20.0 20.0 
J225 Old P90 0.0 0.0 -1.6 0.8 2.4 0.8 
J226 Old P90 0.0 1.4 4.2 5.6 5.6 2.8 
J228 Old P90 0.0 4.5 6.3 1.8 3.6 9.8 
 
Mean 0.0 6.2 11.4 10.7 11.3 11.1 
 
Standard Error 0.0 3.0 5.1 4.6 4.7 5.0 
 
 
Animal Group Start 10
-11
 M 10
-10
 M 10
-9
 M 10
-8
 M 10
-7
 M 
J219 Old P130 0.0 32.7 44.9 46.9 28.6 28.6 
J220 Old P130 0.0 0.0 0.8 70.2 71.9 66.1 
J222 Old P130 0.0 17.6 42.6 48.1 48.1 42.6 
J224 Old P130 0.0 1.4 42.6 60.3 58.9 56.0 
J225 Old P130 0.0 10.5 26.3 22.1 6.3 2.1 
J226 Old P130 0.0 2.7 9.3 14.7 14.7 13.3 
 
Mean 0.0 10.8 27.8 43.7 38.1 34.8 
 
Standard Error 0.0 5.1 7.7 8.8 10.5 10.1 
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Animal Group Start 10
-11
 M 10
-10
 M 10
-9
 M 10
-8
 M 10
-7
 M 
J223 Old P130 + Y27632 0.0 0.0 0.0 0.0 0.0 -2.4 
J225 Old P130 + Y27632 0.0 0.0 1.3 -0.7 -0.7 -0.7 
J226 Old P130 + Y27632 0.0 0.0 7.4 12.2 8.8 2.7 
J227 Old P130 + Y27632 0.0 0.6 0.6 0.6 -2.5 -2.5 
J228 Old P130 + Y27632 0.0 1.3 3.5 3.5 3.5 4.0 
 
Mean 0.0 0.4 2.6 3.1 1.8 0.2 
 
Standard Error 0.0 0.3 1.4 2.4 2.0 1.3 
 
 
Animal Group Start 10
-11
 M 10
-10
 M 10
-9
 M 10
-8
 M 10
-7
 M 
J223 Old P90 + LPA 0.0 10.0 10.0 10.0 2.9 1.4 
J224 Old P90 + LPA 0.0 5.6 44.4 44.4 48.6 45.8 
J226 Old P90 + LPA 0.0 5.7 32.9 40.0 32.9 22.9 
J227 Old P90 + LPA 0.0 5.4 28.6 37.5 28.6 21.4 
J228 Old P90 + LPA 0.0 14.8 31.1 36.1 39.3 32.8 
 
Mean 0.0 8.3 29.4 33.6 30.4 24.9 
 
Standard Error 0.0 1.8 5.6 6.1 7.7 7.3 
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Chapter III - Raw Animal and Vessel Characteristics: PE-Induced Constriction  
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J229 Young P90 361.0 183.0 40.4 
J230 Young P90 316.0 228.0 46.5 
J231 Young P90 349.0 176.0 52.3 
J232 Young P90 350.0 253.0 52.2 
J233 Young P90 353.0 142.0 41.5 
J234 Young P90 351.0 195.0 53.3 
 
Mean 346.7 196.2 47.7 
 
Standard Error 6.4 16.1 2.3 
 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J219 Old P90 411.0 135.0 37.0 
J220 Old P90 426.0 90.0 0.0 
J221 Old P90 417.0 221.0 43.9 
J223 Old P90 423.0 56.0 17.9 
J224 Old P90 444.0 157.0 62.4 
J225 Old P90 431.0 147.0 30.6 
J222 Old P90 385.0 104.0 15.4 
J228 Old P90 414.0 139.0 24.5 
 
Mean 418.9 131.1 29.0 
 
Standard Error 6.1 17.5 6.8 
 
 
Animal Group 
Body 
Weight (g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J219 Old P130 411.0 122.0 59.8 
J220 Old P130 426.0 119.0 48.7 
J222 Old P130 402.0 235.0 53.2 
J224 Old P130 444.0 141.0 39.0 
J225 Old P130 432.0 158.0 22.8 
J226 Old P130 385.0 90.0 21.1 
 
Mean 416.7 144.2 40.8 
 
Standard Error 8.8 20.4 6.6 
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Animal Group 
Body Weight 
(g) 
Maximal 
Diameter 
(μm) 
% Spontaneous 
Tone 
J223 Old P130 + Y27632 423.0 173.0 -0.6 
J225 Old P130 + Y27632 432.0 156.0 3.8 
J226 Old P130 + Y27632 385.0 162.0 8.0 
J227 Old P130 + Y27632 410.0 170.0 1.2 
J228 Old P130 + Y27632 414.0 231.0 4.3 
 
Mean 412.8 178.4 3.4 
 
Standard Error 7.9 13.5 1.5 
 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J223 Old P90 + LPA 423.0 122.0 26.2 
J224 Old P90 + LPA 444.0 147.0 71.4 
J226 Old P90 + LPA 385.0 168.0 54.8 
J227 Old P90 + LPA 410.0 159.0 43.4 
J228 Old P90 + LPA 414.0 122.0 50.0 
 
Mean 415.2 143.6 49.2 
 
Standard Error 9.6 9.4 7.4 
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Chapter III - Raw Vasoconstrictor Responses: PE-Induced Constriction 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J229 Young P90 0.0 0.9 0.9 32.1 62.4 62.4 62.4 
J230 Young P90 0.0 5.7 30.3 72.1 93.4 100.0 100.0 
J231 Young P90 0.0 0.0 0.0 46.4 32.1 88.1 90.5 
J232 Young P90 0.0 6.6 9.1 26.4 85.1 83.5 78.5 
J233 Young P90 0.0 0.0 0.0 3.6 16.9 25.3 42.2 
J234 Young P90 0.0 0.0 6.6 63.7 91.2 96.7 96.7 
 
Mean 0.0 2.2 7.8 40.7 63.5 76.0 78.4 
 
Standard 
Error 0.0 1.3 4.8 10.3 13.3 11.5 9.2 
 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J219 Old P90 0.0 2.4 3.5 8.2 22.4 32.9 47.1 
J220 Old P90 0.0 3.3 3.3 3.3 3.3 3.3 5.6 
J221 Old P90 0.0 4.8 8.9 16.9 43.5 66.9 67.7 
J223 Old P90 0.0 2.2 2.2 4.3 17.4 19.6 26.1 
J224 Old P90 0.0 0.0 44.1 61.0 78.0 81.4 86.4 
J225 Old P90 0.0 0.0 -1.0 6.9 15.7 28.4 36.3 
J222 Old P90 0.0 3.4 3.4 4.5 11.4 14.8 21.6 
J228 Old P90 0.0 4.8 13.3 21.9 39.0 41.9 38.1 
 
Mean 0.0 2.6 9.7 15.9 28.8 36.2 41.1 
 
Standard 
Error 0.0 0.7 5.1 6.9 8.5 9.4 9.2 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J219 Old P130 0.0 4.1 16.3 42.9 71.4 71.4 75.5 
J220 Old P130 0.0 0.0 0.0 11.5 21.3 24.6 62.3 
J222 Old P130 0.0 0.0 1.8 22.7 58.2 60.0 76.4 
J224 Old P130 0.0 5.8 4.7 15.1 55.8 76.7 91.9 
J225 Old P130 0.0 4.1 9.8 18.0 42.6 50.8 64.8 
J226 Old P130 0.0 0.0 2.8 2.8 15.5 26.8 29.6 
 
Mean 0.0 2.3 5.9 18.8 44.1 51.7 66.7 
 
Standard 
Error 0.0 1.1 2.5 5.5 9.0 9.0 8.6 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J223 
Old P130 + 
Y27632 0.0 0.6 0.6 1.7 3.4 2.9 4.6 
J225 
Old P130 + 
Y27632 0.0 0.0 2.0 2.0 4.0 4.0 6.0 
J226 
Old P130 + 
Y27632 0.0 0.0 2.0 4.7 26.8 41.6 43.0 
J227 
Old P130 + 
Y27632 0.0 0.0 1.8 3.6 6.0 6.5 5.4 
J228 
Old P130 + 
Y27632 0.0 0.5 0.5 2.3 7.2 10.4 12.2 
 
Mean 0.0 0.2 1.4 2.9 9.5 13.1 14.2 
 
Standard 
Error 0.0 0.1 0.4 0.6 4.4 7.2 7.3 
 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J223 
Old P90 + 
LPA 0.0 0.0 1.1 3.3 21.1 22.2 30.0 
J224 
Old P90 + 
LPA 0.0 0.0 0.0 42.9 47.6 52.4 52.4 
J226 
Old P90 + 
LPA 0.0 1.3 1.3 13.2 52.6 63.2 60.5 
J227 
Old P90 + 
LPA 0.0 0.0 0.0 26.7 64.4 75.6 73.3 
J228 
Old P90 + 
LPA 0.0 0.0 14.8 54.1 78.7 82.0 86.9 
 
Mean 0.0 0.3 3.4 28.0 52.9 59.1 60.6 
 
Standard 
Error 0.0 0.3 2.8 9.3 9.6 10.5 9.6 
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APPENDIX C CHAPTER IV RAW DATA 
Chapter IV - Raw Animal and Vessel Characteristics: NE-Induced Constriction 
Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
Young P90 345.0 181.0 34.8 
Young P90 364.0 149.0 77.9 
Young P90 367.0 178.0 66.9 
Young P90 357.0 93.0 5.4 
Young P90 335.0 200.0 0.0 
Mean 353.6 160.2 37.0 
Standard Error 6.0 18.7 15.7 
 
 
 
  
Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
Old P90 400.0 112.0 47.3 
Old P90 436.0 95.0 33.7 
Old P90 417.0 95.0 63.2 
Old P90 417.0 72.0 0.0 
Old P90 417.0 111.0 75.7 
Old P90 394.0 118.0 26.3 
Old P90 444.0 109.0 39.4 
Old P90 444.0 112.0 42.0 
Old P90 436.0 115.0 52.2 
Mean 422.8 104.3 42.2 
Standard Error 6.1 4.9 7.3 
 
 
Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
Old P130 417.0 113.0 30.1 
Old P130 417.0 170.0 25.9 
Old P130 444.0 121.0 26.4 
Old P130 436.0 140.0 26.4 
Old P130 436.0 115.0 26.1 
Mean 430.0 131.8 27.0 
Standard Error 5.5 10.7 0.8 
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Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
Old P90 + Y27632 400.0 144.0 3.5 
Old P90 + Y27632 417.0 100.0 -4.0 
Old P90 + Y27632 436.0 118.0 8.5 
Old P90 + Y27632 436.0 99.0 6.1 
Mean 422.3 115.3 3.5 
Standard Error 8.7 10.5 2.7 
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Chapter IV - Raw Vasoconstrictor Responses: NE-Induced Constriction 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J210 Young P90 0.0 14.4 22.0 28.0 66.9 83.1 92.4 
J211 Young P90 0.0 18.2 54.5 87.9 100.0 100.0 100.0 
J213 Young P90 0.0 54.2 86.4 100.0 100.0 100.0 100.0 
J216 Young P90 0.0 3.4 4.5 15.9 18.2 50.0 70.5 
J217 Young P90 0.0 0.0 4.5 55.5 76.5 84.0 90.0 
 
Mean 0.0 18.0 34.4 57.5 72.3 83.4 90.6 
 
Standard 
Error 0.0 9.7 15.9 16.3 15.0 9.1 5.4 
 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J191 Old P90 0.0 0.0 5.1 30.5 39.0 59.3 54.2 
J192 Old P90 0.0 0.0 3.2 20.6 77.8 100.0 100.0 
J193 Old P90 0.0 0.0 0.0 11.4 11.4 40.0 60.0 
J194 Old P90 0.0 0.0 8.3 15.3 18.1 33.3 61.1 
J194 Old P90 0.0 7.4 33.3 55.6 100.0 100.0 100.0 
J195 Old P90 0.0 0.0 10.3 54.0 62.1 73.6 77.0 
J196 Old P90 0.0 7.6 63.6 80.3 87.9 92.4 93.9 
J196 Old P90 0.0 -7.7 6.2 70.8 95.4 100.0 100.0 
J198 Old P90 0.0 5.5 23.6 56.4 78.2 80.0 90.9 
 
Mean 0.0 1.4 17.1 43.9 63.3 75.4 81.9 
 
Standard 
Error 0.0 1.6 6.8 8.4 11.0 8.7 6.4 
 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J193 Old P130 0.0 2.5 24.1 24.1 59.5 64.6 59.5 
J194 Old P130 0.0 0.8 5.6 33.3 42.1 46.8 57.1 
J196 Old P130 0.0 0.0 2.2 12.4 24.7 38.2 44.9 
J198 Old P130 0.0 -1.0 1.9 9.7 44.7 55.3 66.0 
J199 Old P130 0.0 1.2 12.9 20.0 51.8 80.0 85.9 
 
Mean 0.0 0.7 9.3 19.9 44.5 57.0 62.7 
 
Standard 
Error 0.0 0.6 4.2 4.2 5.8 7.2 6.7 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J191 
Old P90 + 
Y27632 0.0 1.4 2.9 3.6 2.2 10.1 11.5 
J194 
Old P90 + 
Y27632 0.0 0.0 1.9 2.9 7.7 16.3 20.2 
J199 
Old P90 + 
Y27632 0.0 0.0 0.0 3.7 6.5 5.6 12.0 
J199 
Old P90 + 
Y27632 0.0 0.0 0.0 0.0 1.1 -2.2 2.2 
 
Mean 0.0 0.4 1.2 2.5 4.4 7.5 11.5 
 
Standard 
Error 0.0 0.4 0.7 0.9 1.6 3.9 3.7 
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Chapter IV - Raw Animal and Vessel Characteristics: Ang II-Induced Constriction 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J182 Young P90 364.0 200.0 13.0 
J182 Young P90 364.0 123.0 82.1 
J183 Young P90 332.0 158.0 33.5 
J184 Young P90 354.0 237.0 77.2 
J184 Young P90 354.0 133.0 63.9 
J185 Young P90 357.0 105.0 29.5 
J187 Young P90 311.0 176.0 10.2 
J187 Young P90 311.0 126.0 52.4 
J188 Young P90 351.0 118.0 33.9 
J189 Young P90 312.0 159.0 53.5 
J235 Young P90 336.0 155.0 1.3 
J236 Young P90 370.0 194.0 28.4 
 
Mean 343.0 157.0 39.9 
 
Standard Error 6.3 11.3 7.5 
 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J175 Old P90 455.0 150.0 32.0 
J176 Old P90 407.0 218.0 20.6 
J177 Old P90 324.0 200.0 40.5 
J177 Old P90 324.0 203.0 38.4 
J179 Old P90 486.0 201.0 64.7 
J191 Old P90 400.0 112.0 58.9 
J194 Old P90 417.0 101.0 60.4 
J194 Old P90 417.0 72.0 23.6 
J195 Old P90 394.0 118.0 32.2 
J196 Old P90 444.0 109.0 57.8 
J196 Old P90 444.0 112.0 62.5 
 
Mean 410.2 145.1 44.7 
 
Standard Error 15.2 15.5 5.0 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J192 Old P130 436.0 132.0 12.1 
J193 Old P130 417.0 113.0 48.7 
J194 Old P130 417.0 170.0 14.1 
J196 Old P130 444.0 121.0 43.0 
J198 Old P130 436.0 140.0 39.3 
J199 Old P130 436.0 115.0 24.3 
 
Mean 431.0 131.8 30.3 
 
Standard Error 4.6 8.7 6.3 
 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J191 Old P90 + Y27632 400.0 144.0 3.5 
J194 Old P90 + Y27632 417.0 100.0 -8.0 
J198 Old P90 + Y27632 436.0 115.0 0.9 
J199 Old P90 + Y27632 436.0 118.0 5.9 
J199 Old P90 + Y27632 436.0 99.0 9.1 
 
Mean 425.0 115.2 2.3 
 
Standard Error 7.3 8.2 2.9 
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Chapter IV - Raw Vasoconstrictor Responses: Ang II-Induced Constriction 
Animal Group Start 10
-11
 M 10
-10
 M 10
-9
 M 10
-8
 M 10
-7
 M 
J182 Young P90 0.0 0.0 5.2 7.5 13.2 13.2 
J182 Young P90 0.0 13.6 27.3 45.5 54.5 59.1 
J183 Young P90 0.0 8.6 89.5 100.0 100.0 59.0 
J184 Young P90 0.0 48.1 48.1 48.1 40.7 40.7 
J184 Young P90 0.0 62.5 85.4 79.2 83.3 83.3 
J185 Young P90 0.0 31.1 67.6 67.6 62.2 50.0 
J187 Young P90 0.0 17.1 15.2 25.3 21.5 32.9 
J187 Young P90 0.0 20.0 41.7 55.0 55.0 48.3 
J188 Young P90 0.0 -7.7 32.1 46.2 48.7 56.4 
J189 Young P90 0.0 0.0 5.4 16.2 23.0 23.0 
J235 Young P90 0.0 2.6 7.8 7.8 3.9 2.0 
J236 Young P90 0.0 34.5 46.0 46.0 46.0 41.7 
 
Mean 0.0 19.2 39.3 45.4 46.0 42.5 
 
Standard Error 0.0 6.1 8.6 8.2 8.1 6.4 
 
 
Animal Group Start 10
-11
 M 10
-10
 M 10
-9
 M 10
-8
 M 10
-7
 M 
J175 Old P90 0.0 24.5 24.5 27.5 18.6 18.6 
J176 Old P90 0.0 19.7 39.9 46.8 48.6 49.1 
J177 Old P90 0.0 5.9 33.6 39.5 41.2 41.2 
J177 Old P90 0.0 8.0 39.2 39.2 38.4 37.6 
J179 Old P90 0.0 0.0 14.1 39.4 39.4 39.4 
J191 Old P90 0.0 4.3 4.3 13.0 19.6 19.6 
J194 Old P90 0.0 0.0 17.5 70.0 70.0 70.0 
J194 Old P90 0.0 0.0 3.6 3.6 3.6 3.6 
J195 Old P90 0.0 0.0 0.0 6.3 6.3 8.8 
J196 Old P90 0.0 8.7 21.7 28.3 28.3 28.3 
J196 Old P90 0.0 0.0 26.2 52.4 66.7 66.7 
 
Mean 0.0 6.5 20.4 33.3 34.6 34.8 
 
Standard Error 0.0 2.6 4.2 6.1 6.6 6.5 
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Animal Group Start 10
-11
 M 10
-10
 M 10
-9
 M 10
-8
 M 10
-7
 M 
J192 Old P130 0.0 0.0 0.0 0.0 -1.7 -1.7 
J193 Old P130 0.0 0.0 -1.7 -1.7 -1.7 0.0 
J194 Old P130 0.0 3.4 4.1 17.1 24.0 24.7 
J196 Old P130 0.0 0.0 0.0 1.4 -1.4 -1.4 
J198 Old P130 0.0 0.0 0.0 0.0 4.7 4.7 
J199 Old P130 0.0 -6.9 11.5 11.5 8.0 5.7 
 
Mean 0.0 -0.6 2.3 4.7 5.3 5.3 
 
Standard Error 0.0 1.4 2.0 3.1 4.1 4.1 
 
 
Animal Group Start 10
-11
 M 10
-10
 M 10
-9
 M 10
-8
 M 10
-7
 M 
J191 Old P90 + Y27632 0.0 0.0 0.0 0.0 0.7 0.7 
J194 Old P90 + Y27632 0.0 -1.9 -1.9 -1.9 -0.9 -1.9 
J198 Old P90 + Y27632 0.0 0.0 0.0 2.6 2.6 2.6 
J199 Old P90 + Y27632 0.0 0.0 0.0 0.9 0.9 0.9 
J199 Old P90 + Y27632 0.0 -2.2 0.0 0.0 -3.3 -3.3 
 
Mean 0.0 -0.8 -0.4 0.3 0.0 -0.2 
 
Standard Error 0.0 0.5 0.4 0.7 1.0 1.1 
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Chapter IV - Raw Animal and Vessel Characteristics: PE-Induced Constriction 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J182 Young P90 364.0 200.0 29.5 
J182 Young P90 364.0 123.0 80.5 
J183 Young P90 332.0 157.0 51.0 
J184 Young P90 354.0 237.0 60.8 
J184 Young P90 354.0 133.0 78.9 
J185 Young P90 357.0 105.0 61.9 
J187 Young P90 311.0 176.0 65.3 
J187 Young P90 311.0 126.0 53.2 
J188 Young P90 351.0 118.0 64.4 
J189 Young P90 312.0 159.0 78.6 
 
Mean 341.0 153.4 62.4 
 
Standard Error 7.1 13.1 4.9 
 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J175 Old P90 455.0 150.0 33.3 
J176 Old P90 407.0 218.0 59.2 
J177 Old P90 324.0 200.0 57.5 
J177 Old P90 324.0 203.0 36.5 
J179 Old P90 486.0 201.0 65.2 
J191 Old P90 400.0 112.0 52.7 
J196 Old P90 444.0 109.0 56.0 
J196 Old P90 444.0 112.0 61.6 
 
Mean 410.5 163.1 52.7 
 
Standard Error 21.1 16.8 4.1 
 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J193 Old P130 417.0 113.0 30.1 
J194 Old P130 417.0 170.0 51.8 
J196 Old P130 444.0 121.0 33.9 
J198 Old P130 436.0 140.0 37.1 
J199 Old P130 436.0 115.0 30.4 
 
Mean 430.0 131.8 36.7 
 
Standard Error 5.5 10.7 4.0 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J194 Old P90 + Y27632 417.0 100.0 31.0 
J191 Old P90 + Y27632 400.0 144.0 4.2 
J198 Old P90 + Y27632 436.0 115.0 -1.7 
J199 Old P90 + Y27632 436.0 118.0 8.5 
J199 Old P90 + Y27632 436.0 99.0 4.0 
 
Mean 425.0 115.2 9.2 
 
Standard Error 7.3 8.2 5.7 
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Chapter IV - Raw Vasoconstrictor Responses: PE-Induced Constriction 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J182 Young P90 0.0 0.0 0.7 14.2 18.4 24.8 28.4 
J182 Young P90 0.0 0.0 29.2 70.8 87.5 100.0 100.0 
J183 Young P90 0.0 0.0 13.0 100.0 100.0 100.0 100.0 
J184 Young P90 0.0 6.5 57.0 92.5 100.0 100.0 100.0 
J184 Young P90 0.0 14.3 28.6 78.6 82.1 85.7 85.7 
J185 Young P90 0.0 0.0 7.5 45.0 50.0 65.0 70.0 
J187 Young P90 0.0 0.0 6.6 77.0 85.2 85.2 83.6 
J187 Young P90 0.0 0.0 3.4 30.5 61.0 72.9 89.8 
J188 Young P90 0.0 19.0 7.1 35.7 85.7 95.2 97.6 
J189 Young P90 0.0 2.9 50.0 73.5 100.0 100.0 100.0 
 
Mean 0.0 4.3 20.3 61.8 77.0 82.9 85.5 
 
Standard 
Error 0.0 2.2 6.3 9.0 8.4 7.5 7.1 
 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J175 Old P90 0.0 15.0 28.0 45.0 72.0 78.0 83.0 
J176 Old P90 0.0 25.8 30.3 33.7 64.0 73.0 80.9 
J177 Old P90 0.0 5.9 17.6 34.1 45.9 68.2 76.5 
J177 Old P90 0.0 4.7 10.9 14.7 35.7 64.3 69.0 
J179 Old P90 0.0 -1.4 25.7 52.9 67.1 67.1 67.1 
J191 Old P90 0.0 0.0 5.7 11.3 39.6 56.6 50.9 
J196 Old P90 0.0 0.0 4.2 20.8 66.7 79.2 79.2 
J196 Old P90 0.0 0.0 9.3 48.8 72.1 81.4 81.4 
 
Mean 0.0 6.2 16.5 32.7 57.9 71.0 73.5 
 
Standard 
Error 0.0 3.4 3.7 5.6 5.3 3.0 3.8 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J193 Old P130 0.0 12.7 16.5 40.5 78.5 86.1 86.1 
J194 Old P130 0.0 0.0 6.1 23.2 31.7 34.1 36.6 
J196 Old P130 0.0 0.0 0.0 11.3 20.0 37.5 36.3 
J198 Old P130 0.0 0.0 0.0 3.4 15.9 35.2 39.8 
J199 Old P130 0.0 0.0 1.3 5.0 13.8 46.3 46.3 
 
Mean 0.0 2.5 4.8 16.7 32.0 47.8 49.0 
 
Standard 
Error 0.0 2.5 3.1 6.9 12.0 9.8 9.4 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J194 
Old P90 + 
Y27632 0.0 0.0 5.8 4.3 4.3 4.3 1.4 
J191 
Old P90 + 
Y27632 0.0 0.0 0.0 0.0 0.7 2.2 2.9 
J198 
Old P90 + 
Y27632 0.0 1.7 1.7 3.4 4.3 4.3 4.3 
J199 
Old P90 + 
Y27632 0.0 0.9 0.0 3.7 2.8 3.7 3.7 
J199 
Old P90 + 
Y27632 0.0 0.0 0.0 0.0 1.1 3.2 5.3 
 
Mean 0.0 0.5 1.5 2.3 2.6 3.5 3.5 
 
Standard 
Error 0.0 0.3 1.1 0.9 0.8 0.4 0.6 
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APPENDIX D CHAPTER V RAW DATA 
Chapter V - Raw Animal and Vessel Characteristics: ACh-Induced Dilation 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J114 Young P90 292.0 182.0 55.5 
J123 Young P90 367.0 130.0 46.2 
J124 Young P90 355.0 158.0 44.3 
J125 Young P90 357.0 199.0 79.9 
J130 Young P90 355.0 223.0 43.0 
J146 Young P90 368.0 147.0 57.8 
J147 Young P90 394.0 192.0 69.8 
 
Mean 355.4 175.9 56.6 
 
Standard Error 11.8 12.3 5.3 
  
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J67 Old P90 332.0 179.0 64.8 
J115 Old P90 432.0 221.0 69.7 
J117 Old P90 460.0 161.0 57.8 
J118 Old P90 428.0 216.0 66.7 
J120 Old P90 428.0 141.0 28.4 
J126 Old P90 390.0 210.0 52.9 
J127 Old P90 419.0 169.0 49.1 
J129 Old P90 413.0 184.0 59.8 
J131 Old P90 470.0 226.0 53.1 
J141 Old P90 454.0 178.0 53.9 
J143 Old P90 446.0 224.0 54.5 
J145 Old P90 463.0 192.0 70.8 
 
Mean 427.9 191.8 56.8 
 
Standard Error 11.0 8.0 3.3 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J117 Old P130 460.0 204.0 47.5 
J118 Old P130 428.0 193.0 79.8 
J119 Old P130 424.0 204.0 38.7 
J120 Old P130 428.0 182.0 44.5 
J127 Old P130 419.0 133.0 39.1 
J129 Old P130 413.0 146.0 51.4 
J142 Old P130 433.0 227.0 59.5 
J143 Old P130 446.0 159.0 54.1 
J144 Old P130 469.0 196.0 44.4 
J145 Old P130 463.0 186.0 38.7 
 
Mean 438.3 183.0 49.8 
 
Standard Error 6.3 9.2 4.0 
  
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J64 Old HPHSS 425.0 230.0 30.9 
J67 Old HPHSS 332.0 207.0 29.0 
J69 Old HPHSS 370.0 146.0 24.7 
J115 Old HPHSS 432.0 247.0 41.7 
J117 Old HPHSS 460.0 214.0 56.1 
J118 Old HPHSS 428.0 201.0 36.3 
J120 Old HPHSS 428.0 182.0 53.3 
J127 Old HPHSS 419.0 156.0 28.2 
J128 Old HPHSS 443.0 191.0 28.3 
J129 Old HPHSS 413.0 201.0 71.6 
J131 Old HPHSS 470.0 243.0 30.5 
J141 Old HPHSS 454.0 161.0 28.6 
J142 Old HPHSS 433.0 130.0 49.2 
J143 Old HPHSS 446.0 241.0 38.2 
J145 Old HPHSS 463.0 174.0 50.6 
 
Mean 427.7 194.9 39.8 
 
Standard Error 9.3 9.5 3.5 
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Chapter V - Raw Vasodilator Responses: ACh-Induced Dilation 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J114 Young P90 0.0 11.9 56.4 82.2 87.1 87.1 67.3 
J123 Young P90 0.0 0.0 1.7 15.0 23.3 13.3 13.3 
J124 Young P90 0.0 0.0 -24.3 78.6 84.3 90.0 90.0 
J125 Young P90 0.0 45.9 68.6 84.3 86.8 88.1 86.8 
J130 Young P90 0.0 0.0 49.0 82.3 90.6 92.7 92.7 
J146 Young P90 0.0 0.0 7.1 87.1 92.9 94.1 100.0 
J147 Young P90 0.0 12.7 73.1 74.6 89.6 93.3 93.3 
 
Mean 0.0 10.1 33.1 72.0 79.2 79.8 77.6 
 
Standard 
Error 0.0 6.4 14.3 9.6 9.4 11.1 11.4 
  
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J67 Old P90 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
J115 Old P90 0.0 33.1 62.3 52.6 61.7 58.4 53.2 
J117 Old P90 0.0 4.3 46.2 43.0 58.1 51.6 38.7 
J118 Old P90 0.0 6.3 -2.8 18.1 17.4 18.1 18.1 
J120 Old P90 0.0 15.0 20.0 32.5 37.5 37.5 37.5 
J126 Old P90 0.0 3.6 9.0 9.0 9.0 9.0 9.0 
J127 Old P90 0.0 44.6 59.0 59.0 60.2 49.4 43.4 
J129 Old P90 0.0 14.5 33.6 38.2 38.2 44.5 44.5 
J131 Old P90 0.0 5.0 36.7 51.7 51.7 26.7 26.7 
J141 Old P90 0.0 35.4 43.8 53.1 59.4 63.5 63.5 
J143 Old P90 0.0 4.1 4.1 39.3 39.3 39.3 39.3 
J145 Old P90 0.0 0.0 11.8 55.9 67.6 69.1 69.1 
 
Mean 0.0 13.8 27.0 37.7 38.5 38.9 34.1 
 
Standard 
Error 0.0 4.4 6.6 5.6 7.0 6.3 6.4 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J117 Old P130 0.0 6.2 22.7 22.7 29.9 29.9 40.2 
J118 Old P130 0.0 18.8 53.9 52.6 52.6 50.6 49.4 
J119 Old P130 0.0 17.7 58.2 62.0 62.0 53.2 53.2 
J120 Old P130 0.0 3.7 51.9 59.3 63.0 63.0 63.0 
J127 Old P130 0.0 46.2 57.7 57.7 51.9 51.9 46.2 
J129 Old P130 0.0 5.3 9.3 24.0 30.7 32.0 29.3 
J142 Old P130 0.0 15.6 33.3 44.4 59.3 59.3 59.3 
J143 Old P130 0.0 23.3 55.8 64.0 72.1 72.1 72.1 
J144 Old P130 0.0 0.0 0.0 21.8 24.1 24.1 24.1 
J145 Old P130 0.0 0.0 0.0 31.9 16.7 16.7 50.0 
 
Mean 0.0 13.7 34.3 44.0 46.2 45.3 48.7 
 
Standard 
Error 0.0 4.5 7.1 5.6 5.4 5.2 4.9 
  
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J64 Old HPHSS 0.0 23.9 78.9 78.9 87.3 87.3 87.3 
J67 Old HPHSS 0.0 0.0 30.0 38.3 38.3 38.3 63.3 
J69 Old HPHSS 0.0 0.0 0.0 2.8 8.3 8.3 8.3 
J115 Old HPHSS 0.0 46.6 82.5 90.3 90.3 90.3 97.1 
J117 Old HPHSS 0.0 0.0 0.0 0.0 33.3 39.2 39.2 
J118 Old HPHSS 0.0 0.0 0.0 19.2 19.2 31.5 34.2 
J120 Old HPHSS 0.0 6.2 42.3 42.3 38.1 40.2 60.8 
J127 Old HPHSS 0.0 50.0 56.8 72.7 75.0 75.0 75.0 
J128 Old HPHSS 0.0 0.0 0.0 18.5 40.7 48.1 37.0 
J129 Old HPHSS 0.0 23.6 35.4 35.4 42.4 42.4 41.0 
J131 Old HPHSS 0.0 0.0 39.2 17.6 64.9 64.9 64.9 
J141 Old HPHSS 0.0 6.5 6.5 19.6 34.8 34.8 34.8 
J142 Old HPHSS 0.0 0.0 29.7 51.6 53.1 60.9 60.9 
J143 Old HPHSS 0.0 8.7 71.7 93.5 96.7 100.0 100.0 
J145 Old HPHSS 0.0 14.8 36.4 39.8 43.2 52.3 54.5 
 
Mean 0.0 12.0 34.0 41.4 51.0 54.2 57.2 
 
Standard 
Error 0.0 4.4 7.5 7.8 6.8 6.5 6.6 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J219 
Old HPHSS + 
L-NNA 0.0 10.3 17.2 20.7 27.6 27.6 31.0 
J220 
Old HPHSS + 
L-NNA 0.0 0.0 6.3 6.3 6.3 12.7 14.3 
J221 
Old HPHSS + 
L-NNA 0.0 0.0 -4.5 0.0 4.5 4.5 9.1 
J223 
Old HPHSS + 
L-NNA 0.0 1.6 4.1 8.1 9.8 11.4 15.4 
 
Mean 0.0 3.0 5.8 8.8 12.1 14.1 17.5 
 
Standard 
Error 0.0 2.5 4.5 4.3 5.3 4.9 4.7 
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Chapter V - Raw Animal and Vessel Characteristics: Flow-Induced Dilation  
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J114 Young P90 292.0 182.0 48.4 
J123 Young P90 367.0 130.0 66.2 
J124 Young P90 355.0 158.0 40.5 
J130 Young P90 355.0 223.0 74.0 
J147 Young P90 394.0 192.0 52.1 
J148 Young P90 326.0 197.0 66.0 
 
Mean 348.2 180.3 57.8 
 
Standard Error 14.4 13.3 5.2 
  
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J115 Old P90 432 221 47.05882353 
J117 Old P90 460 161 50.31055901 
J118 Old P90 428 216 56.48148148 
J120 Old P90 428 141 31.91489362 
J126 Old P90 390 210 40.47619048 
J129 Old P90 413 184 52.17391304 
J131 Old P90 470 226 47.78761062 
J141 Old P90 454 178 41.01123596 
J143 Old P90 446 224 50 
J145 Old P90 463 192 48.95833333 
 
Mean 438.4 195.3 46.61730411 
 
Standard Error 7.899648375 9.209958378 2.225128678 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J117 Old P130 460.0 204.0 40.2 
J118 Old P130 428.0 193.0 75.6 
J119 Old P130 424.0 204.0 29.4 
J120 Old P130 428.0 182.0 45.6 
J142 Old P130 433.0 227.0 54.2 
J143 Old P130 446.0 159.0 56.6 
J144 Old P130 469.0 196.0 65.3 
J145 Old P130 463.0 186.0 52.2 
 
Mean 443.9 193.9 52.4 
 
Standard Error 6.4 7.0 5.1 
  
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J219 Old HPHSS + L-NNA 411.0 54.0 38.9 
J220 Old HPHSS + L-NNA 426.0 107.0 80.4 
J221 Old HPHSS + L-NNA 417.0 98.0 76.5 
J222 Old HPHSS + L-NNA 402.0 124.0 55.6 
J223 Old HPHSS + L-NNA 423.0 179.0 50.3 
 
Mean 415.8 112.4 60.3 
 
Standard Error 4.3 20.3 7.9 
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Chapter V - Raw Vasodilator Responses: Flow-Induced Dilation 
 
 
Animal Group Start 2cmH2O 4cmH2O 6cmH2O 8cmH2O 10cmH2O 
J114 Young P90 0.0 26.1 37.5 37.5 33.0 33.0 
J123 Young P90 0.0 8.1 8.1 12.8 12.8 12.8 
J124 Young P90 0.0 0.0 10.9 23.4 35.9 40.6 
J130 Young P90 0.0 33.3 58.2 53.3 44.8 44.8 
J147 Young P90 0.0 12.0 24.0 24.0 24.0 25.0 
J148 Young P90 0.0 13.1 17.7 19.2 20.0 20.0 
 
Mean 0.0 15.4 26.1 28.4 28.4 29.4 
 
Standard Error 0.0 5.0 7.7 6.0 4.8 5.0 
 
Animal Group 15cmH2O 20cmH2O 30cmH2O 40cmH2O 
J114 Young P90 26.1 25.0 26.1 30.7 
J123 Young P90 12.8 12.8 12.8 12.8 
J124 Young P90 40.6 40.6 40.6 40.6 
J130 Young P90 50.3 50.3 50.3 50.9 
J147 Young P90 25.0 25.0 24.0 24.0 
J148 Young P90 23.1 25.4 25.4 25.4 
 
Mean 29.7 29.9 29.9 30.7 
 
Standard Error 5.5 5.5 5.5 5.5 
 
Animal Group Start 2cmH2O 4cmH2O 6cmH2O 8cmH2O 10cmH2O 
J115 Old P90 0.0 4.8 4.8 12.5 12.5 17.3 
J117 Old P90 0.0 0.0 3.7 6.2 6.2 8.6 
J118 Old P90 0.0 1.6 4.1 9.8 12.3 23.8 
J120 Old P90 0.0 0.0 0.0 11.1 11.1 4.4 
J126 Old P90 0.0 9.4 16.5 16.5 21.2 21.2 
J129 Old P90 0.0 0.0 0.0 0.0 -2.1 -2.1 
J131 Old P90 0.0 35.2 35.2 33.3 23.1 23.1 
J141 Old P90 0.0 0.0 0.0 13.7 23.3 23.3 
J143 Old P90 0.0 0.0 0.0 0.0 0.0 3.6 
J145 Old P90 0.0 33.0 33.0 33.0 33.0 26.6 
 
Mean 0.0 7.6 8.8 12.1 12.5 12.9 
 
Standard Error 0.0 4.2 4.2 3.8 3.7 3.8 
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Animal Group 15cmH2O 20cmH2O 30cmH2O 40cmH2O 
J115 Old P90 17.3 17.3 17.3 22.1 
J117 Old P90 8.6 8.6 8.6 8.6 
J118 Old P90 23.8 21.3 10.7 10.7 
J120 Old P90 13.3 11.1 17.8 15.6 
J126 Old P90 14.1 14.1 4.7 4.7 
J129 Old P90 -2.1 -2.1 4.2 9.4 
J131 Old P90 9.3 9.3 -10.2 -10.2 
J141 Old P90 23.3 23.3 23.3 23.3 
J143 Old P90 3.6 3.6 3.6 3.6 
J145 Old P90 27.7 27.7 27.7 21.3 
 
Mean 11.9 11.6 9.2 9.2 
 
Standard Error 3.5 3.3 3.7 3.6 
 
Animal Group Start 2cmH2O 4cmH2O 6cmH2O 8cmH2O 10cmH2O 
J117 Old P130 0.0 12.2 26.8 26.8 25.6 25.6 
J118 Old P130 0.0 71.2 44.5 40.4 40.4 39.0 
J119 Old P130 0.0 0.0 11.7 20.0 26.7 30.0 
J120 Old P130 0.0 12.0 19.3 19.3 25.3 25.3 
J142 Old P130 0.0 11.4 15.4 21.1 41.5 56.9 
J143 Old P130 0.0 22.2 26.7 30.0 41.1 41.1 
J144 Old P130 0.0 16.4 30.5 34.4 38.3 38.3 
J145 Old P130 0.0 0.0 -9.3 -9.3 -4.1 5.2 
 
Mean 0.0 13.2 11.5 11.4 13.7 16.1 
 
Standard Error 0.0 7.4 7.8 8.6 11.2 11.6 
 
Animal Group 15cmH2O 20cmH2O 30cmH2O 40cmH2O 
J117 Old P130 17.1 17.1 20.7 20.7 
J118 Old P130 39.0 37.0 37.0 37.0 
J119 Old P130 30.0 30.0 33.3 33.3 
J120 Old P130 25.3 25.3 25.3 25.3 
J142 Old P130 65.0 46.3 46.3 28.5 
J143 Old P130 41.1 43.3 43.3 43.3 
J144 Old P130 40.6 44.5 44.5 44.5 
J145 Old P130 12.4 16.5 16.5 17.5 
 
Mean 16.6 15.5 12.6 14.1 
 
Standard Error 12.2 11.7 15.2 12.0 
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Animal Group Start 2cmH2O 4cmH2O 6cmH2O 8cmH2O 10cmH2O 
J219 
Old HPHSS 
+ L-NNA 0.0 -19.0 -23.8 -23.8 -47.6 -52.4 
J220 
Old HPHSS 
+ L-NNA 0.0 0.0 0.0 1.2 3.5 4.7 
J221 
Old HPHSS 
+ L-NNA 0.0 8.0 8.0 8.0 10.7 13.3 
J222 
Old HPHSS 
+ L-NNA 0.0 -2.9 -4.3 -8.7 -11.6 -11.6 
J223 
Old HPHSS 
+ L-NNA 0.0 -1.1 -4.4 -5.6 -7.8 -10.0 
 
Mean 0.0 -3.0 -4.9 -5.8 -10.6 -11.2 
 
Standard 
Error 0.0 4.4 5.2 5.3 10.1 11.3 
 
Animal Group 15cmH2O 20cmH2O 30cmH2O 40cmH2O 
J219 
Old HPHSS + 
L-NNA -52.4 -61.9 -71.4 -71.4 
J220 
Old HPHSS + 
L-NNA 7.0 9.3 5.8 5.8 
J221 
Old HPHSS + 
L-NNA 16.0 22.7 26.7 28.0 
J222 
Old HPHSS + 
L-NNA -13.0 -8.7 -10.1 -10.1 
J223 
Old HPHSS + 
L-NNA -11.1 -15.6 -18.9 -18.9 
 
Mean -10.7 -10.8 -13.6 -13.3 
 
Standard 
Error 11.8 14.4 16.4 16.6 
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Chapter V - Raw Animal and Vessel Characteristics: SNP-Induced Dilation 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J114 Young P90 292.0 182.0 44.5 
J123 Young P90 367.0 130.0 43.8 
J124 Young P90 355.0 158.0 33.5 
J125 Young P90 357.0 199.0 54.8 
J130 Young P90 355.0 223.0 40.4 
J146 Young P90 368.0 147.0 44.9 
J147 Young P90 394.0 192.0 66.7 
J148 Young P90 326.0 197.0 51.3 
 
Mean 351.8 178.5 47.5 
 
Standard Error 10.2 10.3 3.4 
 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J67 Old P90 332 179 64.80446927 
J115 Old P90 432.0 221.0 47.1 
J117 Old P90 460.0 161.0 47.8 
J118 Old P90 428.0 216.0 62.5 
J120 Old P90 428.0 141.0 30.5 
J127 Old P90 419.0 169.0 52.7 
J129 Old P90 413.0 184.0 34.2 
J131 Old P90 470.0 226.0 42.0 
J141 Old P90 454.0 178.0 35.4 
J143 Old P90 446.0 224.0 31.7 
J145 Old P90 463.0 192.0 31.8 
 
Mean 431.4 190.1 43.7 
 
Standard Error 11.5 8.6 3.7 
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Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J117 Old P130 460.0 204.0 43.1 
J118 Old P130 428.0 193.0 93.8 
J119 Old P130 424.0 204.0 30.9 
J120 Old P130 428.0 182.0 30.8 
J127 Old P130 419.0 133.0 44.4 
J129 Old P130 413.0 146.0 50.7 
J141 Old P130 433.0 227.0 28.6 
J143 Old P130 446.0 159.0 31.4 
J144 Old P130 469.0 196.0 41.3 
J145 Old P130 463.0 186.0 38.7 
 
Mean 438.3 183.0 43.4 
 
Standard Error 6.3 9.2 6.1 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous Tone 
J63 Old HPHSS 381.0 218.0 28.0 
J70 Old HPHSS 324.0 137.0 71.5 
J114 Old HPHSS 292.0 209.0 43.1 
J122 Old HPHSS 341.0 127.0 26.8 
J123 Old HPHSS 367.0 130.0 12.3 
J124 Old HPHSS 355.0 192.0 41.1 
J125 Old HPHSS 357.0 143.0 35.0 
J146 Old HPHSS 368.0 154.0 46.8 
J148 Old HPHSS 326.0 154.0 32.5 
 
Mean 345.7 162.7 37.4 
 
Standard Error 9.3 11.5 5.5 
 
Animal Group 
Body Weight 
(g) 
Maximal Diameter 
(μm) 
% Spontaneous 
Tone 
J219 
Old HPHSS + 
L-NNA 411.0 54.0 33.3 
J220 
Old HPHSS + 
L-NNA 426.0 107.0 62.6 
J221 
Old HPHSS + 
L-NNA 417.0 98.0 41.8 
J223 
Old HPHSS + 
L-NNA 423.0 179.0 69.3 
 
Mean 419.3 109.5 51.8 
 
Standard 
Error 3.3 25.9 8.5 
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Chapter V - Raw Vasodilator Responses: Flow-Induced Dilation 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J114 Young P90 0.0 6.2 9.9 17.3 29.6 48.1 64.2 
J123 Young P90 0.0 0.0 5.3 5.3 14.0 21.1 21.1 
J124 Young P90 0.0 11.3 17.0 17.0 17.0 47.2 75.5 
J125 Young P90 0.0 5.5 9.2 15.6 30.3 43.1 57.8 
J130 Young P90 0.0 22.2 44.4 81.1 92.2 92.2 100.0 
J146 Young P90 0.0 0.0 0.0 0.0 16.7 31.8 48.5 
J147 Young P90 0.0 0.0 12.5 44.5 50.8 67.2 74.2 
J148 Young P90 0.0 0.0 5.9 35.6 41.6 41.6 58.4 
 
Mean 0.0 5.7 13.0 27.1 36.5 49.0 62.5 
 
Standard 
Error 0.0 2.6 4.6 8.8 8.6 7.3 7.6 
 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J67 Old P90 0.0 2.6 6.0 6.0 6.0 6.9 6.9 
J115 Old P90 0.0 14.4 29.8 38.5 45.2 69.2 85.6 
J117 Old P90 0.0 0.0 15.6 32.5 37.7 53.2 64.9 
J118 Old P90 0.0 12.6 20.0 20.0 31.9 37.8 49.6 
J120 Old P90 0.0 20.9 27.9 37.2 60.5 60.5 72.1 
J127 Old P90 0.0 13.5 24.7 30.3 41.6 49.4 67.4 
J129 Old P90 0.0 11.1 11.1 25.4 25.4 30.2 41.3 
J131 Old P90 0.0 0.0 7.4 21.1 32.6 56.8 70.5 
J141 Old P90 0.0 3.2 17.5 36.5 50.8 50.8 68.3 
J143 Old P90 0.0 14.1 14.1 31.0 33.8 39.4 39.4 
J145 Old P90 0.0 13.1 18.0 21.3 39.3 42.6 49.2 
 
Mean 0.0 9.6 17.5 27.3 36.8 45.2 55.9 
 
Standard 
Error 0.0 2.1 2.4 2.9 4.2 5.1 6.5 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J117 Old P130 0.0 13.6 18.2 23.9 29.5 29.5 31.8 
J118 Old P130 0.0 14.4 9.4 16.0 16.0 16.0 16.0 
J119 Old P130 0.0 7.9 17.5 41.3 42.9 54.0 54.0 
J120 Old P130 0.0 12.5 19.6 28.6 39.3 46.4 58.9 
J127 Old P130 0.0 13.6 54.2 37.3 40.7 40.7 62.7 
J129 Old P130 0.0 21.6 37.8 55.4 60.8 78.4 82.4 
J141 Old P130 0.0 12.3 30.8 49.2 60.0 60.0 73.8 
J143 Old P130 0.0 8.0 14.0 18.0 22.0 22.0 32.0 
J144 Old P130 0.0 0.0 7.4 17.3 40.7 50.6 72.8 
J145 Old P130 0.0 0.0 0.0 31.9 16.7 16.7 50.0 
 
Mean 0.0 10.4 20.9 31.9 36.9 41.4 53.5 
 
Standard 
Error 0.0 2.1 5.1 4.4 5.1 6.5 6.7 
 
 
Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J63 Old HPHSS 0.0 0.0 0.0 -11.5 -11.5 -11.5 -4.9 
J70 Old HPHSS 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
J114 Old HPHSS 0.0 15.6 17.8 24.4 24.4 57.8 66.7 
J122 Old HPHSS 0.0 0.0 0.0 0.0 2.9 17.6 17.6 
J123 Old HPHSS 0.0 37.5 50.0 50.0 62.5 62.5 62.5 
J124 Old HPHSS 0.0 7.6 7.6 19.0 24.1 50.6 50.6 
J125 Old HPHSS 0.0 16.0 28.0 46.0 46.0 68.0 80.0 
J146 Old HPHSS 0.0 4.2 26.4 31.9 31.9 31.9 65.3 
J148 Old HPHSS 0.0 0.0 0.0 18.0 34.0 34.0 38.0 
 
Mean 0.0 9.0 14.4 19.8 23.8 34.6 41.8 
 
Standard 
Error 0.0 4.2 5.9 7.0 7.8 9.4 10.3 
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Animal Group Start 10
-9
 M 10
-8
 M 10
-7
 M 10
-6
 M 10
-5
 M 10
-4
 M 
J219 
Old HPHSS + 
L-NNA 0.0 22.2 50.0 72.2 88.9 94.4 100.0 
J220 
Old HPHSS + 
L-NNA 0.0 29.9 59.7 74.6 82.1 89.6 94.0 
J221 
Old HPHSS + 
L-NNA 0.0 12.2 31.7 53.7 65.9 82.9 90.2 
J223 
Old HPHSS + 
L-NNA 0.0 8.9 25.8 30.6 37.9 41.1 67.7 
 
Mean 0.0 18.3 41.8 57.8 68.7 77.0 88.0 
 
Standard 
Error 0.0 4.8 7.9 10.2 11.3 12.2 7.0 
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Chapter V – Raw Immunoblot Data 
 
Vessel 
Number Group p-eNOS (AU) 
GAPDH 
(AU) 
eNOS 
(AU) 
p-eNOS/eNOS 
(AU) 
23 Young P90 7049423 3541279 8612774 0.818484614 
28 Young P90 6035031 2582973 4693192 1.285911806 
15 Young P90 
 
2578274 6078506 
 22 Young P130 10563665 6105513 6982380 1.512903193 
27 Young P130 8290191 2005734 7207833 1.150164134 
17 Young P130 
 
3774056 4897565 
 21 Young HPHSS 10082046 2670927 5877678 1.715311046 
24 Young HPHSS 5534233 3686680 5564259 0.994603774 
16 Young HPHSS 
 
3068108 4478580 
 12 Old P90 14998157 3447798 12720134 1.179087972 
13 Old P90 4580879 2094186 3637923 1.259201748 
8 Old P90 
 
4226605 6441522 
 7 Old P130 4877122 1445052 2166950 2.250685064 
14 Old P130 15680721 1996756 8458625 1.85381442 
9 Old P130 6662436 16712135 10107164 0.659179568 
5 Old HPHSS 6786598 1515446 1683500 4.031243243 
6 Old HPHSS 11658465 1480357 4721402 2.469280311 
3 Old HPHSS 7242649 3680499 7878838 0.919253448 
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Vessel 
Number Group 
eNOS/GAPDH 
(AU) 
p-eNOS/GAPDH 
(AU) 
peNOS/eNOS 
Normalized to 
Young P90 (AU)  
23 Young P90 2.432108286 1.990643211 0.777880637 
28 Young P90 1.816972922 2.336466932 1.222119363 
15 Young P90 2.357587285 
  22 Young P130 1.14361889 1.730184671 1.437849998 
27 Young P130 3.59361361 4.133245485 1.09310596 
17 Young P130 1.297692721 
  21 Young HPHSS 2.200613495 3.774736636 1.630216655 
24 Young HPHSS 1.509287218 1.501142763 0.94526275 
16 Young HPHSS 1.459720453 
  12 Old P90 3.68935013 4.350068362 1.120594923 
13 Old P90 1.73715372 2.187427 1.196734357 
8 Old P90 1.524041636 
  7 Old P130 1.499565414 3.375049479 2.139031452 
14 Old P130 4.23618359 7.853098225 1.761849054 
9 Old P130 0.60477994 0.39865858 0.626478511 
5 Old HPHSS 1.110894087 4.478284281 3.831258413 
6 Old HPHSS 3.189367159 7.875441532 2.346782468 
3 Old HPHSS 2.140698313 1.967844306 0.873650458 
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Vessel 
Number Group 
eNOS/GAPDH 
Normalized to Young 
P90 (AU) 
P-eNOS/GAPDH 
Normalized to Young 
P90 (AU) 
23 Young P90 1.104387917 0.920079751 
28 Young P90 0.825063157 1.079920249 
15 Young P90 1.070548925 
 22 Young P130 0.519302077 0.79969523 
27 Young P130 1.631811985 1.910395321 
17 Young P130 0.589264948 
 21 Young HPHSS 0.999269222 1.744691728 
24 Young HPHSS 0.685347185 0.693831547 
16 Young HPHSS 0.662839578 
 12 Old P90 1.675284661 2.010611341 
13 Old P90 0.788818323 1.011033659 
8 Old P90 0.692046969 
 7 Old P130 0.680932643 1.559955429 
14 Old P130 1.923594438 3.629719589 
9 Old P130 0.2746225 0.184260888 
5 Old HPHSS 0.50444218 2.069873025 
6 Old HPHSS 1.448249066 3.640046716 
3 Old HPHSS 0.972062537 0.909542046 
 
 
eNOS/GAPDH                                 
Normalized to Young P90 Mean SE 
Young P90 1 0.088012203 
Young P130 0.91345967 0.359743537 
Young HPHSS 0.782485328 0.10858651 
Old P90 1.052049984 0.312866995 
Old P130 0.959716527 0.496006537 
Old HPHSS 0.974917928 0.272457321 
  
 
p-eNOS/GAPDH           
Normalized to Young P90 Mean SE 
Young P90 1 0.079920249 
Young P130 1.355045276 0.555350045 
Young HPHSS 1.219261638 0.52543009 
Old P90 1.5108225 0.499788841 
Old P130 1.791311969 1.001322592 
Old HPHSS 2.206487262 0.79118298 
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p-eNOS/eNOS                                  
Normalized to Young P90 Mean SE 
Young P90 1 0.222119363 
Young P130 1.265477979 0.172372019 
Young HPHSS 1.287739703 0.342476952 
Old P90 1.15866464 0.038069717 
Old P130 1.509119672 0.454554069 
Old HPHSS 2.35056378 0.853789968 
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